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Abstract
Cognitive–behavioural therapy-based intervention to reduce
fear of falling in older people: therapy development and
randomised controlled trial – the Strategies for Increasing
Independence, Confidence and Energy (STRIDE) study
Steve W Parry,1* Claire Bamford,2 Vincent Deary,3 Tracy L Finch,2
Jo Gray,4 Claire MacDonald,5 Peter McMeekin,4 Neil J Sabin,6
I Nick Steen,2 Sue L Whitney7 and Elaine M McColl2,5
1Institute of Cellular Medicine, Newcastle University, c/o Falls and Syncope Service, Royal Victoria
Infirmary, Newcastle upon Tyne, UK
2Institute of Health and Society, Newcastle University, Newcastle upon Tyne, UK
3Department of Health Psychology, Northumbria University, Newcastle upon Tyne, UK
4Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK
5Clinical Trials Unit, Newcastle University, Newcastle upon Tyne, UK
6Department of Clinical Psychology, Newcastle Tyne and Wear NHS Foundation Trust, Newcastle
upon Tyne, UK
7Department of Otolaryngology, Pittsburgh University, Philadelphia, PA, USA
*Corresponding author swparry@hotmail.com; steve.parry@nuth.nhs.uk
Background: Falls cause fear, anxiety and loss of confidence, resulting in activity avoidance, social
isolation and increasing frailty. The umbrella term for these problems is ‘fear of falling’, seen in up to 85%
of older adults who fall. Evidence of effectiveness of physical and psychological interventions is limited,
with no previous studies examining the role of an individually delivered cognitive–behavioural therapy
(CBT) approach.
Objectives: Primary objective To develop and then determine the effectiveness of a new CBT intervention
(CBTi) delivered by health-care assistants (HCAs) plus usual care compared with usual care alone in
reducing fear of falling. Secondary objectives To measure the impact of the intervention on falls, injuries,
functional abilities, anxiety/depression, quality of life, social participation and loneliness; investigate the
acceptability of the intervention for patients, family members and professionals and factors that promote
or inhibit its implementation; and measure the costs and benefits of the intervention.
Design: Phase I CBTi development. Phase II Parallel-group patient randomised controlled trial (RCT) of the
new CBTi plus usual care compared with usual care alone.
Setting: Multidisciplinary falls services.
Participants: Consecutive community-dwelling older adults, both sexes, aged ≥ 60 years, with excessive or
undue fear of falling per Falls Efficacy Scale–International (FES-I) score of > 23.
Interventions: Phase I Development of the CBTi. The CBTi was developed following patient interviews
and taught to HCAs to maximise the potential for uptake and generalisability to a UK NHS setting. Phase II
RCT. The CBTi was delivered by HCAs weekly for 8 weeks, with a 6-month booster session plus usual care.
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Main outcome measures: These were assessed at baseline, 8 weeks, 6 months and 12 months. Primary
outcome measure Fear of falling measured by change in FES-I scores at 12 months. Secondary outcome
measures These comprised falls, injuries, anxiety/depression [Hospital Anxiety and Depression Scale
(HADS)], quality of life, social participation, loneliness and measures of physical function. There were
process and health-economic evaluations alongside the trial.
Results: Four hundred and fifteen patients were recruited, with 210 patients randomised to CBTi group
and 205 to the control group. There were significant reductions in mean FES-I [–4.02; 95% confidence
interval (CI) –5.95 to –2.1], single-item numerical fear of falling scale (–1.42; 95% CI –1.87 to 1.07) and
HADS (–1; 95% CI –1.6 to –0.3) scores at 12 months in the CBTi group compared with the usual care
group. There were no differences in the other secondary outcome measures. Most patients found the CBTi
acceptable. Factors affecting the delivery of the CBTi as part of routine practice were identified. There was
no evidence that the intervention was cost-effective.
Conclusions: Our new CBTi delivered by HCAs significantly improved fear of falling and depression scores
in older adults who were attending falls services. There was no impact on other measures.
Further work: Further work should focus on a joint CBTi and physical training approach to fear of
falling, more rational targeting of CBTi, the possibility of mixed group and individual CBTi, and the
cost-effectiveness of provision of CBTi by non-specialists.
Trial registration: Current Controlled Trials ISRCTN78396615.
Funding: This project was funded by the NIHR Health Technology Assessment programme and will be
published in full in Health Technology Assessment; Vol. 20, No. 56. See the NIHR Journals Library website
for further project information.
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Plain English summary
‘Fear of falling’ refers to some of the psychological and social difficulties faced by older people withfalls. The problem is common, affecting up to 85% of older people who fall. There is little good
evidence to guide us on how to treat fear of falling, but some research suggests that talking treatments
used for depression and anxiety, in particular cognitive–behavioural therapy (CBT), may be helpful.
We developed a new CBT intervention (CBTi) to try and help older people with this problem, and then
compared the new intervention with care as usual in patients with fear of falling. To try and make this
more affordable for the UK NHS, we trained health-care assistants to deliver it. We examined whether or
not the new intervention could improve falls, injuries, quality of life, depression, loneliness and physical
abilities. We also looked at how acceptable this intervention was to those having the treatment and to
those delivering it, and whether or not it provided value for money.
Fear of falling reduced significantly for those having CBTi, as did depression scores. There was no change
in any of the other things that we measured. Although our new intervention was acceptable to older
people, there was no evidence that the new intervention was cost-effective. Our new intervention reduces
fear of falling in older people and may help improve depression but not other measures. Future research
should focus on whether or not such an intervention, delivered with physical training, helps improve fear
of falling further.
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Scientific summary
Background
Adverse consequences of falls are by no means limited to physical injury. Many older individuals, both
fallers and non-fallers, suffer from a variety of adverse psychosocial difficulties related to falling including
fear, anxiety, loss of confidence and impaired self-efficacy (in this context the self-perception of ability to
walk safely without falling) resulting in activity avoidance, social isolation and increasing frailty. The
umbrella term for these problems is ‘fear of falling’, a common and disabling problem in older individuals,
found in around 50% of community-dwelling elders who fall, and up to 50% of those who have
never fallen.
Current understanding of its management is limited. There is a small evidence base to support the use
of some physical therapies to improve the syndrome, and promising early data from a few studies
supporting the use of psychological therapies, in particular cognitive–behavioural therapy (CBT). The
cognitive–behavioural quintet of a situation or practical problem (falls, declining mobility, social isolation),
altered thinking and emotion, altered physical symptoms with behavioural change, and activity reduction
and avoidance is paradigmatic for fear of falling, and offers the hope of a viable therapeutic option.
Previous studies are hampered by poor documentation of power calculations, high dropout rates from
intervention groups, group rather than individual therapy, lack of recording of quality-of-life measures and
the absence of health-economic analysis.
There is a need for many more trained cognitive–behavioural therapists than are currently available;
the development of a cognitive therapeutic package for the management of fear of falling that can be
delivered routinely by non-specialist staff, such as health-care assistants (HCAs), is vital if this common
condition is to be tackled effectively. CBT can be delivered by suitably trained non-psychotherapist staff,
but to our knowledge this approach has not yet been attempted with HCAs.
It is important to collect longitudinal ethnographic data that help us to understand the social processes
and relationships that lead any such intervention and trial to take a particular shape and direction.
May and Finch (May C, Finch T. Implementing, embedding, and integrating practices: an outline of
normalization process theory. Sociology 2009;43:535–54) previously developed a robust explanatory model
of normalisation processes that defines psychological and sociological mechanisms of behaviour and
action, which are important in the implementation of complex interventions. This approach is vital for the
understanding and more widespread adoption of such an intervention and is a key component of our
study. Our aim was to develop a novel CBT intervention (CBTi; Phase I) and then conduct a randomised
controlled trial (RCT) of the individually tailored CBTi delivered by HCAs compared with control subjects to
test its effectiveness in community-dwelling elders with fear of falling attending falls services (Phase II).
Objectives
Primary objectives
In Phase I, our objective was to develop a new CBTi for delivery by HCAs, aimed at reducing fear of falling
in community-dwelling older adults who were attending falls services. In Phase II, our objective was to
determine the effectiveness of the CBTi plus usual care compared with usual care alone in reducing fear of
falling in community-dwelling older adults who were attending falls services.
DOI: 10.3310/hta20560 HEALTH TECHNOLOGY ASSESSMENT 2016 VOL. 20 NO. 56
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Parry et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
xxix
Secondary objectives
Our secondary objectives were to:
(a) measure the impact of the intervention compared with control on fall and injury rates in the trial
participants, and its impact on functional abilities
(b) measure the effectiveness of the intervention compared with control on anxiety and depression,
quality of life, loneliness, social isolation and social participation
(c) investigate the acceptability of the intervention for patients, family members and professionals
(d) investigate further the professional and organisational factors that promote or inhibit the
implementation and integration of the intervention
(e) measure the costs and outcomes of the intervention in this setting.
Methods
Phase I: cognitive–behavioural therapy intervention development
The development of the CBTi followed established principles in CBT but required in-depth exploration of
the issues relevant to the client population and the development of a training approach that would equip
non-specialist HCAs to deliver the CBTi to trial participants. The initial assessment interviews conducted to
inform the intervention development opened up and challenged notions of the concept of ‘fear of falling’,
uncovering both its heterogeneity (diversity of views and experiences) and complexity (in terms of
associations between falls, appraisals of these, and related behaviours). In developing the intervention it
was necessary to acknowledge and accommodate the importance of the network of comorbid physical
complaints, interpersonal relationships and/or social isolation revealed as central to fear of falling. This was
addressed by introducing individualised formulations, which added to the complexity of the intervention
and created uncertainty over the feasibility of successful delivery of the CBTi by relatively inexperienced
HCAs. To deliver the CBTi, HCAs needed to learn complex new skills. Although the training was generally
felt to be adequate by the psychologists and the HCAs, further adaptation for a non-specialist audience is
recommended. The HCAs’ ability to embed and develop their CBTi skills was facilitated by individual and
group supervision sessions and the HCAs’ self-initiated peer support sessions.
Phase II: randomised controlled trial of cognitive–behavioural therapy
intervention compared with usual care
Our study was a two-arm, parallel-group patient RCT of the novel CBTi plus usual multidisciplinary care
compared with usual multidisciplinary care alone in community-dwelling older patients, who had a
significant fear of falling and were attending multidisciplinary falls services. Significant fear of falling was
defined by a Falls Efficacy Scale–International version (FES-I) score of > 23, with the main exclusions being
cognitive impairment and need for alternative psychological treatment. The CBTi was delivered by three
HCAs, with ongoing training, supervision and quality control from the supervising psychologists who
developed the intervention. Individual 1-hour sessions were delivered almost exclusively in patients’ homes
for 8 weeks, with a top-up session at 6 months.
The study began as a single site study but, owing to recruitment difficulties, two further sites in our region
were added, and, in addition, our power calculation was changed to reflect 80% power. A computer-
generated blocked allocation was used to allocate patients in a 1 : 1 ratio to intervention and control
groups. Randomisation was stratified by site, patient gender, baseline score on a numeric rating scale for
pain when walking (0 vs. 1–10) and whether or not the patient had been referred for strength and
balance training. The impact of missing data was assessed using an approach based on multiple
imputation to impute missing values for the FES-I score at each of the follow-up time points, in those cases
when the instrument was not completed at all or could not be scored. A further ‘as treated’ analysis took
into account the number of CBTi sessions completed by each participant.
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The primary outcome measure was change in fear of falling as assessed by the FES-I at 12 months.
Secondary outcomes comprised falls, injuries, anxiety and depression [as measured by the Hospital Anxiety
and Depression Scale (HADS)], quality of life, social participation and isolation measures and effects on
physical function. The process evaluation began at study commencement and continued throughout the
study and we also measured the costs and outcomes of the intervention in this setting.
Results of the randomised controlled trial
Four hundred and fifteen participants were recruited to the study, with 210 randomised to the CBTi and
205 to usual care groups. The groups were well matched in all respects at baseline, with mean FES-I scores
of 40 in both groups. There was a significant difference between study arms in the primary outcome
measure, with the estimated impact of the CBTi on FES-I scores at 12 months being a reduction in mean
score of 4.02 [95% confidence interval (CI) 2.10 to 5.95].
The baseline standard deviation (SD) of FES-I was 9.37. The reduction in mean score of 4.02 can be expressed
as a standardised effect size by dividing by this SD, yielding a point estimate of effect size of 0.43 and an
interval estimate of between 0.22 and 0.64. Using a number of assumptions, the ‘as treated’ analysis estimated
a mean reduction in FES-I scores of between 3.54 and 4.4. In addition, the single-item numerical fear of falling
scale score fell significantly by –1.42 points (95% CI –1.87 to 1.07). There was a significant reduction in the
HADS Depression score (–1; 95% CI –1.6 to –0.3) at 12 months in the CBTi group, but there were no
differences in the other secondary outcome measures. There was no evidence that the CBTi was cost-effective.
The process evaluation found that the HCAs’ delivery of the CBTi was evaluated positively by the
psychologists, although some skills could be further developed. The delivery of the CBTi was shaped over
time by the HCAs’ growing experience of the client group, the complexity of fear of falling, and the
tendency to revert to existing skill sets. The value of the CBTi for older people attending their falls services
was recognised by some professional staff who were providing usual care. Participant engagement with,
and understandings of, the CBTi varied, although participants valued their interactions with the HCAs and
perceived a range of benefits from the CBTi including confidence and independence. The organisation
and delivery of the CBTi in terms of the materials, session content, frequency and duration was generally
acceptable to participants, although more flexibility over the follow-up session was suggested. There was a
strong preference for delivery in the participant’s home.
Discussion
Our novel CBTi delivered by HCAs, in addition to usual care in community-dwelling elders attending falls
services, resulted in a significant reduction in fear of falling, as measured by the FES-I, compared with
those receiving usual care alone. Similar improvements in FES-I scores were seen at 8 weeks and 6 months
as at 12 months, despite the absence of intervention for the final 6 months of follow-up, and our study
was powered on the basis of a 4-point reduction in FES-I scores. Although there are no definitions of
minimal clinically significant changes in FES-I, or any other fear of falling measure, our FES-I effect size
is among the highest reported, with recent randomised studies on interventions in fear of falling using the
FES-I reporting significant decreases in scores ranging from 0.53 to 3.7.
There were significant improvements in HADS Depression scores in the CBTi group, an important finding
given the high incidence of depression in older people, in particular those with fear of falling. There were
no differences in social participation, loneliness, quality of life or physical function on a variety of measures;
the fact that this client group suffers a multitude of comorbid psychological and physical difficulties that
could not be addressed by the CBTi may explain the lack of responsiveness of these measures. There were
no significant harms associated with the CBTi, with lower fall and fracture rates in the intervention group,
although these were not statistically significant.
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This study uncovered the extent to which older people’s lives are curtailed by medical and psychosocial
events. Although very few of these participants would have considered, or been eligible, for help from
existing psychological services, their physical and psychosocial difficulties were marked. One of the key
components of the STRIDE study was the delivery of the CBTi by HCAs, and this showed both the
feasibility and effectiveness of using non-specialist staff with brief training to address these unmet needs.
The fact that they were able to significantly reduce fear of falling indicates the potential for the UK NHS to
address the comorbid needs of older adults without investing heavily in trained CBT therapists and clinical
psychologists. This is not to underestimate the complexity involved in meeting these needs and we would
emphasise the importance of recruitment, training and supervision of HCAs in any attempt to translate our
findings into routine clinical practice.
Implications for health care
l We can be confident in concluding that our novel CBTi reduces fear of falling (as measured both
by the FES-I and 11-point fear of falling rating scale) in community-dwelling older adults attending falls
services. There is also evidence that the intervention reduced depression in such individuals. The fact
that the intervention was successfully delivered by HCA-grade staff has important implications for its
adoption into routine practice.
l When CBTi is integrated into existing services, it is important to ensure that the intervention is aligned
with existing practices, as there is a potential for conflicting messages that can confuse patients and
potentially confound the effects of the intervention. Public and patient involvement-based ‘scripts’ for
introducing the CBTi to patients with fear of falling is important, as our process evaluation work
showed clearly that clients conceptualise the intervention in various ways, which are highly dependent
on how it is presented to them. This, in turn, profoundly influences engagement with the CBTi and the
internalisation of its principles and techniques.
l Although our study did not set out to demonstrate which subset of individuals with fear of falling
would benefit most from the intervention, it was clear that those with the lowest FES-I scores and
those who least considered themselves to suffer from fear of falling were most likely to drop out of the
study. This may have resource and clinical implications for targeting of patients for the CBTi.
Recommendations for research
l Our work shows clearly the heterogeneous nature of fear of falling and the importance of physical
factors in its genesis and promotion. There are some small studies examining the role of a joint CBT
and physical training approach in managing fear of falling, but these need to become larger scale,
appropriately powered RCTs using findings such as ours to inform power calculations.
l Research into targeting of CBTi in older people with fear of falling will aid more rational use of scarce
health service resources. As we discussed above, there is some evidence from our study of differential
uptake and completion of CBTi but these factors need to be more explicitly explored.
l Previous studies have examined group CBT for fear of falling, whereas our intervention was individually
based. From both individual effectiveness and resource perspectives it would be useful to trial a mix
of approaches.
l This study highlighted the value of an embedded reflexive component to the design and conduct of
any large trial. The presence of a qualitative component fostered a culture of reflection and open
communication, which enabled the early identification of procedural and interpersonal issues and
facilitated the conduct of the study.
l Stakeholders identified a number of potential service models for the future delivery of CBTi, for
example in primary care and/or in generic CBT teams working into a range of departments in
secondary care. Future research could explore the feasibility and cost-effectiveness of alternative service
provision of CBTi.
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Trial registration
This trial is registered as ISRCTN78396615.
Funding
Funding for this study was provided by the Health Technology Assessment programme of the National
Institute for Health Research.
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Chapter 1 Background
Falls and fear of falling
Falls are common, frequently devastating events in older people, with between 30% and 62% of older
individuals falling per year.1,2 Falls are responsible for considerable morbidity and mortality, with around
10% of falls resulting in fractures.3 The economic costs of falls are considerable; as long ago as 2003, the
cost of falls to the UK economy was estimated at £981M,4 with more recent data showing that 0.07–0.20
of the gross domestic product and 0.85–1.5% of total health-care expenditure in Western economies was
accounted for by falls and their consequences.5 Adverse consequences of falls are by no means limited to
physical injury and escalating levels of dependence. Many older individuals, both fallers and non-fallers,
suffer from a variety of adverse psychosocial difficulties related to falling,6–16 including fear, anxiety, loss of
confidence and impaired self-efficacy (the self-perception of ability to perform within a particular domain
of activities),10,13 resulting in activity avoidance, social isolation and increasing frailty.6–16 The umbrella term
for these problems is ‘fear of falling’, a common and disabling problem in older individuals, found in
between 3% and 85% of community-dwelling elders who fall, and up to 50% of those who have
never fallen.8–10,16
Physical treatments for fear of falling
The optimal management strategy for fear of falling and its adverse physical and psychosocial
consequences is poorly understood. Clinical and laboratory observations show that concerns about falling
have a clear effect on gait patterns in older people. For example, experimental data in older people who
are undergoing gait and balance studies on elevated walkways show disproportionately slow walking
speeds and other dysfunctional gait adjustments17 alongside abnormalities in postural balance compared
with younger subjects.18 These experimental data and the observation of higher rates of falls and physical
frailty in older individuals with fear of falling suggest that physical interventions may help to ameliorate
fear of falling. Much of the research focusing on physical treatments includes home- and community-
based exercise interventions, t’ai chi and multifactorial interventions aimed at reducing fall rates, with fear
of falling reported as a secondary outcome in the majority of these studies.8 A meta-analysis of nine
studies examining t’ai chi in the management of fall prevention, fear of falling, and balance in older adults
concluded that insufficient evidence existed to recommend such an intervention in this context.19,20 A more
recent randomised controlled study in 176 elders, randomised to one of three groups (intensive t’ai chi
with cognitive–behavioural strategies, t’ai chi alone and a usual care control group) showed improvements
in fear of falling as measured by the Falls Efficacy Scale13 (FES) in the cognitive strategies group compared
with the other two groups.21 So, although t’ai chi can help to prevent falls in older adults,22 its role
specifically in the management of fear of falling is less clear.
A previous systematic review found 12 high-quality randomised controlled trials (RCTs) that included fear
of falling among the outcomes that they assessed,8 but only one of these trials was primarily aimed at
reducing fear of falling.23 The interventions were conducted across a variety of settings – home-based
exercise, community t’ai chi and home-based multifactorial interventions – and all improved fear of falling.8
In a subsequent trial, a geriatric outpatient-based multifactorial intervention study found no such benefit.24
More recently, a Cochrane review of exercise (three-dimensional exercise, such as t’ai chi and yoga,
balance training or strength and resistance training) for reducing fear of falling in older people living in the
community found that exercise ‘probably’ reduces fear of falling to a limited extent immediately after
intervention, with inadequate evidence of an effect in the longer term.25 The authors called for further
evidence, with priority being given to the establishment of core outcomes, including fear of falling, in all
trials of exercise intervention in community-dwelling elders.25
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Psychological treatments for fear of falling
Although such physical interventions may be of benefit in selected populations, the profile of the disorder and
its psychosocial complications suggest that well-designed psychological interventions may help ameliorate
the fear of falling more definitively. Several studies have examined an explicitly cognitive–behavioural
therapeutic approach in fear of falling in community-dwelling elders, or used cognitive–behavioural therapy
(CBT) techniques as part of a wider multifactorial intervention strategy. CBT is an evidence-based form of
therapeutic intervention, which seeks to alter difficult emotional and physical states by altering the
behaviours and cognitions that maintain them. As used in the CBT interventions for fear of falling studies
described below, fear of falling is usually conceptualised as an anxiety disorder maintained by negative
reinforcement (avoidance behaviour) and fearful cognitions. Tennstedt et al.’s26 Matter of Balance study
assessed the ability of an eight-session, 4-week group cognitive–behavioural approach with exercise
instruction to improve fear of falling and related activity restriction. A total of 434 community-dwelling
elders aged ≥ 60 years were randomised to intervention and control groups, with significant differences
seen in fear of falling as measured by the FES13 and activity during follow-up. The magnitude of
improvement in FES scores attenuated over time, prompting the authors to suggest that a booster session
should be used in future studies and in clinical practice.26 Clemson et al.27 similarly used what they described
as a ‘small-group learning environment’ (although, in practice, some of the methods used included
cognitive–behavioural techniques) of 12 individuals per group for 2 hours per session over 7 weeks to
improve self-efficacy and reduce falls.27 The intervention incorporated a variety of learning strategies to
facilitate behaviour change, including education regarding exercises to reduce falls risks, medication and
home environmental review, and medication management.27 There was a 31% reduction in the number of
falls [relative risk 0.69, 95% confidence interval (CI) 0.50 to 0.96; p= 0.025] in the intervention group,
although, interestingly, there was no corresponding change in FES scores.27
More recently, Zijlstra et al.28 conducted a RCT of a multicomponent cognitive–behavioural group
intervention in older community-dwelling elders. Five hundred and forty participants were drawn from a
random sample of 7431 individuals sent questionnaires who reported ‘at least some fear of falling’,
although the method of assessment was not specified. Following randomisation, the intervention group
underwent a structured 2-hour group CBT intervention (CBTi), based on the investigators’ previous work,
once weekly for 8 weeks, with a booster session 6 months following the last session. A primary outcome
was not specified and, although a power calculation was supplied based on a difference of 2.5 points,
the authors fail to specify on which scale. The beginning of the trial predates widespread use of the
FES–International version (FES-I)29 (advocated by the same group as the most appropriate measure for such
studies),8 instead using a single-item question on fear of falling as well as an unspecified scale, probably
the original FES from the description and reference supplied.28 Other outcomes included perceived control
over falling and daily activity as well as falls. There were no measures of physical function despite the prior
evidence base suggesting improvement in fear of falling with the exercise-related interventions as
described above. All outcomes showed significant differences between control and intervention groups at
2 and 8 months’ follow-up, with between-group differences persisting at 14 months in fear of falling and
perceived control over falling, but not in the other outcome measures. There was a 30% attrition rate in the
intervention group and 19.6% attrition rate in the control group.28 The study intervention was carefully
developed and grounded in cognitive–behavioural theory, but interpretation of findings is hampered
considerably by the lack of clarity on sample size calculation and outcome measures, and the absence of
generic quality-of-life measures and measures of physical functioning. The same research group later
reported a before-and-after design study20 implementing a similar protocol into routine health care in
125 community-living older people, with significant improvements in concerns about falling.
The relative effectiveness of group-based psychological interventions thus remains uncertain. A theoretical
re-examination of models of fear of falling and a recent cohort study of 500 older adults both suggest that
the fear of falling population is a complex and heterogeneous one, in which psychosocial and physiological
interventions also need to be individualised.30,31 This suggests that individually based interventions may be
more appropriate but, to date, trials have examined only group-level interventions.
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What kind of intervention could be implemented in the
UK NHS?
Fear of falling is a common, disabling and debilitating condition in older adults, but the current understanding
of its management is limited. There is a small evidence base to support the use of some physical therapies to
improve the syndrome, and promising early data from a few studies supporting the use of psychological
therapies, in particular CBT. The cognitive–behavioural quintet32 of a situation or practical problem (falls,
declining mobility, social isolation), altered thinking and emotion, altered physical symptoms with behavioural
change, and activity reduction and avoidance is paradigmatic for fear of falling, and offers the hope of a
viable therapeutic option. Previous studies are hampered by the factors already described, whereas the issue
of the economic viability of such a treatment has yet to be explored. There is a need for many more trained
cognitive–behavioural therapists than are currently available; the development of a cognitive therapeutic
package for the management of fear of falling that can be delivered routinely by non-specialist staff such as
health-care assistants (HCAs) is vital if this common and debilitating condition is to be tackled effectively. CBT
can be delivered by suitably trained non-psychotherapist staff33,34 but, to our knowledge, this approach has
not been attempted in a randomised controlled study in the context of fear of falling. In addition, only group
interventions have been studied so far, with therapy delivered on a one-to-one basis yet to be tested in a fear
of falling cognitive–behavioural intervention study despite suggestive evidence that this approach may prove
more fruitful.
Any new treatment for potential implementation in the NHS needs to have clinical efficacy, but also
needs to be able to be embedded into routine clinical practice. Understanding the dynamics of developing,
delivering and trialling a novel cognitive–behavioural intervention by non-specialist staff as a process
is useful because it will contribute to understanding the professional and organisational factors that
promote or inhibit adherence to treatment protocols and intervention delivery, and how practical and
methodological problems are defined, understood and resolved by the project team in the course of the
study. The need for understanding the dynamics of complex interventions35 and undertaking process
evaluation is now well understood.36,37 Such work is important to underpin the transportability, workability
and integration of interventions into routine clinical practice. In the case of this trial, our aim was to collect
longitudinal ethnographic data that would help us to understand the social processes and relationships
that lead the intervention and trial to take a particular shape and direction. In earlier studies of trials and
other interventions, May and Finch38 developed a robust explanatory model of normalisation processes,
which defines psychological and sociological mechanisms of behaviour and action that have been
empirically demonstrated to be important in the implementation of complex interventions, and that have
been revealed by evaluation in randomised controlled clinical trials. This approach is vital for the
understanding and more widespread adoption of any cognitive–behavioural intervention in fear of falling.
Aims
Our aims were to develop a cognitive behaviour-based intervention to be delivered by HCAs on a one-to-one
basis to community-dwelling older individuals attending falls services with an excessive or undue fear of
falling and then to conduct a pragmatic, patient RCT of this intervention plus usual multidisciplinary care
compared with usual multidisciplinary care alone, with integrated health-economic and process evaluations.
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Chapter 2 Phase I: intervention development
This chapter reports the development of the CBTi for fear of falling, and the initial process evaluationwork that was undertaken to inform the organisation and delivery of the CBTi in preparation for
the RCT.
Developing the intervention
The aim of the development work was to develop a CBTi that could be delivered by HCAs (non-specialist,
relatively low-paid staff) after training in basic CBT skills. The cognitive–behavioural model32 underpinning
the intervention distinguishes between predisposing factors (what made a person vulnerable to a problem),
precipitating factors (what triggered the current problem) and perpetuating factors (what is currently
maintaining it). The model further distinguishes between physical, emotional, cognitive, behavioural
and social factors in each domain. To develop the CBTi appropriately for the client group, assessment
interviews with patients with fear of falling were undertaken. The intervention development process also
included the preparation of supporting materials (‘manuals’).
Although existing literature on fear of falling indicated some of the likely intervention points, to further
refine our intervention we chose to interview people who were affected by the problem. This work
took the cognitive–behavioural assessment structure as its starting point, and followed on successful
intervention development work that some of our team had previously undertaken in intervention
development in other areas, such as medically unexplained symptoms.34,39
Methods of intervention development
To develop the intervention, we conducted semistructured functional assessment interviews with
15 patients who had significant fear of falling. This number was determined by our previous research in
developing psychosocial interventions. These interviews took the form of a standard cognitive–behavioural
clinical assessment interview, used to elicit the predisposing, precipitating and perpetuating factors of
participants’ problems, be they anxiety or depression (see Interview format). The model makes no
assumptions about the content of any of its a priori domains; rather it assumes that there will be an
interaction of physiological, cognitive, emotional, behavioural and social factors, which will be implicated,
in some way, in the onset and maintenance of any given problem. It is the goal of the interview, then,
to ascertain the unique interplay of factors maintaining the problem for each individual.
The patients were recruited from the North Tyneside Falls Prevention Service. These patients were seen as
part of normal clinical practice by the multidisciplinary team of physicians, HCA and senior physiotherapist,
during which a FES-I29 (see Appendix 1) was administered as routine. The clinical team identified potentially
eligible patients on the basis of their age and FES-I scores (see Inclusion and exclusion criteria for patients).
Inclusion and exclusion criteria for patients
Consecutive patients aged ≥ 60 years of both sexes. Those with significant fear of falling, as defined by a
FES-I score of > 23,40 were eligible for the study. Patients with cognitive impairment [Mini-Mental State
Examination (MMSE) score of < 2441] were excluded from the study, as there is a paucity of data on the
use of fear of falling measures in this patient group, and given the difficulties of conducting CBT
interventions in those with significant cognitive impairment. Regionally, the population under study had a
particularly low proportion of ethnic minorities. Therefore, given the level of communicative nuance
needed for the development of a CBT intervention, we excluded those who did not speak English. To
avoid participant burden, patients recruited to the CBTi development study were excluded from the Phase I
process evaluation work (described later in this chapter) and vice versa.
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Sample size
Fear of falling is one of a range of falls-related psychological concerns,42 with emotional and behavioural
components including anxiety and activity avoidance, respectively.43 In the CBTi development study we
anticipated interviewing between 10 and 12 patients, although up to 30 were allowed for if data
saturation was not reached with fewer numbers. Our rationale for this was that clinically significant anxiety
(which fear of falling to be can be a manifestation of) tends to have a fairly narrow range of maintaining
factors, which, most usually, are catastrophic beliefs and activity avoidance. The psychological construct of
fear of falling as it appeared in the literature suggested that a similar range of maintaining factors was
likely to be in operation in our patient group. We therefore expected that the number of patients needed
to consistently identify such factors to be relatively small. In fact 15 patients were needed as the construct
was more heterogeneous than we anticipated.
Identification, recruitment and consent of participants
The initial approach to patients for the CBTi development study was by a member of staff at the North
Tyneside Falls Prevention Service. The staff member provided a brief oral explanation of the research to
those patients who met age, FES-I score and cognitive impairment eligibility criteria. Those expressing a
preliminary interest were given a Patient Information Sheet (PIS) and an expression of interest (EoI) form
(with stamped addressed return envelope addressed to the University) to take home and discuss with
family and carers as they felt appropriate. There was no further direct study-related contact with the
patients unless they returned the EoI form indicating their willingness to participate in the study. On receipt
of an expression of interest form, a telephone call was made by the interviewer (VD) to discuss
participation. Questions about the process were actively sought, and if patients required further time for
reflection or discussion with family or carers this was encouraged. If patients consented, the interviewer
(VD) contacted them by phone and arranged an appointment for the interview. Written consent was
obtained prior to the commencement of the interview. These were conducted in the patient’s preferred
location, at either at the North Tyneside Falls Prevention Service or, in most cases (14/15 patients), at the
patient’s home.
Interview format
The CBTi development interviews were undertaken by VD, a qualified cognitive–behavioural therapist and
practitioner health psychologist. The main form of data collection was notes taken by the interviewer as
the interview was being conducted, and notes and reflections made in collaboration with the interviewee.
All sessions were also audio-recorded in case there should be any need to clarify points from the notes.
The format was a standard CBT assessment, as used by cognitive–behavioural therapists and clinical
psychologists. It brings to light which factors are key in having caused the patient’s problem, and which
factors are key in keeping the problem going. The structure is often referred to as the ‘three P’s’: what
factors predisposed the patient to the problem (such as a history of anxiety); what factors precipitated the
current problem (such as a fall or loss of physical capability) and what factors might be perpetuating the
problem in terms of cognitions, behaviours, emotional, physical and social factors. Using this model as a
template, we investigated the relevant factors in the cause and maintenance of the individuals’ fear
of falling.
The interview began with a general open question about the main presenting problem, for example ‘tell
me a bit about your concerns about balance and falls’. It then asked more detailed questions about how
the problem was affected by different situations, times, people, places and events. Then more detail was
sought on what could and could not be done as a result of the problem, and on what made the problem
better or worse. Coping strategies and beliefs were then asked about, as well as any current treatments.
Next the onset and development of the problem was explored, from what was happening in the
interviewee’s life just before they started being concerned about falls, up to the present moment. More
general questions were then posed about the interviewee’s current mood and mental state, and about the
type of person they perceived themselves to be. This was followed by some questions about any past
experiences of emotional or physical problems. Finally, a brief family and social history of family, spouse or
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partner, carers and social contacts was taken, as well as details of previous and current employment
and relationship status as appropriate. The interview ended with the interviewer feeding back to the
interviewee some of the information that might help make sense of their fear of falling problem, and with
a general discussion of what the interviewee thought of as being the important factors in the cause and
management of their problem.
Analysis
The cognitive–behavioural framework (of predisposing, precipitating and perpetuating factors) described
above further distinguishes between physical, emotional, cognitive, behavioural and social factors in each
domain. Finally, it looks for interactions between the perpetuating factors (such as how anxious thoughts
may increase physiological arousal, and vice versa). As a first step of analysis, collected data were sorted
into this framework, then their perpetuating factors were identified, and their possible interaction was
discussed with participants to attempt an individualised formulation of their fear of falling. This analysis
was discussed with them at the end of their interview, and their input was used to develop and refine it.
As a last stage of analysis, the interviews were written up as case formulations for each interviewee
in terms that attempted to model the onset and maintenance of their condition in terms of the
cognitive–behavioural framework. Finally, comparisons were made between individual interviews and a
tally of common factors and themes in different domains were made. Factors, and themes and patterns of
interaction, were analysed to see if there were recurrent themes between interviewees with significant fear
of falling.
Results: understanding fear of falling
The most striking initial finding was how heterogeneous fear of falling was, both in its development and in
its maintaining factors. This is what necessitated running to 15 interviews. After this point it became
clearer that there were three broad types of fear of falling into which the interviewed participants fell,
namely primarily psychological factors, primarily physical factors and ‘the stoics’. To make this clear we will
present the three categories with illustrative examples from participants.
Primarily psychological factors
About one-third of the interviewees conformed to the prevailing picture of fear of falling in the medical
literature whereby fear, often but not always occasioned by a fall, is maintained by avoidance of activity,
leading to loss of confidence, physical weakening and more fear of falling. However even in these cases,
the picture was more complicated than this. Interviewee 1, who we will call Amelia, was the closest to the
picture that we see in the literature. Her problem had begun 4 years prior to the interview when she had
tripped and fallen on her face. Although nothing was broken, she vividly recalled the sense of being out
of control and the ‘concrete coming up to meet my face’ (all quotes are directly from participants).
Subsequent to this she had become very cautious about walking outside. She altered her walking in that
it became much slower and she would almost continually look down. If possible she would ‘link up’,
i.e. link arms, with a family member or a friend and increasingly took to either not going out on her own
or sticking to areas that she knew well. To refer back to the CBT framework, these behaviours were
reinforced and maintained by cognitions. She had come to perceive walking as dangerous, she had the
image of the previous fall often in her mind when walking, and she was very aware of the fact that
she could no longer ‘stride out’ as she used to (it was Amelia’s story that inspired the name of the
intervention). These cognitions and behaviours in turn affected her mood. She was generally anxious when
walking, and her mood was low (though she was not depressed) because her life contained much less
enjoyment than previously. Her inability to ‘stride out’ and her lack of independence in turn generated a
fair amount of frustration about her loss of ability. Physically, she reported being largely OK, but more tired
than previously, and specifically mentioned that this type of walking (cautious and slow) was more tiring
than how she used to walk, and also much less enjoyable.
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As such it was clear from this interview that in Amelia’s case, there was a traumatic precipitating event,
although with no obvious predisposing factors. This was the case with most participants, where there was
no past history of anxiety disorders. Furthermore, there was a clear interaction of physical, affective, cognitive
and behavioural factors that were further reinforced by social isolation (she lived on her own). In CBT
literature, the interaction of factors is often presented to the client in the form of a ‘hot cross bun’:44
Amelia’s hot cross bun is presented in Figure 1.
Thus, it was clear that Amelia’s fear of falling was maintained by safety and avoidance behaviours, and by
anxiogenic and catastrophic cognitions. As such, the obvious intervention would be to target these
cognitions and behaviours with the appropriate evidence-based techniques.
However, she was one of the few participants who so neatly fitted this fear/avoidance model. Even when
the factors maintaining the inactivity and avoidance were psychological, they were not always primarily to
do with anxiety about falling. For instance, one participant was also largely physically capable, although he
benefited from walking with a stick. However, he led a largely sedentary life because he was very
self-conscious about being perceived as ‘old’. Although self-deprecatingly dismissing his own concerns
as ‘vanity’, he nevertheless was clear that the main barrier to him going outside was that he felt very
overlooked by his neighbours, and did not want to be seen as the old man with a stick. He was further
restricted by social isolation and lack of companionship, and for him the main thing he thought would
help would be someone to walk with. Another participant reported that since losing her best friend
2 years prior to the interview, she no longer saw the point in going out. The interview uncovered an
interplay of ongoing grief and low mood, which were the main impediments to her engagement with the
outside world.
Primarily physical factors
For another proportion of the interviewees, the primary impediments to walking were physical. For
instance, one participant, whom we will call Fred, had multiple physical problems. He was overweight, had
angina and breathlessness, a frozen right shoulder and a ‘shattered’ left shoulder (from a previous fall).
As a result of pain and arthritis in his knees and ankles, he could walk only with sticks, and then with
considerable pain. All of these physical ailments had left him severely limited in his physical capacity. He
felt very vulnerable when out walking, as he was aware of being only one fall away from being bedbound
or hospitalised. Although this latter anxiety was certainly a barrier to activity, he perceived his principal
barriers to be his breathlessness, pain and fatigue. He also reported what emerged as a recurring fear
among the cohort – that hospitalisation was a ‘one-way ticket to death’ – ‘once you go in you don’t get
out’. Although he worked hard to maintain a social life, his activity was haunted by this fear of loss of
independence and ultimate death. His ‘hot cross bun’ is presented in Figure 2.
Physiology
Physically mainly OK
More tired than when active
Finds this kind of walking more tiring
Tense and anxious when active
Behaviour
Walks much slower, looks down, links up
with daughter, does not like walking with
others, avoids and curtails journey, looks
down, no walks for pleasure 
Cognition
Walking = danger
Images of fall
‘Can’t stride out’
‘Hope I’ll be OK’
‘Feel old’
Emotion
Frustrated in general
Anxious
Less enjoyment 
FIGURE 1 Amelia’s hot cross bun.
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About one-third of the cohort reported similar issues, with pain and fatigue, as a result of other physical
problems, being the most commonly reported barriers to activity, rather than primarily fear.
‘The stoics’
The third group were a surprising finding. These were participants who had considerable psychological
and/or physical impediments to activity but who, nevertheless, continued to be active. We perceived an
element of this in Fred above. Despite considerable physical problems and very real fears, he continued to
pursue his hobby of photography, and he saw this as a ‘passion that keeps me going’. Another more
marked example comes from a participant whom we will call Violet. She was the oldest, and perhaps the
most physically frail of the people interviewed, and had a very unsteady gait. She also highlighted the
heterogeneity of fear-of-falling precipitants. She had become aware of her unsteadiness only when her
husband of 60 years had died, and she was no longer able to walk arm in arm with him. Now that he was
gone she became aware that she would ‘suddenly list’ and ‘stagger unpredictably’. She had also seen her
husband decline very rapidly after hospital admission and die there. Like Fred, she had the fear that
admission to hospital was a ‘one-way ticket to loss of independence and ultimate death’. Despite both
these physical and psychological ‘inducements’ to inactivity, Violet was the most active participant
interviewed (Figure 3). Indeed she was difficult to pin down for interview as she was on (solo) holidays to
Spain, Italy and the Netherlands during the study period.
Physiology
Breathlessness (main problem)
Pain+++, fatigue, dizziness, unsteady,
staggers, sight problems  
Behaviour
Much reduced activity but does still do
photography, pub, see girlfriend
Caution: crossing roads, upstairs, in house,
chair lift, stick, slows down
Cognition
Breaking hip or left shoulder going
Losing independence, ‘once you go in you
don't get out’
Falling into television or door
Other people, dark nights, vulnerable
‘Why?’ body does not work
Hobby, ‘passion keeps me going’
Emotion
Fear
Mood OK 
FIGURE 2 Fred’s hot cross bun.
Physiology
Staggers unpredictably, suddenly lists
Diabetes
Medication – some dizziness and low
energy
Behaviour
Walks by walls, avoids stairs
Uses neighbours and sticks
Spain, Italy and the Netherlands
Cognition
Worries: breaking a bone, losing
independence, experience of husband,
falling down stairs
Carrying bags
Motivation: ‘only here once’
Emotion
Fear
Mood OK but still grief, upset
FIGURE 3 Violet’s hot cross bun.
DOI: 10.3310/hta20560 HEALTH TECHNOLOGY ASSESSMENT 2016 VOL. 20 NO. 56
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Parry et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
9
Violet’s experience was not unique. Several other participants reported ‘keeping going’ despite obvious
reasons to stop. This provided a new avenue of enquiry for these interviews: ‘What keeps you going?’. For
each person it was different. For Violet it was the belief that ‘you are only here once’. She did not believe
in God or an afterlife, and so was committed to get the most out of her life while she still could. Seeing
her husband decline, although still a source of grief for her, was a further motivation to make the most of
the time she had left. Another participant also struggled with both illness and anxiety, but kept going
because she was committed to looking after her sisters, both of whom were housebound. She also had a
dog to which she was committed to walking daily. In these cases it was clear that there was something
that mattered more, a value that superseded the urge to avoid physical or psychological distress, and
allowed the latter to be tolerated. We encouraged the interviewees to reflect on this, with the express
purpose of helping us to help others with our intervention.
Shaping the intervention and training for the
health-care assistants
One of the main conclusions that we drew from these interviews was that fear of falling was a
heterogeneous condition and one for which a ‘one-size-fits-all’ intervention would not be appropriate.
It also emerged that FES-I scores were, at best, a crude measure of the phenomenology of fear of falling
uncovered in the interviews. The interviewer, the co-trainer and intervention supervisor (NSa, a clinical
psychologist) and other members of the team (principally SWP and CB) discussed how we could turn these
findings into (1) a replicable intervention and (2) a training programme for HCAs. The consensus was that,
rather than focus exclusively on behaviour change techniques, we needed to equip the HCAs to arrive at
the kind of individualised problem formulations that had emerged from the interviews. These formulations
would form the basis of interventions by allowing the HCAs to assess the interplay of factors that were
maintaining the fear of falling/activity avoidance in each individual. Only then would the deployment of
behaviour change techniques be undertaken, in a tailored fashion. As to the latter, it was clear that there
were some key intervention targets, which were fear and avoidance of activity; pain; fatigue; reduced
activity; loss of confidence; catastrophic cognitions; grief; social isolation; and shame/self-image. Fear, pain
and fatigue were the most commonly reported issues and so it became clear that the HCAs needed clear
training for these, and some basic grounding in the evidence-based techniques for tackling the other
recurrent issues.
From this discussion, we put together a ‘menu-based’ treatment protocol and designed the training
accordingly. We also produced supporting training and client manuals (available on request from the
corresponding author of this report, SWP). Treatment was menu based in the sense that once the
assessment had been done, and the intervention targets agreed with clients, here would be a range of
prescribed interventions to draw on for each of these targets, individualised to the specific client. We then
put together the training programme. A detailed description of the intervention using the Template for
Intervention Description and Replication (TIDieR) framework45 is provided in Chapter 3 (see Table 6).
Duration of health-care assistant training
The training was delivered by VD and NSa over a period of 5 days in a classroom at the University
of Northumbria.
Training content
The training gave an overview of CBT and then looked in more detail at the three P’s (predisposing,
precipitating and perpetuating) model. Central to the HCAs’ training were the skills of engagement with
the client, and assessment and formulation development. Standard CBT interventions for identified
problems were described and practised: graded exposure for anxiety; activity monitoring, graded activity
and behavioural activation for pain, fatigue and low mood; and sleep management for fatigue. For other
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recurrent issues HCAs were taught specific cognitive techniques, such as identifying thoughts; making
explicit the links between thoughts, feelings and behaviour; thought diaries; thought challenging; and
cost–benefit analysis for catastrophic and otherwise unhelpful cognitions. Furthermore, the HCAs were
taught how to structure assessment and treatment sessions by working from formulation through to
treatment plan in the first one to two sessions, then to specific treatment strategies in the middle three
to four sessions, and then focusing on consolidation and discharge planning in the final sessions. An
eight-session format was agreed as being most suitable in terms of intervention replicability, with the aim
of weekly delivery.
The treatment plan was guided by end of treatment targets, which were worked out in collaboration with
the clients, meaning that each client had specific and measurable goals that they were working towards
throughout treatment. These individualised and personally meaningful goals aimed to capture that element
of ‘valued activity’ that we found had kept the ‘stoic’ participants going, despite physical and/or
psychological distress. The weekly implementation of treatment plans was carried out using specified
interventions for specified targets in the form of client homework. Subsequent sessions were structured by
homework reviews and problem-solving any additional barriers that had been identified before agreeing
further target-setting for the next session. Finally, treatment review, skills embedding, and relapse
prevention and preparation for discharge shaped the final sessions (Table 1).
Training delivery methods
A mixture of chalk and talk, observation, modelling and practice of the above techniques by the HCAs, as
individuals and in pairs, formed the bulk of the training sessions. A strong emphasis was placed on ‘real
play’, through which the HCAs were encouraged to use their own anxieties and experiences to work on in
assessment, formulation and treatment. This was done with consent, and participants agreed that it
helped to bring the techniques to life. Real fear of falling cases, derived from the interviews outlined
above, suitably anonymised, were used to present the range of issues involved. The content of the training
was summarised in both therapist and participant manuals (available from SWP) and the HCAs were
encouraged to develop their own assessment and treatment props, which they did (see Appendix 2).
Post-training supervision
In the months following the above training the therapists engaged in both individual and group
supervision. The former was of 1 hour every fortnight with NSa within which the focus was on skills
development and consistency of intervention delivery. Individual client session audio tapes were shared and
scrutinised with the supervisor. Discussion about internal and external challenges to the process of the
study were also explored, as were individual issues that were pertinent. Group supervision was led by VD
on a bimonthly basis, and focused on cases brought by the therapists for sharing and exploration of
practice and interventions.
TABLE 1 Outline of CBTi sessions
Session Content
1 Assessment and formulation
2 Goals and target-setting
3, 4, 6 Continuation
5 Review
7 Relapse prevention
8 Final review
6-month follow-up Review and recap, goals, setbacks, outcomes
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Acceptability and feasibility of the cognitive–behavioural
therapy intervention
The previous section focused on the development of the CBTi and associated training materials; in this
section we report the methods and results of Phase I of the process evaluation, which sought to
understand the feasibility and acceptability of the CBTi from the perspectives of the different stakeholder
groups involved (patients, clinicians and CBTi developers). (Phase II of the process evaluation is reported in
Chapter 5, Process evaluation.)
Methods for process evaluation
Interviews with patients and carers
A sample of 14 patients (aged 60–85 years, nine female) and two family members (both female, age not
specified) were interviewed. In contrast with the intervention development interviews, these explored
patient and family members’ perceptions about the proposed CBTi, practical aspects of the CBTi (including
how to describe the intervention, proposed delivery) and perceived relevance of the CBTi to their situation.
Patients were recruited from the North Tyneside Falls Prevention Service to reflect inclusion criteria for the
RCT, using maximum variation sampling (for variety in age, gender and FES-I score). When appropriate,
family members of these patients were invited to take part. Participants were interviewed in their
own homes.
Interviews with professionals
The six professionals (three geriatricians, two physiotherapists and one HCA) who constituted the
multidisciplinary team at the North Tyneside Falls Prevention Service were interviewed. VD and NSa
(hereafter psychologists) were also formally interviewed using a semistructured interview schedule (three
interviews). These interviews explored perceptions of key factors that might impede or facilitate the
proposed CBTi being effective and workable in practice.
Observation
Clinical sessions at the North Tyneside Falls Prevention Service (n= 5) were observed to gain an understanding
of the clinical context of the study. Professionals sought verbal consent from patients and any companions
for the observation. No audio or audiovisual recordings were undertaken of these observations.
The regular meetings of the CBTi development team (VD and NSa) were audio recorded and observed by
CB (n= 9 meetings). These data were supplemented with field notes that were taken of informal
discussions (n= 8) with VD outside these meetings. Other related stakeholder engagement activities,
including a briefing meeting for clinic staff, were also observed.
Data analysis
All qualitative data were analysed thematically using the constant-comparative technique.46 This process
allowed for the meaning of the data, and themes represented within them to emerge freely without the
constraints that might be imposed on the data if coding to a prespecified coding frame. Themes were
identified individually by CB and TF, who developed initial ideas and undertook coding independently, and
then came together to discuss and compare ideas. We systematically worked through different data
sources (professional interviews, patient interviews, intervention development meetings, interviews and
informal discussions with the intervention development researchers, and field notes) identifying themes
separately for each type of data prior to producing an overarching coding frame. The team members
responsible for intervention development reviewed and commented on the coding frame thus providing
some respondent validation. There were no formal opportunities for respondent validation by patients
and carers; however, the identification of similar themes in the intervention development interviews
conducted by VD, and those conducted as part of the process evaluation, provided some evidence
of trustworthiness.
PHASE I: INTERVENTION DEVELOPMENT
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The process evaluation component of the study was designed not merely to evaluate the development
of the CBTi, but also to collect data to inform and optimise the CBTi for delivery within the RCT. This
was achieved through iterative data collection and feedback loops (that included formal and informal
project-related meetings, and face-to-face and e-mail communications with the psychologists and the
wider project team) to enable practical resolution of problems as they arose. The impacts of the process
evaluation activities on the development and delivery of the CBTi are highlighted below.
Data reported here are attributed using the unique identifier allocated to the participant. Prefixes are as
follows: ‘P’ denotes professionals; ‘C’ denotes patients interviewed for the process evaluation; ‘F’ denotes
family members (caregivers); and ‘R’ denotes study team members.
Results: acceptability and feasibility
The first section of the results explores how the intervention developers adapted the proposed CBTi to fit
with their emerging understandings of fear of falling and achieved an intervention which, from their
perspectives, made sense. The second section highlights the concerns expressed by a range of stakeholders
over the acceptability and feasibility of the proposed CBTi and RCT, in particular the ‘fit’ of trial structures
and processes with older people; the staff who would be delivering the intervention; and the service in
which patients were initially to be recruited. We examine the work undertaken by the research team to
improve the coherence of the trial to stakeholders.
Based on their initial views that fear of falling could be conceptualised as anxiety based and avoidant,
the psychologists had anticipated developing a simple, linear, manualised intervention centred on graded
exposure. The initial clinical interviews conducted by VD (described in the initial section of this chapter)
revealed that fear of falling was a complex and multidimensional phenomenon with diverse precipitating,
perpetuating and predisposing factors. These observations created uncertainty about the feasibility of
developing a CBTi that is suitable for all patients:
. . . it may be that there are certain groups within that, those complex dimensions that you’ve already
described, that actually this may not be an appropriate intervention with all [. . .] groups [. . .]
R12, intervention development meeting, 22 November 2011
I’d be struggling to know what to do with them, to be honest. You can imagine a little change, but
you’re up against the real, as it were.
R4, intervention development meeting, 22 November 2011
Broadening the focus of the CBTi to include work on pain, fatigue and other issues raised issues over the
scope of the intervention and fit with the protocol:
R1: So I think there’s a boundary issue about are we doing CBT for fear of falling.
R4: The boundary issue is key.
R1: Or are we doing CBT for fear of falling and actual (R4: and pain and . . .) [. . .]
R12: . . . in a sense you’ll be working with them with whatever they bring, I mean it might be that you
know the pain is a major factor in them not going out or whatever so I think that’s a legitimate piece
of work.
Intervention development meeting, 15 February 2012
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The decision to focus on individualised formulations also created concerns over the potential mismatch
between the complexity of the client group, the wide range of skills required to deliver the intervention
(Box 1) and the allotted time frame:
Because you’ve identified very challenging, difficult clients [. . .] in terms of actual CBT, how do we get
those relatively inexperienced therapists to actually be able to collect this information and actually then
work – develop a relationship – and then work with these people over six sessions or however long it’s
going to be. Because it’s such a small period of time.
R12, intervention development meeting, 22 November 2011
At the same time there was an emphasis on being realistic and focusing on the aim of the project:
We’re not training psychological therapists; we’re training some healthcare assistants to deliver a very,
very short intervention. So we’ve got to be clear about what’s possible as well.
R12, intervention development meeting, 15 March 2012
Concerns were also raised about the potential generalisability of the intervention. There was an awareness
that, in light of the careful selection, training and supervision of HCAs to meet the demands of this
complex CBTi, the findings may not be replicable elsewhere:
All of which does raise some questions about generalisability, if we were recruiting the ones who are a
bit savvy and we’re giving them a lot of training [. . .] that doesn’t necessarily translate into your ‘Joe
Bloggs care assistant’ who is already working in a very busy . . . but we’ll see, I think we have to prove
it’s doable first.
R4, intervention development meeting, 13 September 2011
Achieving coherence in randomised controlled trial structures and processes
The process evaluation interviews that were conducted with patients and clinic staff indicated a number of
other issues that needed to be addressed to maximise the feasibility and acceptability of the RCT in which
the CBTi was to be evaluated. These issues were iteratively fed back by staff responsible for the process
evaluation (CB and TF) to key members of the project team to allow the development and implementation
of strategies to address them prior to the start of the RCT.
BOX 1 Skills required to deliver the CBTi
l Ability to develop a therapeutic relationship.
l Formulation skills.
l Managing uncertainty during the process of learning CBT skills.
l Willingness to practise new skills under scrutiny.
l Ability to contain potentially distressing emotions.
l Knowing own limitations and ability to judge when referral to more experience professionals is required.
PHASE I: INTERVENTION DEVELOPMENT
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Perceived acceptability of cognitive–behavioural therapy intervention to
older people
A key issue raised by all stakeholders was the extent to which CBT would be acceptable to older people,
as illustrated by the following comments:
I imagine that some stoical North Easterners might think that it was wishy washy mumbo jumbo that
wasn’t necessarily going to help, you know the idea of going and sort of seeing like, effectively having
a sort of a counselling type sessions, some people might not take that seriously.
P2, interview, 6 December 2011
So I think although she would agree to any kind of help I think there’s a part of her that possibly feels
she doesn’t need it, and I think it’s getting over that hurdle.
F2, interview, 9 March 2012
A key issue concerned the name of the CBTi. Patients and clinic staff indicated that the use of terms such
as ‘psychological’ and ‘psychotherapy’ were potentially alienating to the intended client group:
INT: what does psychotherapy treatment mean to you?
C2: Sitting on a couch with a shrink!
INT: And would you then sign up for that do you think?
C2: I don’t know, I don’t know whether that would help me with the problems I’ve got.
C2, interview, 30 January 2012
All stakeholder groups participating in qualitative interviews were asked for advice and suggestions. It was
seen as essential to ensure that the title was positive: avoid the word ‘falling’ (as well as any words
beginning with ‘psych’) and to consider including terms such as ‘confidence’, to which people would be
able to relate. In addition to being non-threatening, we wanted the name to convey a sense of the
purpose and focus of the intervention so that it would not be mistaken for an exercise class. Following
discussions, we agreed on STRIDE as the brief study title (Strategies for increasing independence,
confidence and energy).
Although there were clear reservations about the concept and name of the CBTi, stakeholders were
generally positive about the practical aspects of the CBTi, for example the number, frequency and duration
of sessions, the timing of the follow-up session, and the intention to deliver the intervention at home.
Patients emphasised the need for flexibility and for the sessions to fit around their other commitments.
Several patients suggested group sessions, either instead of, or alongside, individual sessions, and although
the likelihood of individual preferences was noted it was agreed that this could not be accommodated in
the RCT.
Perceived value of cognitive–behavioural therapy intervention for fear
of falling
Clinic staff expressed some reservations about the proposed CBTi for fear of falling, in particular the
possibility that, for some patients, fear of falling may actually be protective with regard to falling:
I don’t know whether it’s protective or not which would be my other question, is it a good thing
people have a fear of falling, if you take that fear of falling away are they going to fall because their
sense of caution has gone?
P3, interview, 7 December 2011
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Clinic staff also expressed reservations over patients’ willingness to engage with an intervention that
focused primarily on fear of falling:
I’m not sure how receptive they will be to addressing fear of falling as a primary factor in the absence
of anything else, any modifications to gait or aids or physical performance, so I don’t know how often
it’s a stand-alone problem.
P3, interview, 7 December 2011
As the North Tyneside Falls Prevention Service focused on identifying underlying medical causes for falls,
it was not surprising that staff were uncertain about the value of psychological interventions such as CBT.
In light of their key role in ‘selling’ the CBTi to eligible patients in Phase I of the study, we organised a
briefing meeting for clinic staff in which the intervention developers fed back the results of the interviews,
described the intervention and illustrated how it would be relevant to different types of clients. This
enabled staff to recognise the similarities between the CBTi and their existing practice:
I mean I’ve used it a lot with working with older people and it’s not actually called CBT but it’s what
you do with them from the point of view you’ve gradually got to build their confidence up through
very simple increasing their activities and things and the way you talk to them and the way you
encourage them and things like that as well, so yes I think it would be very, very helpful actually.
P5, briefing meeting for clinic staff, 17 February 2012
During this briefing meeting, we were able to provide reassurance about the venue of the treatment
(usually in patients’ own homes) and also to address other concerns, for example mechanisms for
informing patients’ general practitioners (GPs) about their participation.
Recruitment of patients to a randomised controlled trial
Observation of the clinical setting in which the RCT was to take place revealed that the service specialised
in fast paced, routinised, structured assessments. Potential barriers to patient recruitment were time
pressures and the lack of any routine discussion of fear of falling within the service. To facilitate
recruitment in these difficult circumstances, we produced a user-friendly leaflet and a ‘script’ that staff
could follow. This was designed to have minimal time implications and to allow staff to follow their
existing approach to referring patients for strength and balance classes provided by a local
voluntary organisation.
Relevance and acceptability of the primary outcome measure
A final issue that emerged from discussions with clinic staff related to the adequacy of the FES-I as a
means of identifying potential participants and the primary outcome measure despite clear published
evidence of its validity.29 These concerns over the outcome measure undermined the perceived validity of
the proposed RCT. A key concern was the perceived lack of correlation between apparent fear of falling
and FES-I scores:
She’s an agoraphobic and was very, very frightened of falling [. . .] she won’t go to the hairdresser and
that sort of thing, but because the FES was so low from that point of view then obviously she
wouldn’t fit your criteria then would she?
P5, briefing meeting for clinic staff, 17 February 2012
Staff felt that responses on the FES-I often reflected functional limitations (e.g. arthritis or other pain) that
affect mobility rather than fear of falling. Given the extent of clinic staff concerns over the use of the FES-I
as the primary outcome measure, we added a visual analogue scale, on which patients could rate their
fear of falling, to be included alongside other measures used in the RCT.
PHASE I: INTERVENTION DEVELOPMENT
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Chapter 3 Phase II: randomised controlled
trial methods
Objectives of the randomised controlled trial
Primary objective
To determine the effectiveness of a new cognitive–behavioural therapy-based intervention (CBTi) plus usual
care compared with usual care alone (the control condition) in reducing fear of falling in community-dwelling
older adults attending falls services.
Secondary objectives
To:
(a) measure the impact of the intervention compared with the control on fall and injury rates in the trial
participants, and its impact on functional abilities
(b) measure the effectiveness of the intervention compared with control on anxiety and depression,
quality of life, loneliness, social isolation and social participation
(c) investigate the acceptability of the intervention for patients, family members and professionals
(d) further investigate the professional and organisational factors that promote or inhibit the
implementation and integration of the intervention
(e) measure the costs and outcomes of the intervention in this setting.
Objectives (c) and (d) relate to the process evaluation, the methods and findings of which are described in
Chapter 5; objective (e) relates to the health-economic evaluation, the methods and findings of which are
described in Chapter 6.
Summary/overview of trial design
Two-arm, parallel-group patient RCT of a novel CBTi plus usual multidisciplinary care compared with usual
multidisciplinary care alone in older patients with significant fear of falling and who are attending
multidisciplinary falls services. Patients were randomised in a 1 : 1 ratio.
Trial registration and protocol availability
The trial was registered as ISRCTN78396615 on 17 May 2012. The latest version of the full protocol is
available at www.nets.nihr.ac.uk/projects/hta/097004 and a published version is also available.47 Table 2
summarises key changes to the original STRIDE trial protocol as approved by the research ethics
committee (REC).
Ethics and governance
The Newcastle upon Tyne Hospitals NHS Foundation Trust was the sponsor for the trial. Favourable ethical
opinion for Phase II (the RCT) was obtained on 16 February 2012 from the Newcastle and North Tyneside 1
REC (REC reference 12/NE/0006) and subsequent Research & Development and Caldicott approvals were
granted by each participating site. Approval was sought and obtained for all substantive protocol amendments.
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Trial setting
This trial was conducted in three community-based Falls Services in the North East of England: North
Tyneside Falls Prevention Service, Newcastle upon Tyne Hospitals NHS Foundation Trust; Galleries Day Unit,
Washington, South Tyneside NHS Foundation Trust; and Falls and Syncope Service, Newcastle upon Tyne
Hospitals NHS Foundation Trust. The trial was originally designed as a single-site study at North Tyneside
Falls Prevention Service but, as a result of recruitment problems, the other sites were subsequently added
(June 2013 for Galleries Day Unit; May 2013 for the Falls and Syncope Service).
The North Tyneside Falls Prevention Service was a community falls prevention service focusing on early
identification of patients at risk of falls. The Galleries Day Unit was a nurse-led community falls service
providing assessment and rehabilitation. The Falls and Syncope Service was a specialist centre serving both
local and national communities. Key characteristics of each site are summarised in Table 3.
The routine (i.e. for patients outwith the STRIDE trial) patient assessment process is summarised in Table 4,
using the National Institute for Health and Care Excellence (NICE) guidance on possible content of
multifactorial falls assessment.48 As can be seen there were marked variations between sites.
A key characteristic of the North Tyneside Falls Prevention Service was that all recording was carried out
electronically during consultations; as each professional completed their assessment with an individual
patient, the colour of the patient’s electronic record changed so that their colleagues could see that the
assessment was completed and could access the notes. The consultant saw patients last, and, following
detailed explanation of findings, printed out a summary of the assessment at the end of the consultation
for patients to take home with them; a hard copy was also sent to the patient’s GP.
A key difference between the Falls and Syncope Service and the other two sites was that patients were not
routinely assessed by the physiotherapist; this reflects the more varied patient group seen in the Falls and
Syncope Service, a significant proportion of whom were younger patients who were referred for dizziness
and blackouts rather than falls. The physiotherapist within this service therefore operated like an
outpatient clinic, with patients being referred for assessment when required. Patients who were referred to
the physiotherapist had an initial assessment of 60 minutes, with review appointments of 30 minutes. In
contrast with the physiotherapy assessments in the other two sites, the dynamic gait index was performed,
for which patients are asked to walk at different speeds, turn their head horizontally and vertically when
walking, turn and stop, and to negotiate obstacles while walking. Other aspects of the physiotherapy
TABLE 2 Changes to protocol
Description Version Date
Update to recruitment procedures; administrative updates 2.0 15 March 2012
Update to prospective recruitment of participants to the RCT 3.0 27 November 2012
Revision of the sample size
Update of the protocol to incorporate additional recruitment sites
4.0 5 April 2013
Staff member update
Update of study duration
Update of procedures for follow-up of non-returned self-completion
questionnaires and completion of questionnaires via telephone
5.0 6 March 2014
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TABLE 3 Key characteristics of participating sites
Service specifications
and characteristics
North Tyneside Falls
Prevention Service Galleries Day Unit Falls and Syncope Service
Year established 2009 2007 1991
Aim To investigate, diagnose and
help manage syncope
(blackouts/loss of
consciousness) and falls
To provide assessment and
rehabilitation to patients
who are either known fallers
or are at risk of falling
To investigate, diagnose and
help manage syncope and falls
Staff HCA; physiotherapist;
consultant physician
HCA; physiotherapist; nurse Nurse; physiotherapist;
consultant physician
Age group, years 60+ 60+ 16+
Catchment area from
which patients drawn
All GP practices within a
geographically defined area
All GP practices within a
geographically defined area
Primarily local (Newcastle, North
Tyneside and Northumbria), but
with regional and national
referrals
Method of access of
patients to service
Screening questionnaire
administered by GP practice
to patients aged 60+ years
to identify patients at risk of
falling, referrals from GPs
Health or social care
professional (including the
ambulance service)
Referrals from GPs, ambulance
service, A&E department; tertiary
referral centre
Patients’ living
arrangements
Community dwelling Any Any
Premises Shared rooms within a
health centre
Dedicated rooms within a
health centre
Dedicated clinic in a hospital
Availability 2.5 days per week 5 days per week 5 days per week
Duration of initial
appointment (minutes)
90 120 90
Typical number of
visits
1 8–12 for patients on
rehabilitation programme
3–4
Documentation of
care
Electronic care pathway only Loose-leaf sheets Care pathway booklet
(with separate booklet for
physiotherapist documentation)
A&E, accident and emergency.
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TABLE 4 Overview of assessment process at different sites
Clinical assessments
North Tyneside Falls
Prevention Service
Galleries
Day Unit
Falls and Syncope
Service
Identification of falls history
l Number of episodes Y Y Y
l Frequency Y Y Y
l Before, during, after falls and/or syncope Y Y Y
l Precipitants Y Y Y
l Fractures Y Y Y
l Soft tissue injury Y Y Y
Assessment of gait, balance and mobility and muscle weakness
l Foot assessment (including proprioception) PRN Y PRN
l Joints Y Y Y
l Gait Y Y Y
l Balance Y Y PRN (physio)
l Mobility/transfers Y Y Y
l Strength Y Y Y
l Range of movement Y Y PRN (physio)
l Posture Y Y Y
l Timed up and go Y Y Y
Assessment of osteoporosis risk FRAX FRAX FRAX
Assessment of perceived functional ability and fear relating to falling
l Social/activities of daily living Y Y Y
l Informal carer needs PRN Y PRN
l Pain Y Y PRN (physio)
l Fear of falling (FES) Y Y PRN (physio)
l Fear of falling (visual analogue scale) N Y N
Assessment of visual impairment
l Visual acuity Y Y Y
Assessment of cognitive impairment and neurological examination
l Cognitive function (MMSE) Y PRN PRN
l Neurological examination Y Y Y
l Hallpike manoeuvre PRN PRN PRN
l Autonomic function tests N N PRN
Assessment of urinary incontinence PRN Y PRN
Assessment of home hazards PRN Y/PRN PRN
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assessment were similar to those observed in the North Tyneside Falls Prevention Service and Galleries Day
Unit. The Falls and Syncope Service also performed the Epley manoeuvre for patients with benign
positional paroxysmal vertigo (BPPV), whereas patients attending the North Tyneside Falls Prevention
Service and Galleries Day Unit had to be referred to Ear, Nose and Throat services for this treatment.
The care pathways and interventions offered by the different sites post initial assessment also varied
(Table 5). In the North Tyneside Falls Prevention Service, following assessment, patients were referred:
l back to their GP for medication or other review
l to secondary care, day hospital, community physiotherapy and occupational therapy as appropriate
l for bone densitometry at the local hospital, and/or
l to targeted strength and balance training classes run in conjunction with the voluntary sector (Age UK)
in North Tyneside.
Patients were also signposted patients to local exercise classes, such as t’ai chi run by Age UK. In the Galleries
Day Unit, the main outcome of initial assessment was referral to the in-house rehabilitation programme,
although other options were available including home exercises or in-house t’ai chi and referral to the lead
consultant geriatrician and falls specialist at Sunderland Royal Hospital for ongoing investigation.
Arrangements for follow-up and management, post initial assessment, were more fluid in the Falls and
Syncope Service; this related to the range of investigations available within the service (e.g. carotid sinus
massage, tilt table), as well as the options for physiotherapy intervention (within the service, community
physiotherapy, day hospital, community strength and balance training via the Staying Steady project, etc.).
TABLE 4 Overview of assessment process at different sites (continued )
Clinical assessments
North Tyneside Falls
Prevention Service
Galleries
Day Unit
Falls and Syncope
Service
Cardiovascular examination and medication review
l Electrocardiogram Y Y Y
l BP Y Y Y
l Pulse Y Y Y
l Active stand (lying and standing BP) Y Y Y
l Tilt table test (20/15, front-loaded GTN,
lower body negative pressure)
N N PRN
l Carotid sinus massage N N PRN
Other
l Height Y Y Y
l Weight Y Y Y
l Body mass index Y Y Y
l Vestibular PRN PRN PRN
l Mood (Geriatric Depression Scale, 15-item) Y N N
l Blood tests Via GP PRN PRN
l Urinalysis N PRN Y
l Chest X-ray PRN PRN PRN
BP, blood pressure; FRAX, Fracture Risk Assessment Tool; GTN, glyceryl trinitrate; N, no; PRN, as needed; Y, yes.
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The in-house rehabilitation programme provided at the Galleries Day Unit comprised six stages, although
most patients started at stage 4. Rehabilitation sessions typically lasted 15–20 minutes. The patients were
reviewed by the physiotherapist typically before moving on to stage six when a decision was made
whether or not to continue, repeat some of the earlier sessions or discharge the patient.
In the Falls and Syncope Service, patients requiring physiotherapy intervention were often given an individual
exercise programme to follow at home and reviewed after about 6 weeks. Patients who were frailer and
required more input tended to be referred to a day hospital where more support and dedicated transport
were available. Many of the patients requiring intervention began with home exercises and were later
referred to Staying Steady – evidence-based community exercise groups which ran over 36 weeks, alternating
periods of exercise classes and home exercises. However, access to this intervention varied according to
where patients lived and there were significant waiting lists in some areas of the city. In the North Tyneside
Falls Prevention Service, approximately 25% of patients were referred to strength and balance training classes
run in conjunction with Age UK, with tailored exercise programmes for up to 10 individuals provided weekly
for 10 weeks, following which participants were encouraged to attend follow-on exercise classes.
Study participants
Participants were community-dwelling older patients aged ≥ 60 years, of both sexes, attending one of
the above falls services with excessive or undue fear of falling as assessed by the FES-I29 score of > 23.
The cut-off score of > 23 was informed by a comprehensive longitudinal study of the clinical and
psychometric properties of the FES-I in 500 community-dwelling elders, which suggested this threshold as
indicating high levels of concern about falls.40
As described below, patients provided written informed consent for participation in the study prior to any
study-specific procedures.
Inclusion criteria
l FES-I score of > 23.
l Aged ≥ 60 years.
TABLE 5 Overview of interventions at different sites
Intervention
North Tyneside Falls
Prevention Service Galleries Day Unit Falls and Syncope Service
Referral to community
exercise
Strength and balance
classes
Yes (Age UK classes or gym
membership)
Staying Steady intervention
In-house physiotherapy No No Yes (typically prescribed home
exercises and reviewed four to five
times)
In-house rehabilitation
programme
No Yes (typically 11–12 sessions) No
In-house exercise/t’ai chi No Yes No
Home exercises Yes (sheets provided) Yes (sheets provided and
HCA could visit patients at
home to provide 1 : 1
exercises where appropriate)
If referred to in-house or
community physiotherapist, home
exercises might be provided PRN
(sheets provided)
PRN, as needed.
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Exclusion criteria
l Cognitive impairment [Mini Mental State Examination (MMSE) score of < 24/30].41
l Life expectancy < 1 year or unlikely for any other reason to be unable to complete 1-year follow-up
l Requiring psychosocial interventions that are unrelated to fear of falling.
l Current involvement in other investigational studies or trials, or involvement within 30 days prior to
study entry.
l Patients who had taken part in Phase I (i.e. qualitative work to develop the intervention) of the study.
A small number of these patients acted as ‘pilot clients’ and received the intervention (as part of the
training of the HCAs) but did not complete any of the outcome measures.
During the course of the study, it became apparent that some couples both fulfilled study eligibility criteria.
To avoid contamination, it was decided that only one member of each household should be randomised.
Therefore, if a spouse or partner of an otherwise eligible individual was already participating in the study,
the second individual to be identified was excluded at the second stage of screening by research assistants
(RAs) (see below).
Interventions
The control group received usual care for the falls services in which they were recruited, as described
above. The intervention group received usual care as detailed above plus a CBTi. The rationale for this
choice of intervention and the theoretical basis for it are described in greater detail in Chapter 2 (see Phase I:
intervention development) and intervention materials (therapist and patient manuals) can be obtained from
the corresponding author of this report (SWP). The CBTi was developed by our team in Phase I of this
research; the development process is described in Chapter 2 (see Phase I: Intervention development). It was
delivered face to face, on a one-to-one basis, by one of three trained HCAs, at participants’ homes, the North
Tyneside Falls Prevention Service or community centres or facilities (e.g. Age UK offices in North Shields),
Newcastle University or the Royal Victoria Infirmary, Newcastle upon Tyne (RVI), as per patient choice. HCAs
were trained in basic CBT assessment, formulation and treatment skills by a qualified cognitive–behavioural
therapist and practitioner health psychologist (VD) and a clinical psychologist (NSa) (hereafter ‘psychologists’).
Assessment and formulation skills allowed them to identify, with the patient, the unique set of beliefs,
behaviours, emotions and physical factors that were maintaining the fear of falling in that individual.
Treatment sessions focused on targeting these beliefs and behaviours. CBTi sessions lasted approximately
45 minutes, with 15 minutes’ preparation time, and were based on an individualised formulation that
identified and targeted the beliefs and behaviours maintaining fear of falling for that individual. The planned
course of treatment was once per week for 8 weeks, with a single reinforcement session 6 months after the
last CBTi session. The intervention is summarised using the Template for Intervention Description and
Replication (TIDieR) framework45 in Table 6.
Other therapeutic interventions were permitted in both intervention and usual care arms of the study per
routine clinical care. None was prohibited.
Outcomes
Primary outcome measure
There is considerable variation in the literature on what constitutes fear of falling and how it should be
measured.12,25,43 Single-item questions are sometimes used, but have been criticised for their inability to
measure variability in degrees of fear of falling.12 We included a single-item, 11-point rating scale of fear of
falling (see next section) in our battery of outcomes, but felt that a multi-item scale would be a more
appropriate primary outcome measure. A number of scales have been developed following Tinetti’s initial
FES,13 but its modified version, the FES-I29 has gained currency as a measure of fear of falling because of its
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TABLE 6 Intervention description according to TIDieR checklist45
Item no. Item Explanation
1 Brief name: Provide the name or a phrase that
describes the intervention
STRIDE
2 Why: Describe any rationale, theory, or goal of the
elements essential to the intervention
Based on the cognitive–behavioural model32
3 What materials: Describe any physical or informational
materials used in the intervention, including those
provided to participants or used in intervention delivery
or in training of intervention providers. Provide
information on where the materials can be accessed
(such as online appendix, URL)
Patient manual; therapist manual; training materials
4 Procedures: Describe each of the procedures, activities,
and/or processes used in the intervention, including
any enabling or support activities
Formulation, tailored intervention
5 Who provided: For each category of intervention
provider (such as psychologist, nursing assistant),
describe their expertise, background, and any specific
training given
HCAs
Five-day training programme. Two recent
psychology graduates: one with experience as HCA
managing patients with falls; one physiotherapist
6 How: Describe the modes of delivery (such as face to
face or by some other mechanism, such as internet or
telephone) of the intervention and whether or not it
was provided individually or in a group
Individual face-to-face sessions
7 Where: Describe the type(s) of location(s) where the
intervention occurred, including any necessary
infrastructure or relevant features
Patients’ homes (or convenient clinic if preferred)
8 When and how much: Describe the number of times
the intervention was delivered and over what period of
time including the number of sessions, their schedule,
and their duration, intensity or dose
Planned as eight sessions over a period of 8 weeks,
with each session lasting about 1 hour; behavioural
and cognitive homework (e.g. graded exposure to
avoided situations, fearful thoughts recorded and
challenged) to be completed between sessions.
One review session scheduled at 6 months after
completion of initial intervention
9 Tailoring: If the intervention was planned to be
personalised, titrated or adapted, describe what, why,
when, and how
Intervention to be determined by individual ‘hot
cross bun’ formulations, as described in Chapter 2
(see Results: understanding fear of falling)
10 Changes: If the intervention was modified during the
course of the study, describe the changes (what, why,
when, and how)
No formal modifications were made although the
intervention evolved during the study (see Box 2)
11 How well – planned: If intervention adherence or
fidelity was assessed, describe how and by whom, and
if any strategies were used to maintain or improve
fidelity, describe them
Intervention delivery was monitored through
individual and group supervision, which included
listening to recordings of therapy sessions (see
Table 37)
12 How well – actual: If intervention adherence or fidelity
was assessed, describe the extent to which the
intervention was delivered as planned
See Chapter 4
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simplicity, ease of administration and widespread validation across patient groups49–52 and cultures.40,52,53
Tinetti’s original FES13 measured purely self-efficacy, an individual’s belief in his or her own capabilities in
performing specific activities,54 but the FES-I modification (see Appendix 1) more explicitly measures
concerns about falling.29,55 We re-examined this issue in 200 older people using a more detailed principal
factor-analytic approach than the original validation study,29 and found that the FES-I more robustly
measures concerns about falling than had previously been found.56 An integrative review of tools to
measure fear of falling, considering papers published between 1982 (when the concept of fear of falling
was first defined) and 2010, concluded that the FES-I is the best assessment tool for assessing fear of
falling in community-dwelling elders.57
Secondary outcome measures
Numeric rating scales for pain and fear of falling when walking
As summary measures of pain and fear of falling, participants were asked to rate these constructs on a
11-point scale, ranging from 0 (no concern/no pain) to 10 (as bad as it could be); a similar approach has
been used in a number of studies as summarised by Scheffer et al.10
Falls
l Number of patients falling.
l Number of falls.
l Fractures and significant soft tissue injuries.
The close relationship between fear of falling and falls6,8–16,23,24,26,27,29,58,59 means that measurements of falls
and their adverse consequences are vital. Falls research is often hampered by poor definitions and hence
difficult interpretation of falls outcome data. In line with consensus guidelines,60 falls were defined as
‘an unexpected event in which the participant comes to rest on the ground, floor, or lower level’.
Anxiety and depression
Hospital Anxiety and Depression Scale
Although fear of falling was the primary outcome measure, the inter-related nature of fear of falling and
anxiety mean that change in anxiety was clinically highly relevant. In addition, it was considered vital to
assess depression in this population.11 The Hospital Anxiety and Depression Scale (HADS), although widely
used, was originally validated in a population with a maximum age of 65 years.61 However, a large-scale
UK study in four centres across England, Wales and Scotland has shown that the scale’s psychometric
constructs are intact and applicable to community-dwelling older people.62
Generic quality of life
l World Health Organization Quality of Life questionnaire – older adults module (WHOQOL-OLD).63
l European Quality of Life-5 Dimensions [EQ-5D (5L)], the five-level version.64
l Short Form six-dimension health survey [Short Form questionnaire-6 Dimensions (SF-6D), derived from
the Short Form questionnaire-36 items (SF-36)].65,66
The 24-item WHOQOL-OLD is a module of the World Health Organization’s broad measure of quality of
life, the WHOQOL, which was designed for adults of all ages. The WHOQOL-OLD includes additional items
that specific to older people. The EQ-5D (5L) is a generic quality-of-life measure that has the added
benefits of enabling cost–utility analysis (CUA) (see Chapter 6), as does the SF-6D.
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Social participation and social isolation
Social Disconnectedness and Perceived Isolation Scales67,68
Avoidance of social contact and social isolation are crucial co-factors both caused by, and contributing to,
fear of falling. Cornwell and Waite67,68 have shown that the Social Disconnectedness and Perceived
Isolation scales, which measure both social isolation and participation, may be particularly useful in
evaluating interventions in older people. The Lubben Social Network Scale–6 (LSNS-6)69 is a questionnaire
that is designed to gauge social isolation in older adults by measuring perceived social support from family
and friends. It consists of 10 items, which are used to measure size, closeness and frequency of contacts of
a respondent’s social network. The De Jong Gierveld Loneliness Scale70 is a well-validated and reliable
11-item scale that measures loneliness, including two subscales measuring emotional loneliness and
social loneliness.
Impact on physical function
The Short Physical Performance Battery (SPPB) is a well-validated set of lower limb performance tests,71,72
which measures walking speed, a series of chair stands to assess muscle power, plus a test of balance, and
has been used in major surveys such as the Women’s Health and Aging study.73 Performed by a trained
person, the SPPB takes 10–15 minutes to complete, with a composite score being derived by summing the
category scores for each of the three tests. Better (higher) scores on the SPPB have been related to slower
functional decline on the physical subscale of the Medical Outcomes Study SF-36.74 Others have reported
that SPPB scores are related to fatigue in older persons living in the community.75 Functional decline and
fatigue are related to SPPB scores, yet injurious falls were not related to total SPPB scores.76 Injurious falls
were related to taking ≥ 16.7 seconds to complete the five-times chair rise test and a history of falling.76
Silva et al.77 compared the World Health Organization Disability Assessment Schedule 2.0 to the SPPB, and
noted that the self-report and SPPB were not related. Both physical and self-report measures may measure
two different, but important, constructs.
The functional reach test is a good indicator of confidence in balance and increased risk of having a
fall,78,79 whereas the measurement of maximum isometric handgrip strength (using a dynamometer) has
functional relevance for supporting weight (e.g. holding on to a stair rail). Grip strength has been included
in numerous large-scale surveys, and is predictive of both disability and mortality.80–82 Functional reach and
handgrip strength were measured three times at each protocol visit and the mean of the three values
was calculated.
Table 7 summarises the measures used and the time points at which data were collected.
All outcomes were assessed and recorded by RAs/interviewers (unless specified otherwise below) at
baseline and at 8 weeks (the anticipated end of the intervention period), 6 months and 12 months post
randomisation; the later follow-up time points were selected to measure whether or not any immediate
benefits of the intervention were sustained over time, with the 12-month assessment of FES-I comprising
the primary outcome. Over the course of the study, five RAs/interviewers contributed to data collection and
all were trained in the study procedures. Physical measures training was performed via Skype™ (Microsoft
Corporation, Redmond, WA, USA) with one of the investigators (SLW) twice. The first session was
designed to train the associates to collect the physical performance data and in patient safely, as there is
always a risk of falling when asking older adults to perform balance tasks. The research associates were
trained to guard the subjects closely and also to set up the environment so that the study participants
felt safe during the testing. The group also practised timing each of the measures until the stopwatch
measures were ± 0.5 seconds of each other. A subsequent Skype session and e-mails followed up
session 1 in order to answer specific questions that arose in the home during testing. Whenever possible,
all interviews with a given participant were undertaken by the same individual. The assessments took place
in participants’ homes, the North Tyneside Falls Prevention Service or community centres or facilities
(e.g. local Age UK premises), Newcastle University or the RVI, in accordance with participant preference.
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TABLE 7 Data collection at each time point
Outcomes
Visit:
1. Initial
screening
2. Baseline visit
confirmation of
eligibility and
randomisation
3. End of CBTi
intervention
8 weeks
(visit window
± 1 week)
4. 6 months
post
randomisation
(visit window
± 2–4 weeks)
5. 12 months
post
randomisation
(visit window
± 2–4 weeks)
Study discussed/PIS given ✗
Informed consent ✗
Randomisation (post
eligibility checked and
baseline tests)
✗
Numeric rating scale for pain
when walking
✗ ✗ ✗ ✗
Numeric rating scale for fear
of falling when walking
✗ ✗ ✗ ✗
HADS ✗ ✗ ✗ ✗
MMSE ✗ ✗ ✗
FES-I ✗ ✗ ✗ ✗ ✗
Resource utilisation form ✗ ✗
WHOQOL-OLD ✗ ✗ ✗ ✗
EQ-5D (5L) ✗ ✗ ✗ ✗
SF-36 ✗ ✗ ✗ ✗
De Jong Gierveld Loneliness
Scale 11-item
✗ ✗ ✗ ✗
LSNS-6 ✗ ✗ ✗ ✗
Social Participation
Questionnaire
✗ ✗ ✗ ✗
SPPB ✗ ✗ ✗ ✗
Functional reach ✗ ✗ ✗ ✗
Handgrip strength ✗ ✗ ✗ ✗
Adverse events ✗ ✗ ✗
Falls diaries ✗ (monthly)
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Structured, weekly returned, postage-paid falls diaries were used to capture contemporaneous details of
falls (see Appendix 3). Participants and carers were given verbal and written instructions to ‘. . . record each
day any fall including a slip or trip in which you lost your balance and landed on the floor or ground or
lower level’. We have previously used this technique successfully in similar populations, with published data
showing in excess of 90% return rates.83,84
The HADS, WHOQOL-OLD, EQ-5D (5L), SF-36 and LSNS were compiled into a questionnaire booklet and
sent to patients for self-completion at the appropriate time points (see Table 7), prior to the planned visit
date by the RA/interviewer, with a reply-paid envelope for return of the completed questionnaire direct to
the research team. If participants had not returned this self-completion questionnaire within 2 weeks of
the corresponding follow-up visit by the RA, the participant was contacted by a member of the research
team and prompted to return it. If the participant had misplaced the questionnaire, a covering letter,
replacement self-completion questionnaire and reply-paid envelope were provided. If the participant was
unable to self-complete the questionnaire then the data were captured via the telephone by a RA. In these
circumstances, the questions were asked in the following order to obtain the key measures in the event
the participant did not wish to complete the full questionnaire (the HADS was not included, as it was
considered too difficult to administer by telephone):
1. EQ-5D (5L)
2. SF-36
3. WHOQOL-OLD
4. LSNS-6.
At baseline, prior to randomisation, the RA administered the numeric rating scale for pain when walking.
Participants were asked to rate their pain when walking by selecting a number on a scale from 0 to 10
(11-point scale) by circling the number that best described the level of pain they experienced.85 Pain on
walking, dichotomised as ‘no’ (score of 0) compared with ‘yes’ (scores of 1–10) formed one of the
stratification variables in randomisation.
At each of the visits, the RA administered (in order) the FES-I, numeric rating scale for fear of falling when
walking, the De Jong Gierveld Loneliness Scale and the Social Participation Questionnaire, SPPB, functional
reach and handgrip strength tests. A standard chair was used in assessing muscle power, to ensure
consistency. If it was not possible to arrange an in-person visit, but the participant was willing to provide
outcome data, the FES-I, numeric rating scale for concern about falling, Social Participation Questionnaire,
De Jong Gierveld Loneliness Scale and resource utilisation form were administered via telephone by a RA.
Harms
The anticipated potential risks associated with this trial were few. The main anticipated issue centred on
the potential for patients to gain confidence and lose fear of falling in a way that was inconsistent with
their improvement (or lack thereof) in physical function. In other words, patients who had hitherto
considerably limited activity through fear of falling might have the potential to increase activity levels
through amelioration of the condition with the CBTi before any physical interventions had been able to
take effect. In practice, we felt this to be unlikely, given the prolonged course of the CBTi.
All adverse events were elicited and recorded by falls diaries and RAs/interviewers at all visits, and were
categorised as to expectedness, relatedness and severity. All serious adverse events, excluding any
pre-planned hospitalisations (e.g. elective surgery) not associated with clinical deterioration, routine
treatment or monitoring of the studied indication (i.e. fear of falling), not associated with any deterioration
in condition and elective or scheduled treatment for pre-existing conditions that did not worsen during
the study, were likewise recorded throughout the study. Seriousness of adverse events was defined in
accordance with Good Clinical Practice as follows:
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Serious adverse event An untoward occurrence (whether expected or not) that:
l results in death
l is life-threatening (refers to an event in which the subject was at risk of death at the time of the event;
it does not refer to an event that, hypothetically, might have caused death if it were more severe)
l requires hospitalisation, or prolongation of existing hospitalisation
l results in persistent or significant disability or incapacity
l consists of a congenital anomaly or birth defect
l is otherwise considered medically significant by the investigator.
Participant timeline
The schedule of patient visits is summarised in Table 7 and in Figure 4. Patient recruitment took place
between 3 July 2012 and 28 February 2014. The first site, North Tyneside Falls Prevention Service, started
screening on 28 May 2012, and the first patient was recruited from this site on 3 July 2012; the Falls and
Syncope Service started screening on 25 May 2013, and the first patient was recruited from this site on
19 July 2013; the Galleries Day Unit started screening on 5 June 2013, and the first patient was recruited
from this site on 11 July 2013. Study interventions were delivered between 27 July 2012 and 17 November
2014. The last patient/last visit was on 31 January 2015.
Informed consent
The patient signs a consent form or oral informed
consent taken in the presence of an independent witness
Randomisation
Patients randomised via a web-based system
CBTi plus usual falls service care Usual falls service care
8 weeks after randomisation
Assessments: domain specific, health-economic 
and generic quality-of-life questionnaires,
social participation and isolation, and impact on function
6 months after randomisation
 Assessments: domain specific, health-economic 
and generic quality-of-life questionnaires,
social participation and isolation, and impact on function
12 months after randomisation
Assessments: domain specific, health-economic 
and generic quality-of-life questionnaires,
social participation and isolation, and impact on function
Initial assessment:
Patients ≥ 60 years present to falls service 
Process
evaluation
FIGURE 4 Trial flow chart.
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Sample size calculation
As indicated above, the primary outcome was change (from baseline) in fear of falling, as measured by the
FES-I, at 12 months. The estimated standard deviation (SD) of change scores was 12.5.29 The target
difference in group means that we wished to be able to detect was four points (per clinical judgement, in
combination with observed effects in a range of studies27,40 corresponding to a standardised effect size of
0.32). Initially, sample size was calculated for 90% power, 5% significance level. Slow recruitment led to a
review of the power calculation and agreement – by the funder, Trial Steering Committee (TSC) and Data
Monitoring Committee – that power could be reduced to 80%. Accordingly, the number required to
provide full outcome data (80% power, 5% significance level) was calculated as 154 per group, or 308 in
total. We estimated a 25% dropout rate on the basis of previous experience with older fallers in RCTs83
and data from a previous study of CBT in fear of falling in which 30% of the intervention group and 25%
of the usual care group failed to complete the study.28 Accordingly, to allow for 25% dropouts, we aimed
to recruit 412 participants.
Methods for participant recruitment
Identification and screening of participants
Potential participants with significant fear of falling (FES-I score of > 23) were identified prospectively and
retrospectively by staff at the participating community falls services, as described in greater detail below;
the majority were identified and approached prospectively. When the FES-I was not administered routinely
at a particular site, consent was taken prior to administering this measure. At the majority of sites, all other
screening assessments were part of routine clinical practice; when a screening measure was not part of
routine clinical practice, consent was taken prior to administration of that measure.
A screening log was kept at each site to document details of subjects who were invited to participate in
the study. For subjects who declined participation, this documented any reasons that were available for
non-participation. The log also ensured that potential participants were approached only once.
Phase I participants who screened eligible and had expressed an interest in the CBTi intervention were
offered the opportunity to receive the CBTi, but were not randomised and did not complete any
outcome measures.
Recruitment procedures
Prospective recruitment of participants
Original plans for prospective recruitment at North Tyneside Falls Prevention Service and thereafter at the
Galleries Day Unit were to send an invitation letter and summary participant information leaflet providing
details of the STRIDE study with the routine appointment letter inviting patients to attend the falls services.
However, the organisations providing these services felt that this strategy might impact adversely on clinic
attendance, and therefore this approach was abandoned at those sites. Instead, a member of the research
team (STRIDE HCA or interviewer) or a clinical trial associate (CTA) from the Clinical Research Facility (CRF)
was present in the clinic waiting area at North Tyneside to discuss the STRIDE study with patients who
were waiting for their appointment and those who had attended their appointment. This person explained
to patients that their eligibility would be confirmed by the clinic staff following the patient’s appointment.
In the Galleries Day Unit, potentially eligible patients were invited to participate by staff members
(nursing and/or medical) during clinic visits and the study was explained to them by this staff member.
In the Falls and Syncope Service, potentially eligible patients were invited to participate by staff members
(nursing and/or medical) or clinical research network research associates during clinic visits, and the study
was explained to them by the relevant individual.
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In all sites if, following the procedures described above, the patient expressed an initial interest in
participating in the study, a detailed Participant Information Sheet was provided for the patient to take
home, along with an expression of interest form, to be forwarded directly to the research team at
Newcastle University. If the patient expressed an interest in taking part while still in clinic, the member of
clinic staff completed a ‘consent to release contact details’ form, which was passed on to the research
team. Those returning a positive expression of interest form, or for whom we had a ‘consent to release
contact details’ form, were contacted, usually within 1 week, by a RA/interviewer, to discuss further their
participation and arrange a convenient time to meet to take consent and complete the baseline
assessments. If the patient had not returned the expression of interest form to the STRIDE office at
Newcastle University within 1 week of their clinic appointment, a member of the clinical team from the
relevant falls service contacted the patient by telephone to establish whether or not they had any further
questions about the study and to ask if they would like to participate. A RA/interviewer then contacted the
patient by telephone to discuss the study further and answer any questions. Arrangements were then
made to meet those patients who were willing to proceed, in a place of their choice, to take formal
consent and administer the baseline measures.
Retrospective recruitment of participants to the randomised controlled trial
Eligible patients who had attended the Galleries Day Unit in the 3 months preceding the study opening in
that site were identified, retrospectively, by a member of clinic staff prior to prospective recruitment
commencing at that site. The initial retrospective sample was approached following initial poor recruitment
to the study, and following ethical, sponsor, funder, Trial Steering Group and Data Monitoring Committee
review and approval. Patients were routinely asked at this clinic to give consent for their details to be
used for research, and only those who had given this permission were considered. Identified patients were
sent an invitation letter, detailed Participant Information Sheet, expression of interest form and a prepaid
envelope in which to return the expression of interest form to the STRIDE office at Newcastle University.
A member of clinic staff telephoned those patients who had not returned the expression of interest form
after 1 week to check that they had received the letter and to explore their views on participation. If the
patient expressed an interest in taking part, the member of clinic staff completed a ‘consent to release
contact details’ form, which was passed on to the research team. A RA/interviewer then contacted the
patient by telephone to discuss the study further and to answer any questions. Arrangements were then
made to meet those patients who were willing to proceed, in a place of their choice, to take formal
consent and administer the baseline measures.
Consent procedures
Informed consent discussions were undertaken by trained RAs/interviewers, with opportunity for
participants to ask any questions. Following receipt of information about the study, participants were given
reasonable time (minimum of 24 hours) to decide whether or not they wished to participate. Those
wishing to take part provided written, informed consent by signing and dating the study consent form,
which was witnessed and dated by the RA/interviewer. Written informed consent to study-specific
procedures/investigations was obtained prior to randomisation. The original signed consent form was
retained in the Investigator Site file, with a copy placed in the clinical notes and another copy provided to
the participant. Participants specifically consented to their GP being informed of their participation in
the study.
Interpreters were available for all visits of patients who required them, either for verbal translation or for
deaf subjects wishing to take part in the study, via local NHS arrangements. In practice, no patients
required an interpreter or signer.
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Randomisation
A computer-generated blocked allocation (programmed in Awk, Version 4.1; GNU; Free Software
Foundation, Inc., Boston, MA, USA) was used to allocate patients in a 1 : 1 ratio to intervention and control
groups (permuted random blocks of variable length, block size was not disclosed to the investigators).
Randomisation was stratified by site, patient gender, baseline score on the numeric rating scale for pain
when walking (0 vs. 1–10) and whether or not the patient had been referred for strength and
balance training.
Randomisation was administered centrally via the Newcastle Clinical Trials Unit’s internet-accessed secure
web-based system to ensure concealment of allocation. The Chief Investigator, or other individual with
delegated authority, accessed the web-based system once patient eligibility had been confirmed and
informed consent obtained. Patient screening ID, initials and stratifying variables were entered into the
web-based system, which returned the allocation status. Participants were informed of their allocated
treatment group immediately after randomisation.
Blinding
Owing to the nature of the intervention, it was not possible to blind patients or care providers.
The research team, including those collecting outcome data and the statistician analysing data, were
also unblinded.
Statistical methods
Analyses were conducted using IBM SPSS Statistics release 22 (IBM Corporation, Armonk, NY, USA) and
Stata release 12 (StataCorp LP, College Station, TX, USA).
Primary analysis
The difference between FES-I at the end of treatment (12 months) and FES-I immediately before treatment
(baseline) in two arms was analysed using analysis of covariance. The dependent variable was the FES-I
score at 12 months; baseline FES-I was included as a covariate. Stratification variables (site, gender, pain
when walking, and referral for strength and balance training) were included as fixed effects. A two-tailed
test was performed, with significance level set at 5% (95% CIs of parameters of interest). The primary
analysis was on the basis of intention to treat (ITT) with patients included in the group to which they
were randomised.
Secondary analysis of primary outcome measure
The above analyses were extended to include intermediate measures of FES (8 weeks and 6 months).
Within a multilevel model both variation between occasions within an individual participant and variation
between participants were included as random effects (assumed to have a Gaussian distribution). The
hypothesis to be tested was that fear of falling would be lower in the intervention group at 8 weeks
(i.e. on completion of therapy) and the difference between groups would be maintained until the end of
follow-up at 12 months.
If > 25 patients in the intervention group fail to complete the full course of CBT we planned to investigate
whether or not there was an association between the effectiveness of the intervention and the number
of CBT sessions attended. We indicated that this would be achieved by adding the number of sessions of
therapy as a patient-level covariate to the above model.
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Secondary outcomes
Each of the remaining health status and quality-of-life measures took the form of a score that was treated
as a continuous variable and analysed using analysis of covariance with an assumed normal error structure.
The dependent variable was the response observed at 12 months. Baseline response was included as a
covariate; differences between randomisation strata were included as fixed effects (a binary indicator of
pain when walking, gender, referral for strength and balance training, and treatment centre). Finally, the
difference between groups was fitted as a fixed effect. A 95% CI for the estimated impact of CBTi is
presented. Differences between strata were then removed from the model and unadjusted estimates of
the impact of CBTi are presented for comparison purposes.
Change over time in these outcomes was investigated using a sequence of multilevel models with both
variation between occasions within an individual participant and variation between participants included as
random effects (assumed to have a Gaussian distribution). Differences between strata were included as
fixed effects. An initial model assumed a common linear trend over time in each of the study groups. In a
second model, a separate trend was fitted for each study group; 95% CIs are presented for each estimate
of trend and for the difference between them.
Analyses were designed to:
l measure the impact of the intervention compared with control on fall and injury rates in the trial
participants and its impact on functional abilities
l assess the effectiveness of the intervention compared with control on anxiety (HADS), quality of life
[EQ-5D (5L), SF-6D, WHOQOL-OLD], social isolation and social participation at 6 and 12 months post
randomisation, through analysis of covariance
l summarise the acceptability of the intervention for patients, family members and professionals
(see Chapter 5)
l investigate further the professional and organisational factors that promote or inhibit the
implementation and integration of the intervention (see Chapter 5)
l measure the costs and outcomes of the intervention in this setting (see Chapter 6).
For all analyses, examination of residual plots was used to check model assumptions.
Scoring of questionnaires and handling of missing data
The FES-I scores were calculated in accordance with the authors’ instructions:29 if data were missing one
more than four items, the data were declared as missing; if no more than four of the items were missing,
the score was calculated by adding the responses to all completed items, dividing by the number of items
completed and multiplying the value thus obtained by 16, and then rounding to the nearest whole number.
In respect of secondary outcome data, quality-of-life scores were calculated in accordance with their
authors’ instructions.61,64,67–70,86 For the SF-36, scoring software provided by the developers and distributors
of the instrument was used (www.optum.com/optum-outcomes/what-we-do/health-surveys.html, accessed
1 October 2015). In the absence of any authors’ rule for handling missing data, simple imputation was
used, provided that at least half of the items in any scale had been completed (imputed missing
value=mean value of non-missing items). Secondary outcomes were analysed using mixed models that
made use of all data available.
To address differential dropout in the two groups, in both the protocol and statistical analysis plan, we
originally proposed to use the method of joint modelling described by Henderson et al,87 based on the
assumption that time to dropout would be predictive of final outcome. The rationale behind this approach
is that there is some underlying characteristic of the participant, usually referred to as ‘frailty’, which is
associated both with dropout and outcome.
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In practice, dropout did not occur steadily through this study but rather was triggered by particular activities
arising from participation in the study. A large proportion of the dropout occurred prior to week 8; a smaller
proportion of dropout accrued over the remaining 44 weeks. The fitting of a Cox proportional hazards
model to ‘time to drop out’ would appear to be very questionable, given the pattern of missing data within
the two arms of the trial. Instead, to assess the impact of missing visits, we adopted an approach based on
multiple imputation.88
Multiple imputation was used to attribute missing values for the FES-I score at each of the follow-up time
points, in those cases when the instrument was not completed at all, or could not be scored. The
imputation model included the following variables measured at baseline:
l age
l sex
l gait and balance score
l handgrip strength
l functional reach
l falls efficacy (FES score)
l concern about falling (0–10 scale)
l pain when walking (0–10 scale)
l participation score
l loneliness score
l site.
In addition, the number of sessions of CBT completed was included as a predictor variable.
Four sets of imputation were undertaken. The FES score at 1 year was estimated using a regression model
with the above variables included as predictors. Then FES scores at 8 weeks, 6 months and 1 year were
estimated simultaneously, assuming a multivariate normal model.
Each of these methods was undertaken:
1. separately for each study group (intervention and control)
2. with both groups together (with group added as a predictor variable).
In each case, 50 data sets were imputed.
Imputation was carried out using the ‘mi impute’ procedure in the Stata statistical package. Two different
multivariate data imputation models were used. In both cases, missing values for all of the specified
variables were imputed simultaneously. The first method used a regression model approach (‘mi impute
regress’ in Stata); the second method assumed a multivariate normal distribution (‘mi impute mvn’ in
Stata). These methods were applied using two different approaches. First, the imputation was carried out
using all participants; second, the imputation was done separately for each group. Thus there were four
sets of imputed data. In each case, 50 imputations were undertaken, giving a total of 4 × 50= 200
imputed data sets. Inference on each of the four sets of 50 data sets was carried out using the ‘mi
estimate’ procedure in Stata. Coefficients and standard errors are adjusted for the variability between
imputations according to the combination rules set out by Rubin.89
Safety (harms)
The aim of the analysis of harms was to estimate the difference in the rate of adverse events experienced
by the two treatment groups. For serious adverse events, we determined 95% CI for the hazard ratio
(i.e. risk of a serious adverse event) for a patient randomised to CBTi plus usual care compared with a
patient randomised to usual care.
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Compliance
The number of CBT sessions attended was documented and the date of each session was captured.
Descriptive analysis focused on the number of sessions attended and the time interval over which the first
eight sessions were completed. We also analysed the distribution of time between completion of the first eight
sessions of CBT and the scheduled 8-week and 12-month follow-up assessment of outcomes.
Data archiving
Study documents and data will be archived for 10 years, in line with sponsor policies.
Patient and public involvement
Our group was fortunate to have powerful clinical and research links to North Tyneside Age UK. The North
Tyneside Falls Prevention Service [for which the principal investigator (SWP) was clinical lead] was in
partnership with Age UK to provide targeted strength and balance training classes, developed jointly
between the Service and Age UK. These links allowed us the opportunity of early and comprehensive
involvement of the Age UK executive team, staff, volunteers and clients in the development and
implementation of the study. Indeed, AC, Chief Executive of Age UK North Tyneside, was a co-applicant
for the STRIDE study, and her knowledge and expertise added immeasurably to these processes. The
Health and Wellbeing leads for Age UK North Tyneside (AW and SG) were active members of our TSC,
adding expertise and critical faculty regarding the client group and the conduct of the trial to this
key Committee.
In developing the proposal, in addition to more general information and constructive advice and criticism
of the study methods and recruitment processes, Age UK staff, volunteers and clients gave invaluable
advice on appropriate inclusions in the study, the choice of the primary outcome measure, its clinical
relevance to older people, and what changes in score would be relevant to older people with fear of
falling. They were similarly involved in focus groups informing likely recruitment rates, while these groups
also reviewed study literature to ensure readability and enhance understanding by participants and their
families and carers. Focus groups and staff and client views were also key in providing information on
what duration and frequency of CBT would be acceptable to older people prior to the commencement of
the study.
Our proposal was thus rooted developmentally and during the conduct of the study in the locality and the
ecology of its elder population in a way that would otherwise have been impossible, adding immeasurably
to our understanding of what would was acceptable to this group of older people and so to the successful
design and conduct of the study, and ultimately to the research question we eventually answered.
A specific example of how our links to Age Concern UK informed trial design and conduct relates to
review and refinement of the patient recruitment process. One member of the research team (CB) met
with the Health and Wellbeing lead for Age UK North Tyneside (SG) to discuss possible changes to this
process. Presented with a range of options, SG immediately recommended having a STRIDE therapist or
researcher at the clinic to make the first approach to potential participants. This approach had been used
successfully by one of her colleagues to recruit people to the ‘Fit as a fiddle’ initiative. SG suggested that
we could cite Age UK when making the case for a face-to-face approach in clinic, and that this approach
could be described as having been ‘tried, tested, used and endorsed by Age UK’. She also emphasised the
need to make sure that patients could subsequently opt out in order to manage any potential sense of
coercion. These suggestions were taken on board.
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Chapter 4 Phase II: randomised controlled
trial results
Introduction
In line with Consolidated Standards of Reporting Trials (CONSORT) guidance,90 in this chapter we present
the results of the Phase II of the STRIDE study, the RCT of the CBTi with usual care compared with
usual care. The sections below detail patient flow, screening, eligibility and recruitment data and a
comprehensive overview of usual care in the three recruitment sites, and then baseline and follow-up data
for the primary and secondary outcome measures, including harms.
Participant flow
Screening within the sites
Overall, 2355 patients were initially screened (using information recorded in clinic databases) by the clinic
staff across the three recruitment sites (Table 8). Of those screened, 1346 were considered to be eligible
for the trial (57.1%). Some eligible patients explicitly declined the initial study information that was
available at the clinic.
Rates of eligibility were similar between the Falls and Syncope Service and the North Tyneside Falls
Prevention Service, but were markedly higher at the Galleries Day Unit. Rates of decline of study
information by those who were deemed to be eligible varied significantly across the three sites, with
patients at the Galleries Day Unit most likely to decline information.
One reason for ineligibility was recorded for each patient within the screening log. The reasons for non-
eligibility at initial screening are shown in Table 9; most commonly these were FES-I score of ≤ 23 (78.4%),
MMSE score of < 24 (17%) and patients aged < 60 years (1.6%). There were marked differences between
sites in the stated reasons for ineligibility. This in part reflected inter-site differences in patient case mix and
variations in practice (see Chapter 3) with respect to routine administration of the FES-I and MMSE, and
therefore availability of these data in assessing eligibility.
TABLE 8 Initial screening and eligibility numbers by site
Site
Total
screened
Ineligible
Eligible
Total eligible
Declined
information
Provided with
information
n %a n %a n %b n %b
Falls and Syncope Service 679 300 44.2 379 55.8 131 34.6 248 65.4
Galleries Day Unit 239 66 27.6 173 72.4 90 52.0 83 48.0
North Tyneside Falls Prevention Service 1437 647 45.0 790 55.0 161 20.4 629 79.6
Total 2355 1013 43.0 1342 57.0 382 28.4 960 71.3
a Percentage of patients screened.
b Percentage of eligible patients.
DOI: 10.3310/hta20560 HEALTH TECHNOLOGY ASSESSMENT 2016 VOL. 20 NO. 56
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Parry et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
37
Screening prior to randomisation
The RAs made a further check on eligibility by reviewing each of the inclusion and exclusion criteria with
patients who returned an expression of interest form. This was to ensure that their eligibility had not
changed prior to randomisation. Some additional participants were excluded at this stage, the reasons for
exclusion are shown in Table 10.
Rates of non-contact did not vary significantly between the three sites. Among the 682 patients contacted,
rates of eligibility were 91.4% for the Falls and Syncope Service, 90.7% for the Galleries Day Unit and
92.6% for North Tyneside Falls Prevention Service. A total of 627 of those contacted were deemed
eligible, of whom 211 (33.7%) did not consent to randomisation. Rates of non-consent were 40.6% for
the Falls and Syncope Service, 43.2% for the Galleries Day Unit, and 26.6% for the North Tyneside Falls
Prevention Service; pairwise comparisons indicated that the rate of non-consent at the North Tyneside
Falls Prevention Service was significantly different from the rates at the other two sites. There appeared
to be some variation across sites in the reasons for declining consent, but this may be due, in part, to
inconsistency between RAs/interviewers in how the reasons offered were categorised (Table 11).
The overall participation rate (i.e. number consenting and randomised as a percentage of those returning
an expression of interest form) was 58%, with site-specific rates of 51.0%, 50.5% and 64.7% for the Falls
and Syncope Service, Galleries Day Unit and North Tyneside Falls Prevention Service, respectively. Pairwise
comparisons showed that the participation rate for the North Tyneside Falls Prevention Service was
significantly different from the rates at the other two sites. When reasons for non-participation were
grouped as ‘no contact’, ‘ineligible’, ‘declined consent’ and ‘died post randomisation’, there were no
significant differences between sites.
TABLE 9 Reasons for non-eligibility by site
Description
Site
Total
Falls and Syncope
Service
Galleries
Day Unit
North Tyneside Falls
Prevention Service
n % n % n % n %
FES-I score of ≤ 23 265 88.3 13 19.7 516 79.8 794 78.4
Cognitive impairment (MMSE score
of < 24)
13 4.3 39 59.1 120 18.5 172 17.0
Aged < 60 years 0 0.0 9 13.7 7 1.1 16 1.6
Care home resident 11 3.7 0 0.0 0 0.0 11 1.1
No reason provided 0 0.0 5 7.6 2 0.3 7 0.7
Patient requires psychosocial
interventions unrelated to fear of
falling
2 0.7 0 0.0 2 0.3 4 0.4
Current involvement in other
investigational studies or trials, or
involvement within 30 days prior to
study entry
8 2.7 0 0.0 0 0.0 8 0.8
Life expectancy of < 1 year 1 0.3 0 0.0 0 0.0 1 0.1
Total number of patients considered
ineligible
300 100.0 66 100.0 647 100.0 1013 100.0
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TABLE 11 Reasons for non-consent to participate by site
Description
Falls and Syncope
Service
Galleries Day
Unit
North Tyneside Falls
Prevention Service Total
n %a n %a n %a n %a
Felt no intervention needed 6 7.0 0 0.0 9 10.3 15 7.1
Felt CBTI ‘not for me’ 25 29.1 15 39.5 11 12.6 51 24.2
Wanted only strength and balance training 2 2.3 0 0.0 6 6.9 8 3.8
Too busy 14 16.3 8 21.1 15 17.2 37 17.5
Illness 23 26.7 11 28.9 17 19.5 51 24.2
No reason given 16 18.6 4 10.5 29 33.3 49 23.2
Total 86 38 87 211
a Percentage of all those declining.
TABLE 10 Reasons for non-participation following RA screening
Description
Falls and Syncope
Service
Galleries
Day Unit
North Tyneside Falls
Prevention Service Total
n %a n %a n %a n %a
Returned expression of interest form 245 99 371 715
Unable to contact 13 5.3 2 2 18 4.9 33 4.6
Reason for ineligibility on RA screening
FES-I score of ≤ 23 4 1.6 2 2 14 3.8 20 2.8
Patient has cognitive impairment
(MMSE score of < 24)
7 2.9 3 3 0 0 10 1.4
Patient requires psychosocial interventions
unrelated to fear of falling
4 1.6 0 0 2 0.5 6 0.8
Aged < 60 years 0 0 1 1 0 0 1 0.1
Current involvement in other
investigational studies or trials, or
involvement within 30 days prior to
study entry
4 1.6 2 2 5 1.3 11 1.5
Spouse randomised 1 0.4 1 1 5 1.3 7 1
Total ineligible 20 8.2 9 9.1 26 7.1 55 7.7
Total declining 86 35.1 38 38.4 87 23.5 211 29.5
Consented but died shortly thereafter 1 0.4 0 0 0 0 1 0.1
Total non-participation (including unable
to contact)
120 49 49 49.5 131 35.3 300 42
Consented and randomised 125 51 50 50.5 240 64.7 415 58
a Percentage of those returning expression of interest form.
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Recruitment
Monthly recruitment is shown in Figure 5.
Randomisation
The screening, recruitment, randomisation and trial follow-up are summarised in the CONSORT diagram
shown in Figure 6.
Recruitment by strata
A total of 415 participants were randomised; 240 (57.8%) came from the North Tyneside Falls Prevention
Service, the first site to open; 125 (30.1%) came from the Falls and Syncope Service; 50 (12.1%) came
from the Galleries Day Unit). In addition to recruitment site, the sample was stratified by three other
variables: gender, pain when walking (dichotomised as yes/no from ratings on a 11-point scale) and
referral to strength and balance training (yes/no) (Table 12). Overall, 124 (29.9%) of those randomised
were men (95% CI 25.5% to 34.5%). Two hundred and one participants (48.4%; 95% CI 43.5% to
53.4%) reported that they suffered pain when walking; 288 participants (69.4%; 95% CI 64.7% to
73.8%) had been referred for strength and balance training.
Strata were included as fixed effects in analyses of covariance. To inform this approach, the level of
collinearity in these potential explanatory variables was examined.
There were systematic differences between the three sites only with respect to the percentage of
participants referred for strength and balance training, reflecting variation in ‘usual care’ between these
sites, as described in Chapter 3.
Overall, 50.8% of men and 47.4% of women reported pain on walking [relative risk (RR) 1.04, 95% CI
0.02 to 1.18]. Of those referred for strength and balance training, 50.3% had pain on walking, 49.7% did
not [RR for an individual referred for strength and balance training having pain on walking= 1.09 (95% CI
0.87 to 1.36)]. Across all sites, men were more likely to be referred for strength and balance training than
women (77.4% vs. 66.0%, RR 1.17, 95% CI 1.03 to 1.32).
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FIGURE 5 Recruitment graph.
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Analysed at primary end point
• Complete case analysis, n = 151
• Using imputed values for
   missing data, n = 210
Participants in follow-up at
• 8 weeks, n = 164
• 6 months, n = 151
• 12 months, n = 151
Participants in follow-up at
• 8 weeks, n = 180
• 6 months, n = 162
• 12 months, n = 162
Assessed for eligibility
(n = 2355)
Provided with study details
(n = 960)
Analysed at primary end point
• Complete case analysis, n = 162
• Using imputed values for
   missing data, n = 205
Returned expression of interest form
(n = 715)
Randomised
(n = 415)
Allocated to CBT intervention
(n = 210)
• Received minimum of 1 CBT 
   session (n = 183)
• Received full programme of
   CBT (n = 151)
Allocated to control
(n = 205)
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Excluded at falls clinic
(n = 1395)
• Not meeting inclusion
   criteria, n = 1013
• Declined information,
   n = 382
Excluded pre randomisation
(n = 300)
• Not meeting inclusion
   criteria, n = 55
• Declined, n = 211
• Unable to contact, n = 33
• Deceased, n = 1
FIGURE 6 The STRIDE CONSORT diagram.
TABLE 12 Distribution of stratification variables by site
Description
Falls and Syncope
Service
Galleries Day
Unit
North Tyneside Falls
Prevention Service Total
n %a n %a n %a n %
Total randomised 125 30.1 50 12.1 240 57.8 415 100.0
n %b n %b n %b n %b
Male 35 28.0 19 38.0 70 29.2 124 29.9
Pain on walking 52 41.6 29 58.0 120 50.0 201 48.4
Referral to strength and balance training 124 99.2 48 96.0 116 48.3 288 69.4
a Percentage of total number (415) randomised across all sites.
b Percentage of total randomised at this site.
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Recruitment by arm
Two hundred and five patients (49.4%) were randomised to the control arm; 210 patients (50.6%) were
randomised to receive CBTi (Table 13).
Baseline data
Stratification was successful and study arms were balanced with respect to site, gender, pain on walking
(yes/no) and referral for strength and balance training (Table 14).
Falls Efficacy Scale–International version
Completion of the individual items within the FES-I at baseline was excellent. Four participants did not
complete the item ‘Going to the shop’. Greatest concern was expressed about ‘Walking on slippery
surface’; least concern was expressed about ‘Preparing simple meals’ (see Appendix 4). The scale was
internally consistent; Cronbach’s alpha, based on 402 complete cases, was 0.89. The total FES-I score
could be computed for all 415 participants (Figure 7). FES-I score was not associated with age (correlation
–0.034 (95% CI –0.130 to 0.070)].
Fear of falling 11-point scale
In the baseline interview, participants were asked to rate their concerns about falling on an 11-point scale,
for which ‘0’ meant ‘no fear of falling’ and ‘10’ meant ‘fear of falling as bad as it could be’. All 415
participants responded to this item (Figure 8). The majority of participants scored between 5 and 10
The correlation between FES-I scores and fear of falling numerical rating was 0.53 (95% CI 0.46 to 0.60)
(CI based on bootstrap procedure with 1000 replications). There is clearly a strong association between
FES-I scores and fear of falling, as assessed by the rating scale method (see Appendix 4 for a graphical
presentation of this association).
TABLE 13 Trial arm by site
Site
Trial arm
Total
Control Intervention
n % n %
Falls and Syncope Service 62 49.6 63 50.4 125
Galleries Day Unit 23 46.0 27 54.0 50
North Tyneside Falls Prevention Service 120 50.0 120 50.0 240
Total 205 49.4 210 50.6 415
TABLE 14 Baseline data by study arm and stratification variables
Characteristic
Control Intervention Study population
n % n % n % 95% CI
Male 60 29.3 64 30.5 124 29.9 25.6 to 34.6
Pain on walking 101 49.3 100 47.6 201 48.4 43.5 to 53.4
Referred for strength and balance training 143 69.8 145 69.0 288 69.4 64.7 to 73.6
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Pain when walking, 11-point scale
In the baseline interview, participants were asked to rate their pain on walking on a 11-point scale,
for which zero ‘0’ meant ‘no pain’ and ‘10’ meant pain that was ‘as bad as it could be’ (Figure 9). This
variable was dichotomised as ‘no pain’ (0) versus ‘pain’ (1–10) for purposes of stratification. ‘Pain when
walking’ ratings were weakly but positively correlated with FES-I scores [ρ= 0.35 (95% CI 0.27 to 0.44)]
(see also Appendix 4) and with fear of falling numerical rating scales [ρ= 0.32 (95% CI 0.22 to 0.41)].
Social participation and social isolation scale score
Total participation scores ranged from 0 to 37, with a mean of 9.49 and a median of 7 (Figure 10).
Internal consistency, measured by Cronbach’s alpha, was poor at 0.27. Total participation score was not
correlated with age [ρ = –0.006 (95% CI –0.101 to 0.084)].
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FIGURE 9 Distribution of pain when walking, 11-point scale numerical rating.
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De Jong Gierveld Loneliness Scale
High levels of loneliness were reported by participants. Scores ranged from 0 to 11, with a mean of 8.20,
median of 9 and mode of 11 (Figure 11). Internal consistency of this scale was poor, with a Cronbach’s
alpha (α)= 0.42. Loneliness score was not correlated with age [ρ= –0.035 (95% CI –0.145 to 0.070)] but
was positively, albeit weakly, correlated with total participation score [ρ= 0.148 (95% CI 0.054 to 0.235)].
Short Physical Performance Battery (gait, balance and sit to stand)
Short physical performance battery scores ranged from 0 to 12, with a mean of 5.66 (Figure 12). Lower
scores are associated with poorer physical performance, with higher scores reflecting better physical
condition in relation to these activities. The mean for our participants represents an average performance
for this patient group.
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FIGURE 12 Distribution of SPPB scores at baseline.
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FIGURE 11 Distribution of De Jong Gierveld Loneliness Scale scores at baseline.
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Handgrip strength and functional reach
Data on handgrip strength were not available for 13 participants, with reasons for non-completion
recorded for eight (one refused; in two cases the test was not attempted because the participant felt
unsafe; in one case the participant attempted the test but could not hold the position unaided; and in four
cases, the participant attempted the test but failed). Among those completing the test, scores over three
attempts ranged from 0.3 kg to 54.4 kg, with a mean of 16.5 kg (Figure 13). The mean is low compared
with normative data for older patients, with an overall mean for this age group of 31 kg.91
Data on functional reach were not available for 40 individuals, with reasons recorded for 39 of these (four
participants refused; one participant could not understand the instructions; in sixteen cases the participant
felt unsafe, and in five cases the RA felt that it would be unsafe; in five cases the participant attempted the
test but could not hold the position; in five cases, the participant attempted the test but failed; other
reasons were given for three participants). Among those completing the test, scores averaged over three
attempts ranged from 1.3 cm to 51.1 cm, with a mean of 22.8 cm (Figure 14), with > 22 cm representing
the average normal value for older patients.92
Self-completion questionnaires
Baseline self-completion questionnaires were returned by 323 participants (77.8%). A minority of
respondents (20.8%, 95% CI 16.5% to 25.5%) reported that they had help completing the questionnaire;
the percentage requiring assistance was similar across the two arms (Table 15).
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FIGURE 13 Distribution of mean handgrip strength (kg) at baseline.
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Lubben Social Network Scale–6
Lubben Social Network Scale scores ranged from 0 to 30, with a mean of 14.69 (Figure 15). Internal
consistency of this scale was adequate, with a Cronbach’s α= 0.83.
European Quality of Life–5 Dimensions (5 Level)
The EQ-5D (5L) ratings of ‘Health today’ ranged from 5 to 100, with a mean of 58.6 (median 60, mode 50;
Figure 16). Applying UK tariff values, EQ-5D (5L) ‘Index values’ ranged from –0.20 (a state worse than
death) to 1.0 (perfect health), with a mean of 0.51 (median 0.56; Figure 17). Internal consistency of the
five items in this scale was adequate, with Cronbach’s α= 0.73.
0
0 10 20 30 40 50 60
40
20
60
80
Fr
eq
u
en
cy
100
Mean functional reach
Mean = 23.82
SD = 8.299
n = 1167
FIGURE 14 Distribution of mean functional reach (cm) at baseline.
TABLE 15 Help with completion of baseline self-completion questionnaire by arm
Help provider
Control Intervention Total
n % n % n %
RA 24 14.2 25 14.5 49 14.3
Friends/family 9 5.3 13 7.5 22 6.4
None/not stated 136 80.5 135 78.0 271 79.2
Total 169 100 173 100 342 100
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Hospital Anxiety and Depression Scale
The HADS Anxiety scores ranged from 0 to 21, with a mean of 8.2 (median 8.0, mode 7.0; Figure 18).
Scores of ≤ 7 are considered ‘normal’ and 45.5% of participants had scores in this range at baseline;
percentages with ‘mild’ (8–10), ‘moderate’ (11–14) and ‘severe’ anxiety were 23.7%, 23.9% and 6.9%,
respectively. HADS Depression scores ranged from 0 to 17, with a mean of 6.8 (median and mode both 7.0;
Figure 19). Scores of ≤ 7 are considered ‘normal’ and 62.8% of participants had scores in this range at
baseline; percentages with ‘mild’ (8–10), ‘moderate’ (11–14) and ‘severe’ depression were 22.1%, 12.6%
and 2.5%, respectively. Internal consistency of both scales was adequate, with Cronbach’s α= 0.85 for
HADS Anxiety and 0.77 for HADS Depression.
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FIGURE 17 Distribution of EQ-5D (5L) index values at baseline.
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FIGURE 18 Distribution of HADS Anxiety scores at baseline.
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World Health Organization Quality of Life questionnaire – older adults module
The WHOQOL-OLD total scores ranged from 8.3 to 88.5 with a mean of 57.2 (Figure 20). Internal
consistency for the whole scale was adequate, with a Cronbach’s α= 0.86. Cronbach’s alpha for the
individual subscales ranged from 0.66 for ‘Autonomy’ to 0.95 for ‘Intimacy’.
Short Form questionnaire-36 items
Internal consistency of the seven multi-item domain scores was adequate, with Cronbach’s alphas ranging
from 0.72 (General Health Perception) to 0.93 (Role-Emotional). SF-36 Physical Component Scores (PCSs)
ranged from 8.4 to 63.8 with a mean of 32.1 (Figure 21). SF-36 Mental Component Scores (MCSs) ranged
from 17.2 to 69.7, with a mean of 45.2 (Figure 22). PCSs and MCSs are norm based, with a mean of 50
and SD of 10 in a general population. The observed mean scores for this study population indicate poor
physical health relative to a general population, with the mean score almost two SDs below the norm of
50. MCSs were also below the norm, but to a lesser extent.
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FIGURE 19 Distribution of HADS Depression scores at baseline.
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FIGURE 20 Distribution of WHOQOL-OLD scores at baseline.
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FIGURE 22 Distribution of SF-36 MCSs at baseline.
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Baseline comparability
The study arms were well balanced at baseline (Table 16).
The relationship between baseline scores on the FES-I and stratification variables was examined (see
Appendix 4 for detailed graphs and tables). In general, the difference in mean scores between the strata
across a range of health status and quality-of-life measures was fairly small.
The FES-I scores at baseline were higher at the Galleries Day Unit (indicating that participants have a higher
level of concerns about falling) than at the other two sites (one-way analysis of variance indicated that
differences between sites was statistically significant (F2,412= 8.69; p< 0.001). Similarly, numerical ratings of
fear of falling appeared to differ between sites. The mean fear of falling 11-point numerical rating scores
were 6.64 for participants recruited by the Falls and Syncope Service, 7.62 for participants recruited by the
Galleries Day Unit, and 6.51 for participants recruited by the North Tyneside Falls Prevention Service;
patients from the Galleries Day Unit reported a higher fear of falling per the 11-point scale than patients
from the other two sites, a finding consistent with that reported for FES-I scores above. This difference
between sites persisted even on allowing for a difference between sites in the proportion of patients
reporting pain when walking. For other measures, participants recruited at the Galleries Day Unit tended to
have poorer health status and reported poorer quality of life at baseline than patients from the other
two sites.
TABLE 16 Baseline comparability
Outcome
Control CBTI Combined sample
n µ σ n µ σ n µ 95% CI σ 95% CI
Age, years 205 75.3 8.6 210 75.8 8.5 415 75.5 74.7 to 76.4 8.55 8.14 to 8.94
FES-I score 205 40.9 9.9 210 39.8 8.9 415 40.3 39.4 to 41.2 9.37 8.83 to 9.88
Fear of falling
11-point scale
205 6.7 2.1 210 6.7 2.3 415 6.7 6.5 to 6.9 2.17 2.02 to 2.31
Total social
participation/
isolation score
205 9.4 7.5 210 9.6 7.9 415 9.5 8.8 to 10.3 7.69 7.12 to 8.33
Gait and balance
score
203 6.0 3.0 208 5.8 2.9 411 5.9 5.6 to 6.2 2.96 2.78 to 3.10
Mean handgrip
strength
200 15.9 9.5 202 17.1 10.6 402 16.5 15.5 to 17.5 10.08 9.28 to 10.91
Mean functional
reach
186 22.6 8.5 189 23.0 8.3 375 22.8 21.9 to 23.6 8.40 7.81 to 8.99
HADS Anxiety 167 8.4 4.3 171 8.0 3.9 338 8.2 7.8 to 8.7 4.13 3.85 to 4.41
HADS Depression 167 6.7 3.5 172 7.0 3.3 339 6.9 6.5 to 7.2 3.41 3.16 to 3.64
WHOQOL-OLD
total score
166 56.9 14.1 173 57.4 12.9 339 57.1 55.7 to 58.6 13.47 12.43 to 14.45
LSNS-6 167 14.6 5.4 172 14.9 5.8 339 14.7 14.1 to 15.3 5.63 5.25 to 5.98
EQ-5D (5L) Health
today
166 57.6 19.7 171 59.6 17.6 337 58.6 56.7 to 60.7 18.70 17.34 to 20.15
EQ-5D (5L) Index 165 0.50 0.23 166 0.51 0.21 331 0.50 0.48 to 0.53 0.22 0.20 to 0.24
SF-36 PCS 157 32.3 9.1 164 31.9 8.0 321 32.1 31.1 to 33.0 8.5 7.7 to 9.3
SF-36 MCS 157 45.3 10.6 164 45.0 10.5 321 45.2 44.0 to 46.4 10.5 9.7 to 11.2
PHASE II: RANDOMISED CONTROLLED TRIAL RESULTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
52
The FES-I scores at baseline were similar for men and women. As expected, men were observed to have
greater handgrip strength and greater functional reach than women. Otherwise, differences between men
and women were fairly small.
There was a strong positive association between pain on walking and FES-I score at baseline. Scores on the
fear of falling numerical rating scale were also positively associated with pain when walking at baseline.
The mean fear of falling rating scale scores were 5.99 for those with no pain when walking and 7.42 for
those reporting pain when walking, a difference of 1.43 (95% CI 1.03 to 1.83); participants who suffered
pain with walking reported significantly greater fear of falling than other participants. Of all of the four
randomisation strata ‘pain when walking’ was most highly correlated with the health status of the
participant; those who reported pain when walking tended to report poorer health status and quality
of life.
As already noted, referral for strength and balance training was confounded with site. There was no
evidence of an association between FES-I score at baseline and referral for strength and balance training.
Patients who were referred for strength and balance training actually had higher handgrip strength and
greater functional reach than those who were not referred. Other outcome measures were not associated
with referral for strength and balance training.
Numbers analysed
Table 17 shows the rate of data completion at each time point.
Falls Efficacy Scale–International version completion
The figures in the green boxes indicate the number of participants who completed the FES-I sufficiently to
allow it to be scored; the figures in the unshaded boxes indicate the number of participants for whom no
FES-I items have been scored. We have responses at all four visits for 297 participants (Figure 23).
Attrition was slightly greater in the group that was randomised to CBTi (Table 18).
Completion of falls diaries
The majority of diaries (3288/3309) were completed, as anticipated, on paper. The number of diaries that
were returned fell over the period of follow-up. In general, participants in the control arm were better at
completing and returning falls diaries than participants who were randomised to CBTi (Table 19).
TABLE 17 Number of responses at each time point
Visit
RA interview FES-I questionnaire Self-completion questionnaire
Control CBTi Control CBTi Control CBTi
n % n % n % n % n % n %
Baseline 205 100 210 100 205 100 210 100 169 82.4 173 82.4
8 weeks 180 87.8 164 78.1 180 87.8 164 78.1 155 75.6 146 69.5
6 months 161 78.5 151 71.9 163 79.5 151 71.9 138 67.3 114a 54.3
1 year 163 79.5 151 71.9 163 79.5 151 71.9 145 70.7 141 67.1
a One 6-month questionnaire was completed on the form for a 8-week questionnaire and did not include the resource-
use questions.
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FIGURE 23 Number of participants visited by RA and asked to complete the FES-I.
TABLE 18 Number of participants visited by RA and asked to complete FES-I by time point
Visit
Study arm
Relative difference between
study arms TotalControl CBTi
n %a n %a RR 95% CI n %a
Baseline 205 210 415
8 weeks 180 87.8 164 78.1 0.89 0.82 to 0.97 344 82.9
6 months 163 79.5 151 71.9 0.90 0.81 to 1.01 314 75.7
1 year 163 79.5 151 71.9 0.90 0.81 to 1.01 314 75.7
a Percentage of baseline responses at each follow-up visit.
TABLE 19 Monthly completion of falls diaries by study arm
Month
Proportion of sample providing data (%) Risk ratio
Control CBTi Difference 95% CI Risk ratio 95% CI
1 75.1 71.4 –3.7 –12.2 to 4.8 0.95 0.85 to 1.07
2 76.1 63.3 –12.8 –21.5 to –4.0 0.83 0.73 to 0.95
3 72.7 64.3 –8.4 –17.3 to 0.5 0.88 0.78 to 1.01
4 66.8 58.6 –8.3 –17.5 to 1.0 0.88 0.76 to 1.02
5 64.9 57.1 –7.7 –17.1 to 1.6 0.88 0.76 to 1.03
6 66.3 59.0 –7.3 –16.6 to 2.0 0.89 0.77 to 1.03
7 66.8 56.2 –10.6 –19.9 to –1.3 0.84 0.72 to 0.98
8 67.3 55.2 –12.1 –21.4 to –2.8 0.82 0.70 to 0.96
9 63.9 53.3 –10.6 –20.0 to –1.1 0.84 0.71 to 0.98
10 63.9 54.3 –9.6 –19.0 to –0.2 0.85 0.72 to 1.00
11 62.9 51.9 –11.0 –20.5 to –1.6 0.83 0.70 to 0.98
12 59.5 50.5 –9.0 –18.6 to 0.5 0.85 0.71 to 1.01
13 50.7 43.8 –6.9 –16.5 to 2.7 0.86 0.70 to 1.06
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Sixty-eight participants (16.4%) returned no falls diaries at all (Figure 24); 106 participants (25.5%)
returned all 13 diaries. The mean number of diaries returned was 7.97 (95% CI 7.44 to 8.49). On average,
participants randomised to the CBTi returned 1.18 (95% CI 0.20 to 2.11) fewer diaries than participants in
the control arm.
Delivery of the cognitive–behavioural therapy intervention
One hundred and thirty-nine (66.2%) participants who were randomised to the CBTi completed nine
sessions of therapy (Table 20). Fifty-six (26.7%) participants either failed to complete any sessions or
withdrew after the first one or two sessions. Participants from the North Tyneside Falls Prevention Service
were significantly more likely (76.7%) to complete nine sessions of therapy than those from the Falls and
Syncope Service (52.4%) or the Galleries Day Unit (51.9%) (χ2= 13.73; p= 0.001). A total of five patients
received the initial eight sessions of CBTi but withdrew prior to the 6-month top-up session.
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FIGURE 24 Distribution of the number of diaries returned.
TABLE 20 Number of sessions of CBTi delivered by site
Number Falls and Syncope Service Galleries Day Unit
North Tyneside Falls
Prevention Service Total %
0 8 10 9 27 12.9
1 7 1 10 18 8.6
2 6 1 4 11 5.2
3 1 0 0 1 0.5
4 2 0 0 2 1.0
5 3 0 3 6 2.9
7 0 1 0 1 0.5
8 3 0 2 5 2.4
9 33 14 92 139 66.2
Total 63 27 120 210 100.0
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Case load varied across HCAs, with one (full-time) HCA seeing 47.1% of participants, and the other two
(part-time) HCAs seeing 27.1% and 25.6%, respectively.
Scheduling issues, particularly participant availability, caused delays between randomisation and delivery of
the first session of CBTi (Figure 25). For similar reasons, only 33% of participants completed the initial course
of eight sessions within 8 weeks; 79% completed within 12 weeks, but for a minority of participants the
initial course extended over a longer period, to a maximum of 27 weeks (Figure 26). The mean duration of
therapy was just under 11 weeks. Elapsed time from the eighth visit to the ‘6-month’ top-up session ranged
from 21.4 to 44.4 weeks, with a mean of 27.2 weeks.
A smaller proportion of those patients who, at baseline, reported pain when walking completed the
intervention (Table 21) although the 95% CI for the relative risk included one (RR of completion= 0.84,
95% CI 0.69, 1.02).
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FIGURE 25 Days from randomisation to first CBTi session.
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FIGURE 26 Duration of initial eight sessions of CBTi.
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Participants who did not complete their course of CBTi had lower FES-I scores at baseline, indicative of
fewer concerns about falling (Table 22).
Participants who withdrew early from CBTi were more likely to be lost to follow-up for data collection
(Table 23); only 14 (19.7%) of the 71 participants who did not complete all nine sessions of CBTi provided
data on the primary end point at 12 months.
Timing of randomisation and follow-up data collection relative to
cognitive–behavioural therapy intervention delivery
Eighty-five per cent (95% CI 81.2% to 88.4%) of participants were randomised on day of the baseline
assessment. The week 8 visit took place within 44 and 120 days of randomisation. For those randomised to
the CBTi, the interval from the eighth CBTi session to the week 8 visit could be calculated for 137 individuals
(in the remaining instances, one or both dates were missing either because the participant had withdrawn
from the CBTi or did not have a week 8 visit, or both). In 124 (90.5%) of these cases, the week 8 visit took
place on or before the date of the eighth CBTi session; the delay ranged from zero (one participant) to
141 days, with a mean of 31 days, median of 26 days.
Although there was a wide visit window observed at each follow-up point the difference in the mean time
between date of randomisation and date of visit between control and intervention participants was not
statistically significant (Table 24). At 1 year, the mean difference in timing of ascertainment of primary end
point, vis-à-vis randomisation date, was 1.9 (95% CI –3.7 to 6.8) days.
TABLE 21 Proportion of patients completing CBTi therapy by baseline rating pain when walking
Completed nine sessions of CBTi?
Pain when walking?
TotalNo Yes
n % n % n %
No 31 28.2 40 40.0 71 33.8
Yes 79 71.8 60 60.0 139 66.2
Total 110 100 210
TABLE 22 Baseline FES-I: mean scores by whether subject completed full course of CBTi
Completed nine sessions of CBTi?
DifferenceNo Yes
µ 95% CI µ 95% CI µ 95% CI
41.7 39.6 to 43.8 38.8 37.4 to 40.3 –2.97 –5.47 to –0.50
TABLE 23 Completion of FES-I at all time points by whether or not subject completed full course of CBTi
Visit
Control
Intervention
Completed nine sessions of CBTi?
TotalNo Yes
n % n % n % n %
Baseline 205 100.0 71 100.0 139 100.0 210 100.0
8 weeks 180 87.8 31 43.7 133 95.7 164 78.1
6 months 162 79.0 17 23.9 134 96.4 151 71.9
1 year 162 79.0 14 19.7 137 98.6 151 71.9
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Primary outcome: Falls Efficacy Scale–International version
The primary outcome was the total FES-I score at 12 months.
The number of missing responses on each FES-I questionnaire was calculated. A total of 1387 questionnaires
were completed across all time points. All 16 items were completed for 1310 [94.4% (95% CI 93.1 to
95.6%)] of FES-I questionnaires. The number of missing items ranged from 1 to 11, and the rate of missing
items did not vary between the arms of the trial. Following the developers’ instructions, the total FES-I score
was imputed provided that there were fewer than five missing items. Consequently, data imputation was
undertaken for a total of 95 items spread across 75 questionnaires. A total score could not be determined
for 2 of the 1387 questionnaires.
The distribution of FES-I scores at each time point is displayed graphically in Figure 27. The upper and
lower edges of each box correspond to the 75th and 25th percentiles, respectively; the horizontal line
through the centre corresponds to the median, and the whiskers show the upper and lower limits of the
distribution. The median values decrease over time (corresponding to reduced concern about falling)
and the difference between study arm median values appears to get larger.
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FIGURE 27 Box-and-whisker plots of FES-I scores by visit by study arm.
TABLE 24 Time in days between randomisation and follow-up visits by study arm
Visit
Study arm
DifferenceControl CBTi
n µ 95% CI n µ 95% CI µ 95% CI
8 week visit 180 59.2 57.6 to 61.0 164 59.6 58.1 to 61.1 0.4 –1.8 to 2.7
6 month visit 163 196.0 192.3 to 199.5 151 195.4 192.7 to 198.5 –0.5 –4.7 to 4.2
1 year visit 163 371.8 368.7 to 375.6 151 373.7 369.9 to 377.4 1.9 –3.7 to 6.8
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Analysis of Falls Efficacy Scale–International version scores at 1 year
(the primary end point)
The difference between FES-I at the end of treatment (12 months) and FES-I prior to treatment (baseline)
in two arms was analysed using analysis of covariance. The dependent variable was the FES-I score at
12 months; baseline FES-I was included as a covariate. Stratification variables (site, gender, baseline pain
when walking and referral for strength and balance training) were included as fixed effects.
This was achieved by fitting a simple linear regression model. The regression coefficients are given in
Table 25. FES-I at 1 year was highly correlated with baseline FES-I.
There were significant differences between sites, with participants at the Galleries Day Unit having higher
FES-I scores (reflecting poorer falls-related self-efficacy and fear of falling) than participants from the other
two sites. Participants who reported pain when walking had higher FES-I scores, whereas participants who
had been referred for strength and balance training had lower FES-I scores. The difference between men
and women was not significant. Finally, the difference between study arms was statistically significant; the
estimated impact of CBTi on FES-I scores was a reduction in mean score of 4.02 (95% CI 2.10 to 5.95).
The baseline SD of FES-I was 9.37. The reduction in mean score of 4.02 can be expressed as a
standardised effect size by dividing by this SD, yielding a point estimate of effect size of 0.43 and an
interval estimate of between 0.22 and 0.64.
The change in R2 on adding the effect of therapy to the model including baseline FES-I scores and the
effects corresponding to each of the strata is shown in Table 26. R2 increased from 0.45 to 0.48.
TABLE 26 Change in R2 when adding the impact of the intervention
Model R2 Adjusted R2
Change statistics
R2 change F change df 1 df 2 Significant F change
1 0.447 0.436 0.447 41.146 6 306 < 0.001
2 0.476 0.464 0.029 16.877 1 305 < 0.001
df, degrees of freedom.
TABLE 25 Parameter estimates for FES-I at 12 months
Variable
Regression coefficients Significance
B 95% CI t p-value
Constant 9.26 3.33 to 15.20 3.07 < 0.001
Baseline FES-I 0.74 0.62 to 0.85 12.79 < 0.001
Strataa
Galleries Day Unit 4.46 0.75 to 8.17 2.36 0.02
North Tyneside Falls Prevention Service –0.70 –3.25 to 1.85 –0.54 0.59
Presence of pain when walking 2.78 0.75 to 4.81 2.69 0.01
Referred for strength and balance training –2.83 –5.28 to –0.37 –2.26 0.02
Gender (female) 0.00 –2.13 to 2.14 0.00 1.00
Impact of CBT (study arm) –4.02 –5.95 to –2.10 –4.11 < 0.001
a Reference category for strata are the RVI Falls and Syncope Service (centres); no pain when walking; no referral for
strength and balance training; and male.
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Plots of standardised residuals suggest assumption of a normal error distribution for the residuals
is reasonable.
Impact of non-response on primary outcome measure
As previously described (see Chapter 3), multiple imputation was used to impute missing values for the
FES-I score at each of the follow-up time points, in those cases where the instrument was not completed
at all, or could not be scored. A pooled estimate of the impact of the intervention at 1 year across data
sets was based on an analysis of covariance model with adjustments for baseline FES and randomisation
strata. The parameter estimates are given in Table 27.
Adjusting for missing data reduces the ITT estimate of the effect of the CBTi; all methods of data
imputation result in a smaller estimated impact of the CBTi on fear of falling. This is consistent with the
observations that (1) those patients who withdrew from the CBTi arm had lower FES-I scores at baseline
and (2) in the analysis of imputed data we have a much greater proportion of patients in the CBTi arm
who did not receive the intervention than in the complete case analysis. Point estimates of standardised
effect sizes, adjusting for differential loss to follow-up, range from 0.27 to 0.41.
For comparison purposes we can undertake an ‘as treated’ analysis using the imputed data sets. Here
we replace the study arm variable with a CBTi variable that ranges from 0 (no sessions of CBTi) to 1
(nine sessions of CBTi). This yields an estimate of the effect of the CBTi for those patients who received
nine sessions (Table 28).
The ‘as treated’ analysis suggests a mean improvement in FES-I score of approximately ‘4’ for those patients
who complete the CBTi. The results of the ‘as treated’ analysis are very similar to those obtained from the
‘complete case’ analysis, which, perhaps, reflects the poor outcome completion rate among those failing to
complete the planned CBTi. Point estimates of standardised effect sizes for this ‘as treated’ analysis range
from 0.39 to 0.47. These results are consistent with there being a subgroup of patients who benefit from the
CBTi but when we analyse on an ITT basis the average impact across the target population is somewhat
reduced (from around a mean change of ‘4’ to a mean change of ‘3’ in FES-I score).
TABLE 28 Estimated impact of CBTi based on an ‘as treated’ analysis
Method
Imputation model
Regression model Multivariate normal model
µ 95% CI µ 95% CI
By arm –3.65 –5.84 to –1.46 –4.19 –6.32 to –2.06
Complete sample –4.27 –6.45 to –2.09 –4.37 –6.52 to –2.22
Note
Estimate from complete case ITT analysis= –4.02 (95% CI –5.95 to 2.10).
TABLE 27 Estimated impact of CBTi based on (ITT) analysis of covariance of imputed data sets
Method
Imputation model
Regression model Multivariate normal model
µ 95% CI µ 95% CI
By arm –3.84 –6.52 to –1.17 –2.89 –5.21 to –0.57
Complete sample –3.05 –5.32 to –0.77 –2.51 –4.76 to –0.27
Note
Estimate from complete case analysis= –4.02 (95% CI –5.95 to 2.10).
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Longitudinal analysis of Falls Efficacy Scale–International version
To provide a more detailed picture of how FES-I scores changed over time, a further analysis, utilising data
from all four time points (baseline, 8 weeks, 6 months and 12 months) was conducted. The distribution of
time to completion is shown in Figure 28.
The four distinct CBTis of bars correspond to visits at baseline and 8 weeks, 6 months and 1 year post
randomisation. Time in years was included in this longitudinal analysis as a continuous variable.
l Scores at the follow-up visits were analysed using a mixed-model approach. All models included two
random effects, variation between:
¢ participants
¢ follow-up visits within participants.
Model 1 included the following fixed effects:
l baseline FES-I scores
l pain when walking (stratification variable, binary indicator)
l referral for strength and balance training (stratification variable, binary indicator)
l gender (stratification variable, binary indicator)
l site (two binary indicators: Galleries Day Unit and North Tyneside Falls Prevention Service)
l trend over time
l study arm (an impact of the CBTi).
Additionally, model 2 included an interaction between study arm and time (equivalently to fitting a
separate trend over time for intervention and control patients).
The parameter estimates corresponding to model 1 are given in Table 29.
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FIGURE 28 Time to completion of FES-I.
DOI: 10.3310/hta20560 HEALTH TECHNOLOGY ASSESSMENT 2016 VOL. 20 NO. 56
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Parry et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
61
Sigma_u and sigma_e are the estimated SD of the between-participant and within-participant random
effects, respectively. This model suggests that the annual trend does not differ significantly from zero.
The annual change in FES-I score is –0.78 (95% CI –1.80 to 0.23). In this model the estimated impact of
the intervention corresponds with an average difference in FES-I scores between study arms over the three
follow-up time points; this was –3.54 (95% CI –4.96 to 2.12).
In model 2, we fit separate trends over time for patients in the control and intervention arms.
The parameter estimates corresponding to this model are given in Table 30.
TABLE 29 Model 1: parameter estimates
Effect Coefficient
Test of difference from zero
95% CIz p-value
Constant 9.32 4.14 0.000 4.91 to 13.74
Baseline FES-I 0.71 16.82 0.000 0.63 to 0.79
Strata
Pain when walking 2.23 2.90 0.004 0.72 to 3.73
Strength and balance training –1.66 –1.75 0.080 –3.52 to 0.20
Female 0.43 0.53 0.595 –1.14 to 2.00
Galleries Day Unit 2.03 1.57 0.116 –0.50 to 4.56
North Tyneside Falls Prevention Service –0.45 –0.46 0.642 –2.34 to 1.44
Annual trend –0.78 –1.51 0.131 –1.80 to 0.23
CBTi –3.54 –4.87 0.000 –4.96 to –2.12
Random effects
Sigma_u 5.80 5.24 to 6.43
Sigma_e 5.64 5.33 to 5.96
TABLE 30 Model 2: parameter estimates
Effect Coefficient
Test of difference from zero
95% CIz p-value
Constant 9.37 4.14 0.000 4.93 to 13.81
Baseline FES-I 0.71 16.82 0.000 0.63 to 0.79
Strata
Pain when walking 2.23 2.90 0.004 0.72 to 3.74
Strength –1.66 –1.75 0.080 –3.52 to 0.20
Female 0.42 0.53 0.597 –1.15 to 1.99
Galleries Day Unit 2.03 1.57 0.116 –0.50 to 4.56
North Tyneside Falls Prevention Service –0.44 –0.46 0.645 –2.33 to 1.45
Trend control –0.68 –0.94 0.348 –2.09 to 0.73
Trend CBTi –0.90 –1.20 0.229 –2.36 to 0.57
CBTi –3.64 –4.21 0.000 –5.33 to –1.95
Random effects
Sigma_u 5.80 5.24 to 6.43
Sigma_e 5.64 5.33 to 5.96
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The estimated annual trend in the control arm is –0.68 (95% CI –2.09 to 0.73) and the estimated annual
trend in the intervention arm is –0.90 (95% CI –2.36 to 0.57). The difference in these trends is –0.22
(95% CI –2.26 to 1.81) and does not differ significantly from zero. There is no evidence that rate of
change in FES-I differed between control and intervention patients. In this model the CBTi coefficient
corresponds with the difference between the study arms at a single point in time (because we have non-
parallel regression lines corresponding to the two study arms). The trend variables have been coded in such
a way that this coefficient represents the difference between arms 12 months post randomisation.
As the interaction between time and CBTi is not significant, applying the principle of parsimony, model 1 is
the preferred model. The mean impact of the CBTi over the period of follow-up is a reduction of 3.54
(95% CI 2.12 to 4.96).
Falls
Numbers of falls and injuries sustained
The number of falls and related injuries is summarised in Table 31.
The distribution of the number of falls reported by participants was positively skewed (Figure 29).
TABLE 31 Number of falls and related injuries by study arm
Arm
Number of falls and related injuries
Fallers Falls Soft tissue injuries
Soft tissue injuries requiring
medical intervention Fractures
Control 99 480 48 2 7
CBTi 97 335 50 2 3
All 196 815 98 4 10
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FIGURE 29 Distribution of falls.
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Of the 347 participants who returned at least one diary, 154 (44.4%; 95% CI 39.1% to 50.0%) reported
no falls at all. One participant reported a total of 73 falls.
Sixty-one per cent of men and 53% of women reported at least one fall (relative risk= 1.13; 95% CI 0.93
to 1.38). Fifty-eight per cent of those reporting pain when walking at baseline and 54% of those reporting
no pain when walking reported at least one fall (relative risk= 1.06; 95% CI 0.88 to 1.28). Fifty-eight per
cent of those not referred for strength and balance training and 55% of those who were referred for
strength and balance training reported at least one fall (relative risk= 1.06; 95% CI 0.87 to 1.29). The
proportion of patients reporting a fall was broadly similar across the three sites (Falls and Syncope Service
55.3%, Galleries Day Unit 47.4%, North Tyneside Falls Prevention Service, 57.3%).
The number of falls was analysed using a negative binomial regression model adjusted for randomisation
strata (site, pain when walking, referral for strength and balance training, and gender) and the number of
diaries returned (as an exposure variable). The reference model is shown in Table 32.
The estimated impact of the CBTi on the likelihood of falling corresponds to an incidence risk ratio of 0.88
(95% CI 0.61 to 1.27). The point estimate of 0.88 suggests a slight reduction in the risk of falling but the
95% CI includes one; the difference between arms is not statistically significant. One patient reported
73 falls. Excluding this patient from the analysis changed the estimated impact of CBT to an incidence risk
ratio of 1.02 (95% CI 0.71 to 1.46).
The above analysis is based on the 347 participants who returned at least one diary. To look at the
potential impact of missing diaries, the analysis was repeated making the assumption that for those
patients who returned at least one diary that they had no falls for the missing months. The corresponding
estimate of the incidence rate ratio (IRR) was 0.74 (95% CI 0.51 to 1.06).
Likelihood of a participant reporting at least one fall
The likelihood of a participant reporting at least one fall was analysed using logistic regression.
The modelling strategy (adjusting for strata and the number of diaries returned) is as reported above.
The estimated impact of the CBTi based on the 347 participants who returned at least one diary adjusted
for site, gender, pain when walking, referral for strength and balance training, and the number of diaries
returned corresponded with an odds ratio (OR) of 1.17 (95% CI 0.75 to 1.81).
TABLE 32 Parameter estimates for negative binomial regression of the number of falls
Variable
Regression coefficients Significance
IRR 95% CI z p-value
Constant 3.78 1.70 to 8.42 3.25 < 0.001
Strataa
Galleries Day Unit 0.91 0.47 to 1.73 –0.30 0.77
North Tyneside Falls Prevention Service 0.84 0.51 to 1.39 –0.67 0.50
Presence of pain when walking 1.01 0.69 to 1.49 0.07 0.95
Referred for strength and balance training 0.80 0.49 to 1.31 –0.89 0.38
Gender (female) 0.88 0.57 to 1.36 –0.58 0.57
Impact of CBT (study arm) 0.73 0.51 to 1.06 –1.63 0.10
IRR, incidence rate ratio.
a Reference category for strata are: the RVI Falls and Syncope Service (centres); no pain when walking; no referral for
strength and balance training; and male.
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Sensitivity analysis, accounting for missing data, provided the following estimates. Assumption that:
1. there were no falls corresponding to the missing diaries for the 347 participants who returned at least
one diary. OR 1.10 (95% CI 0.72 to 1.69)
2. patients who did not return any diaries at all did not fall OR 0.92 (95% CI 0.62 to 1.36)
3. patients who did not return any diaries at all did fall OR 1.29 (95% CI 0.86 to 1.92).
Options (2) and (3) represent the most extreme scenarios. In each case, the 95% CI includes ‘1’; there is
no evidence that the CBTi had an impact on the likelihood of reporting one or more falls.
A total of 97 falls resulted in a reported soft tissue injury. The number of soft tissue injuries reported by
individual participants ranged from zero to four, with the vast majority (80%) of participants reporting no
such injuries. Only four (4.1%; 95% CI 1.1% to 10.2%) of these injuries required medical intervention.
A small number of falls (10) resulted in a reported fracture. One participant reported three falls resulting in
a fracture; a second participant reported two falls, both of which resulted in a fracture. Five participants
reported a single fracture resulting from a fall. The CBTi had no impact on the incidence of injurious falls.
Secondary outcomes
The distribution of secondary study outcomes at each visit are displayed graphically, and the change from
baseline for each visit for each of these outcomes is tabulated in Appendix 4.
For each of the secondary outcomes, change from baseline to 12 months was analysed using analysis of
covariance. Estimates of the impact of the intervention, adjusted for randomisation strata, are given in
Table 33. The corresponding unadjusted results are presented in Appendix 4.
TABLE 33 Analysis of covariance: regression coefficients
Measure R2
Baseline response Impact of CBTia
B 95% CI B 95% CI
FES-I score 0.48 0.74 0.62 to 0.85 –4.02 –5.95 to –2.10
Fear of falling 11-point numerical scale 0.24 0.52 0.38 to 0.65 –1.01 –1.55 to –0.46
Total social participation/isolation score 0.33 0.58 0.48 to 0.67 1.03 –0.44 to 2.50
Gait and balance score 0.06 0.70 0.33 to 1.07 0.90 –1.06 to 2.87
Mean handgrip strength 0.62 0.65 0.54 to 0.75 –0.22 –1.82 to 1.38
Functional reach 0.37 0.50 0.38 to 0.61 0.91 –0.85 to 2.66
De Jong Gierveld Loneliness Scale score 0.48 0.78 0.68 to 0.88 0.19 –0.28 to 0.65
HADS Anxiety 0.56 0.80 0.70 to 0.89 –0.70 –1.42 to 0.03
HADS Depression 0.48 0.73 0.63 to 0.83 –0.97 –1.62 to –0.33
WHOQOL-OLD total score 0.47 0.67 0.58 to 0.77 0.85 –1.56 to 3.26
LSNS-6 0.62 0.83 0.74 to 0.91 0.74 –0.16 to 1.65
EQ-5D (5L) Health today 0.24 0.44 0.32 to 0.55 3.07 –1.06 to 7.21
EQ-5D (5L) index 0.54 0.72 0.61 to 0.82 0.01 –0.04 to 0.05
SF-36 PCS 0.48 0.67 0.55 to 0.79 0.99 –0.91 to 2.9
SF-36 MCS 0.34 0.59 0.47 to 0.72 1.17 –1.51 to 3.84
a Estimates adjusted for differences between randomisation strata.
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Considering the 12-month data in isolation, there was a reduction FES-I score, as described above, and a
reduction in fear of falling (as measured by the 11-point numerical rating scale) of –1.42 points (95% CI
–1.87 to 1.07 points) in participants who were randomised to the CBTi relative to participants in the
control arm. There is some evidence of a reduction in depression. The estimated impact of the CBTi is a
reduction in mean HADS Depression score of 1 unit (on a 21-point scale) (95% CI 0.3 to 1.6 units).
The CBTi had a much smaller impact on the other variables of interest.
Longitudinal analyses, utilising data collected at all time points available for the secondary outcomes, was
conducted using the same approach as for the analysis of FES-I scores, described in the previous section.
The estimated trend(s) and difference between study arm are shown in Appendix 4. There is evidence that
fear of falling, anxiety and depression fell more in participants who were randomised to the CBTi than in
control participants. These were the only variables for which there was a significant study arm-by-
time interaction.
Harms
Serious adverse events
Forty-eight participants (11.6%, 95% CI 8.6% to 15.0%) experienced one or more serious adverse events.
A total of sixty-nine serious adverse events were recorded. Thirty-four participants experienced a single
event; 10 participants, two events; three participants, three events; and one participant experienced six
events. Most of the events (89.9%) were categorised as either ‘moderate’ or ‘severe’ (Table 34).
Just over 20% of serious adverse events related to a fall suffered by the participant. Three of the adverse
events culminated with the death of the participant and these events had the following descriptions:
l acute intestinal obstruction and incarcerated incisional hernia: raised number of white blood cells,
raised level of C-reactive protein, low calcium and magnesium levels, and very raised creatinine level
l pneumonia and pulmonary oedema – died in hospital
l stroke – rushed to hospital but died in Casualty at 12.40.
The first of the events listed pertained to a participant who was randomised to CBTi but happened prior to
any of the scheduled CBTi sessions. The other two events involved participants in the control arm. None of
these deaths is believed to be causally related to participation in the study.
There is no evidence that the serious adverse event rate differed between study arm (Table 35).
TABLE 34 Severity of serious adverse events by study arm
Severity
Study arm
TotalControl CBTi
n % n % n %
Mild 3 7.3 1 3.6 4 5.8
Moderate 21 51.2 16 57.1 37 53.6
Severe 17 41.5 8 28.6 25 36.2
Unknown 0 0.0 3 10.7 3 4.3
Total 41 28 69
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The mean number of reported events were:
l 0.20 (95% CI 0.12 to 0.30) for participants in the control arm
l 0.13 (95% CI 0.08 to 0.20) for participants the CBTi arm.
The difference in means between study arms= –0.07 (95% CI –0.18 to 0.04). Adjusting for differences
between strata using negative binomial regression, the estimated IRR = 0.61 (95% CI 0.32 to 1.16); there
is no evidence of a difference in the likelihood of reporting serious adverse events.
One hundred and seventy-five participants (42.2%, 95% CI 37.3% to 47.1%) reported at least one
adverse event. A total of 514 adverse events were recorded. Most of the events (90.9%) were either
‘possibly’ or ‘definitely’ fall related. None of the events was deemed to be ‘possibly’, ‘probably’ or
‘definitely’ attributed to the receipt of CBT. Sixteen events (3.1%) were classified as ‘severe’; two-thirds of
the events were classified as ‘mild’.
The mean number of reported non-serious adverse events were:
l 1.30 (95% CI 0.94 to 1.71) for participants in the control arm
l 1.18 (95% CI 0.86 to 1.54) for participants in the CBTi arm.
The difference in means between study arms= –0.12 (95% CI –0.60 to 0.42). Adjusting for differences
between strata using negative binomial regression, the estimated IRR= 0.91 (95% CI 0.63 to 1.33); there
is no evidence of a difference in the likelihood of reporting adverse events.
Considering all adverse events (both serious and non-serious) the corresponding IRR was 0.88 (95% CI
0.63 to 1.23). CBTi does not appear to be a particularly high-risk intervention.
TABLE 35 Proportion of participants reporting at least one serious adverse event by study arm
Event type
Study arm
Risk ratioControl CBTi
n % n % Risk ratio 95% CI
Any reported serious adverse event? 27 13.2 21 10.0 0.76 0.44 1.30
Any non-fall-related serious adverse event? 22 10.7 15 7.1 0.67 0.36 1.25
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Chapter 5 Process evaluation
Introduction
Process evaluation is important not only for providing insight into the reasons why a trialled intervention
has been shown to be clinically effective (or not), but also is integral to understanding issues concerning
transportability, workability and integration of interventions into routine clinical practice.36,93 Although
process evaluations in fear of falling are limited, there is some evidence to suggest that group-based CBT
for fear of falling is feasible for participants and facilitators,94 and fits with regular care.95 However,
previous process evaluations have not been integrated throughout the study and have therefore not
considered the process of intervention development. Furthermore, they have relied on data from
questionnaires94 or audit,95 rather than a more robust framework. In this study, we drew on normalisation
process theory (NPT)38 to explore psychological and sociological mechanisms of behaviour and action that
have been empirically demonstrated to be important in the development, planning and implementation of
complex interventions.96 NPT focuses on understanding the collaborative ‘work’ in four key areas:
coherence (ways in which an intervention ‘makes sense’ and has clear purpose and objective); cognitive
participation (willingness and ability to commit time and energy needed to make it work); collective action
(the resources, arrangements, skills, etc. required to make an intervention work); and reflexive monitoring
(formal and informal mechanisms for appraising the process and outcomes of an intervention).
Phase I of the process evaluation, the refinement of the intervention, has been reported in Chapter 2. In Phase II,
the process evaluation aimed to identify, describe and explain the professional and organisational factors that
promoted or inhibited the implementation and integration of the CBTi. Specifically the objectives were to:
i. understand the factors that influence the delivery of the CBTi by non-specialist HCAs
ii. explore the acceptability of the CBTi
iii. describe factors influencing the enactment of the RCT.
Within this chapter we have used the terminology used by the psychologists and the HCAs delivering the
intervention. The term ‘clients’ is used to denote participants who were randomised to CBTi; the HCAs are
referred to as ‘STRIDE therapists’, as this was the term agreed on completion of the training to describe
their role and was key to developing a sense of identity. The only exceptions to this are in quotations, in
which we have used the terms used by the speaker.
Methods
Data collection and consent
Data collection involved ethnographic methods, including semistructured interviews, informal discussions
and non-participant observation (captured in field notes). Therapy sessions (notes summaries and audio
recordings) provided data to assess the content and delivery of the CBTi. Participants in the process evaluation
included staff who were working in sites from which clients were recruited (hereafter ‘professionals’); STRIDE
therapists who were involved in delivering the CBTi; clients who were participating in the intervention arm of
the trial and family members (hereafter ‘caregivers’); and members of the study team and TSC. The data
collected for the process evaluation are summarised in Table 36. The average duration of each episode
of data collection was 49 minutes for interviews, 14 minutes for informal discussions, 143 minutes for
observations and 49 minutes for meetings. Overall, 75% of data collected was recorded (although not all was
transcribed). Field notes were also made to support analysis (75 pages in Phase I and 268 pages in Phase II).
All data collection for the process evaluation was undertaken by CB, with the exception of one focus group
with the STRIDE therapists, which was carried out by a student as part of her master’s dissertation.
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TABLE 36 Summary of data collected
Data collection type Phase I Phase II Total
Interviews
Clients 14 20 34
Caregivers 2 3 5
Professionals 5 4 9
STRIDE therapists NA 7 7
Team members 9 12 21
Total interviews 30 46 76
Informal discussions
Professionals 0 1 1
STRIDE therapists NA 15 15
Team members 11 39 50
Other 0 1 1
Total informal discussions 11 56 67
Observation
Clinic observation 3 7 10
Therapy sessions NA 5 5
STRIDE therapist training NA 5 5
STRIDE therapist supervision NA 11 11
Other 0 3 3
Total observation 3 31 34
Meetings
Intervention development 9 0 9
Team meetings 7 17 24
TSC 0 6 6
Office meetings NA 11 11
Other 0 11 11
Total meetings 16 45 61
NA, not applicable.
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Semistructured interviews
Interviews with all participants explored perceptions of key factors that might impede or facilitate the CBTi
being effective and workable in practice. The topic guides were loosely structured around NPT,38 with
ample scope for participants to raise issues that they saw as important (see Appendix 5 for an overview of
topic guides).
Professionals were interviewed about the service provided, their views of the CBTi, and their experiences of
identifying and recruiting clients to take part in the study. Two professionals interviewed in Phase I of the
study were interviewed again towards the end of the study to assess whether or not their perceptions of
the CBTi had changed.
Each STRIDE therapist was interviewed two or three times to explore how their interpretations and
evaluations of the intervention evolved across the duration of the study. For efficiency, their reflections
towards the end of the study were obtained through two focus groups: one conducted by CB and VD,
and the other by a master’s student supervised by VD.
In Phase II (the RCT; see Chapters 3 and 4), interviews with clients and caregivers focused on their
experiences of the intervention, the extent to which the techniques had been embedded into daily life,
and the ‘fit’ of the intervention with other services (such as strength and balance training or the in-house
rehabilitation programme provided by site 2 (see Table 5). Phase II clients were recruited from the database
of trial participants using ethics committee approved recruitment and consent processes (see below).
Maximum variation sampling was used (based on gender, age, degree of fear of falling, STRIDE therapist
seen, and STRIDE therapist’s perception of key factors influencing activity restriction). Caregivers were
recruited via clients who were interviewed.
Members of the study team were interviewed to aid understanding of the conduct of the study, or to
explore key issues as they emerged. Some key team members were interviewed multiple times.
Informal discussion
Informal discussions had not been included in early versions of the protocol (but emerged as a key source
of data for the study). These discussions typically arose in response to an event or issue arising in the
conduct of the study. These contemporaneous discussions helped us to understand and manage emerging
issues. They also allowed a more in-depth exploration of issues that were raised in formal meetings from
different perspectives.
Non-participant observation
Routine practice was observed at participating sites to gain an understanding of the fit between the CBTi
and existing service provision. This included observation of initial assessments, follow-up appointments and
interventions provided directly by, or through, the service (see Tables 4 and 5).
A range of activities involving the STRIDE therapists was also observed, including initial training; individual
and group supervision; and a small number of sessions with clients. Finally, meetings focusing on
intervention development, study management and ad hoc meetings to discuss specific issues (e.g. client
recruitment) were also observed with appropriate consent (see Consent). Observation was supplemented
with recordings and documentation (e.g. training materials) when available.
Content and delivery of the cognitive–behavioural therapy intervention
The STRIDE therapists summarised their work with each client who completed the study on a structured
form (see Appendix 6 for three completed examples). This included details of the formulation
(predisposing, precipitating and perpetuating factors); perceived barriers to activity; focus of the
intervention; goals; planned treatment strategies; a rating of client engagement with the CBTi; perceived
outcomes of the intervention from the perspective of the STRIDE therapist; and a narrative summary.
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Further data on the content and delivery of the CBTi were obtained through non-participant observation of
therapy sessions. Additionally, CB listened to, and made field notes on, a purposive sample of recorded
therapy sessions (including some with clients who dropped out of the CBTi).
Consent
All participants in interviews, informal discussions and meetings were provided with a Participant
Information Sheet and asked to provide written informed consent prior to participation. Verbal consent
was sought prior to each subsequent episode of data collection. The consent form that clients completed
for the RCT included permission to audio-record the CBTi sessions. Professionals sought verbal consent
from clients and any companions for (non-recorded) observation of clinic appointments and interventions.
Variations to protocol
Some variations to the process evaluation protocol (versions 1–4) were required. Fewer follow-up
interviews to assess changes in perceptions over time were conducted than intended. In terms of
professionals, this was because the addition of extra study sites necessitated interviews with a larger
sample of professionals across the three sites. In relation to clients, early follow-up interviews indicated
that they yielded few additional data to justify the additional respondent burden that these posed. Most
clients were therefore interviewed once, but at different points along the intervention trajectory. We
interviewed fewer caregivers than anticipated, as their involvement in the CBTi proved to be the exception
rather than the rule.
Data management and analysis
Details of all data collected for the process evaluation were recorded in a Microsoft Access® version 2010
(Microsoft Corporation, Redmond, WA, USA) database and stored in a password-protected network that
was accessible only to the process evaluation team. Interviews and informal discussions were generally
audio-recorded, transcribed, checked and anonymised. Field notes were anonymised.
All qualitative data were analysed thematically using the constant-comparative technique,46 as described in
Chapter 2. In Phase II, the volume of data collected and the variety of sources meant that analysis was
conducted in a series of rounds of purposively sampled data sources, adapting an approach that previously
used to manage a substantial data set.97 In each round, CB and TF agreed a selection of five data sources
to cover a variety of time points (across the study), perspectives (participant groups) and data types
(interviews, field notes, meetings, etc.), and independently read the data to identify key themes. These
were then discussed and a preliminary coding frame was agreed. A further set of (five) data sources was
identified for the next round of analysis. In each subsequent round, possible themes were compared with
those initially identified, and revised or re-organised as appropriate. This iterative process of reviewing new
data items and modifying the emerging coding frame continued until saturation was reached, with few
new themes being identified.
Data from the STRIDE therapist summaries were extracted using a coding frame that was developed
through discussions with the STRIDE therapists and psychologists. The data were analysed descriptively
using IBM SPSS Statistics release 21 (IBM Corporation, Armonk, NY, USA).
Data reported here are attributed using the unique identifier allocated to the participant. Prefixes are as
follows: ‘P’ denotes professionals; ‘ST’ denotes STRIDE therapists delivering the intervention; ‘C’ denotes
clients (‘PC’ for pilot clients recruited from Phase I of the study); ‘F’ denotes caregivers; and ‘R’ denotes
study team members. When quotations are from joint interviews or focus groups, the speaker is indicated
in bold. The focus group conducted by CB and VD is denoted as focus group 1; the one facilitated by the
student as focus group 2. All STRIDE therapists are referred to as female to prevent identification of the
single male STRIDE therapist. Within this chapter, participating sites have been anonymised as sites 1–3
(the order is unrelated to the order of presentation of the sites in other chapters).
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Results
The development of the CBTi delivered in the present study was described in Chapter 2; here, we focus on
how the principles and techniques for CBTi were transmitted to the STRIDE therapists via training and
supervision, and the factors that influenced the ways in which the STRIDE therapists enacted the CBTi with
clients. We also examine the acceptability of the CBTi to clients and professionals working in participating
sites. The CBTi was embedded within a RCT and we review how the broader study activities impacted on
the delivery of CBTi and describe some of the challenges of implementing this trial. We conclude the
chapter by framing the findings in the NPT framework and drawing out the implications for both the CBTi
and RCTs.
Delivery of cognitive–behavioural therapy intervention by non-specialist
STRIDE therapists
A key aim of the study was to explore the feasibility of training HCAs to deliver the CBTi to older people.
This section describes the training and supervision provided. The recruitment of the STRIDE therapists is
described later (in the section on conduct and delivery of the RCT); briefly, the posts were advertised and
32 people applied, most of whom were graduates. Three people were appointed to share two full-time
posts, two of whom had a background in health care.
Training and supervision of STRIDE therapists
The organisation, content and aims of training and supervision are summarised in Table 37 (further details
of methods of delivery and content are provided in Chapter 2) and the manuals supporting the training are
available from SWP). This section provides a reflective description of the training from the perspectives of
the STRIDE therapists, psychologists (NSa and VD) and process evaluator (CB). In addition to the formal
individual and group supervision provided as part of the study, the STRIDE therapists met informally for
peer support and had a separate NHS line manager.
TABLE 37 Training and supervision of STRIDE therapists
Item Training Individual supervision Group supervision
Frequency One 2-week period at the outset
of the study
Fortnightly (reducing towards
the end of the study; average
35 sessions per STRIDE therapist)
Variable (fortnightly immediately
after training; bimonthly later in
the study; 21 sessions in total)
Duration 5 days spread over 2 weeks 60 minutes 60–90 minutes
Content Overview of CBT
Engagement with the client
Assessment and formulation
Standard CBT interventions
(behavioural and cognitive
techniques)
Relapse prevention
Discharge planning
Overview of all clients
Plans for intervention
Feedback on recordings of
sessions
Practical issues
Group dynamics
Training
Case-based discussion
Intervention fidelity
Practical issues
Group dynamics
Main aim To equip the STRIDE therapists
with enough skills to begin
working with clients
Embedding training and monitoring intervention delivery
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From the perspectives of the psychologists, the initial training achieved the stated aim of equipping the
STRIDE therapists with enough skills to start their work with clients:
In general I’m more confident about the trial now than I was at – than I have been at any point.
I think it’s got a real chance of working if we‘ve got a – if we can give them the support and they’ve
got the time to deliver the intervention as we’ve trained them to.
R4, informal discussion, 5 July 2012
Although the STRIDE therapists reported having been concerned about the duration of the training, once
they started seeing clients, they felt that the training had provided them with the necessary skills:
To be honest it’s weird because at the time we were like ‘this isn’t enough time’. But then looking
back it’s like ‘well I actually learned all of the stuff and I am implementing it’.
ST1, interview, 23 August 2012
One issue raised by the STRIDE therapists related to the extent to which the training was appropriate for
non-specialist trainees. The STRIDE therapists with psychology degrees questioned whether or not
non-specialist staff with a less relevant background would have been able to manage the volume of
information and skills covered in the training:
It’s not something that you can just learn in five days if you have never done anything like this. I think
it also helped for me that I had done a counselling course when I was at University [. . .] if I hadn’t had
done that I think that I might have struggled because empathy is kind of a hard thing to grasp if you
have never really been in an empathetic role before. It’s not something that you learn overnight.
ST3, interview, 4 September 2012
A separate concern that was raised about the training related to the relationship between the CBTi and
the RCT. The training focused on the CBTi, without exploring how it was embedded within the RCT:
Personally I would have preferred an introduction. Right this is where we’re at; this is where it’s
evolved from; this is what we’re planning to do [. . .] I would have preferred to know what the patients
knew about us and it would give us a better understanding of ‘Right so the patients know this, this is
their understanding. This is how we’re going to introduce ourselves to the patients.’ That would’ve
been really useful.
ST2, interview, 27 June 2012
From the perspectives of the STRIDE therapists, the training (and documentation) focused too heavily on
assessment and formulation and they would have valued more time to practise treatment strategies.
This was highlighted both in early interviews and in the focus group towards the end of the study when
the STRIDE therapists acknowledged that treatment strategies had been covered but that:
ST2: We weren’t practised at them.
ST1: Especially –
R1: So it was more hypothetical?
ST3: We didn’t know how to use them.
Focus group 1, 2 July 2014
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Although ‘real play’ was used successfully to practise assessment and formulation skills, the STRIDE
therapists suggested that it could also have been used in relation to treatment strategies as a way of
increasing familiarity and confidence with these techniques. The STRIDE therapists intuitively grasped some
treatment strategies (e.g. graded exposure) but were less certain of others (e.g. cognitive work).
Techniques such as graded exposure also seemed more congruent with client expectations of CBTi
(especially as some clients confused CBTi with strength and balance training). In contrast, clients had
difficulty in distinguishing between behaviours and thoughts that tended to increase the STRIDE therapists’
uncertainty about using thought diaries as a way of approaching cognitive work:
ST1: You try to explain it [ST3: yes], they don’t understand it and they would write in ‘I had lunch’.
Do you know what I mean? [Laughter]
ST2: I thought it was tasty.
Focus group 1, 2 July 2014
Regular supervision was seen as an essential adjunct to consolidate the initial training. Listening to recordings
of CBTi sessions in supervision reassured the psychologists that the STRIDE therapists had embedded the
training to some extent and were applying their new skills. Supervision also allowed new information and
techniques to be introduced, when relevant, to current work with clients. For example, information on
obsessive–compulsive disorder and post-traumatic stress disorder was provided when STRIDE therapists were
working with clients whose difficulties seemed to be consistent with these conditions. Aspects of training and
supervision that helped the STRIDE therapists to embed the CBTi are summarised in Table 38.
TABLE 38 Factors facilitating the embedding of the CBTi
Theme Description Example
Setting realistic
expectations
STRIDE therapists were being
trained to develop useful
interventions for clients with
fear of falling rather than as
CBT therapists
Embedding the skills for CBTi
was seen largely as taking
place through practice
Having clear expectations
helped manage STRIDE
therapist anxiety about learning
new skills
The psychologists made it clear that they did not expect
the STRIDE therapists to be fully up to speed by the end
of the training and that it would probably not be until
they had seen 20 or 30 clients [approximately 10% of
the anticipated number who would receive CBTi in the
trial] that their skills would be fully developed
Field notes of training, day 2, 1 June 2012
Managing STRIDE
therapist anxiety
Learning new skills creates
anxiety
Anxiety can interfere with the
ability to absorb new
information
Tendency to revert to familiar
roles and ways of interacting
when under stress
Before ST1 started the assessment, R4 reminded her
not to worry about getting it wrong, to which ST1
commented ‘I’m well past that point!’ At this point,
ST2 also commented that they should ‘embrace the
wrongness’. This seemed a significant shift from the
start of the day when they had both been very anxious
about getting it right and not making mistakes
Field notes of training, day 2, 1 June 2012
Because it sounds like you are having successes and
actually learning from the ones that are going well is
something that might be worth doing
R4, group supervision, 16 January 2013
continued
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TABLE 38 Factors facilitating the embedding of the CBTi (continued )
Theme Description Example
Use of ‘real play’ (training
technique where STRIDE
therapists used CBT to
explore their own anxieties
e.g. fear of flying)
Embedding new skills
Integrating interpersonal and
technical skills
Providing insight into client
experience
Doing the role play felt really clunky and as if you’re
more concentrating on the pro forma and getting that
right. But doing the real play we could
concentrate more on like the personal, the
empathy and it felt more natural to do that
ST2, interview, 27 June 2012 (author‘s emphasis in
bold text)
Encouraging reflexive
practice (including using
CBT to understand their
own experience of
learning CBT)
Embedding new skills
Providing insight into the
STRIDE therapists’ own learning
process
Providing opportunities for the
STRIDE therapists to experience
‘what it’s like to be a client’
(R12 interview, 2 October 2012)
Increasing awareness of how
the STRIDE therapists’ styles of
interacting might impact on
their work with clients
Managing STRIDE therapist
anxiety (and increasing
confidence in CBT techniques)
I was quite nervous about actually doing this. I was
using this stuff for myself – basically like rationally –
‘well I’ve only had 5 days of training’; ‘it’s my first
patient ever’; ‘it’s practice, if it goes wrong then I’ll
just do it next week, the week after’; ‘this is all a
learning thing, I can’t change it. I know as much as
I can do at this time’. ‘I just rationally, I just used it
on myself basically seeing that the thoughts were
wrong and all that, so the training actually helped me
manage myself within the whole scheme of things’
ST1 interview, 23 August, 2012
Encouraging ownership of
the CBTi
Providing a sense of agency in
the context of learning new
skills
Ensuring a sense of identity in
the STRIDE therapists’ new role
ST2 comments that they were having difficulty
working out how to introduce themselves without
having a term. R4 suggests ‘STRIDE researchers?’
R12 suggests ‘STRIDE clinicians’ then R4 suggests
‘STRIDE therapists’ and then asks ‘is therapists pushing
too far? But people talk about physiotherapists and
occupational therapists’. ST1 seems to agree and then
R12 agrees ‘yes, STRIDE therapists?’ ST1 makes a
comment about how to respond if people say
‘what’s that?’ R4 and R12 comment that they have
been trained in how to give people back their
confidence. There seems to be a consensus and [. . .]
R4 comments ‘I can see that working, ‘one of the
STRIDE therapists will be calling you . . .
Field notes of training, day 5, 15 June 2012
Managing boundaries Developing a sense of what fell
within the remit of the CBTi
Distinguishing between aspects
of life for which therapeutic
intervention was relevant and
those that were part of life
ST1 felt that reducing the checks was the only area
she felt she could address with the client. R12 asked
whether she saw this as part of her responsibility;
ST1 commented that there was nothing else to work
on since the client had no fall anxiety or any fatigue or
pain. So in terms of the usual STRIDE activities she felt
there was nothing she could do apart from working
on the anxiety
Field notes of ST1/R12 supervision, 15 May 2013
If you are having thoughts that are getting in the way
of your walking, and ‘if I go out I’ll break my back’
that’s clearly not a useful thought. But if you’re
actually having those feelings in the evening, you
know, ‘I miss my wife’ you know, that’s not
R4, group supervision, 16 January 2013
PROCESS EVALUATION
NIHR Journals Library www.journalslibrary.nihr.ac.uk
76
Although modelling interpersonal and technical skills that were relevant to the delivery of the intervention
was used extensively during training and supervision, the extent to which the STRIDE therapists were
aware of modelling and/or learned from this approach is unclear. None of them mentioned the value
(or otherwise) of modelling during the interviews and informal discussions that were conducted for the
process evaluation. The psychologists rarely explicitly drew attention to their use of modelling, and this
may have limited the opportunities for the STRIDE therapists to learn and embed these skills in their own
practice. The following example is unusual in that the psychologist explicitly refers to the use of modelling
and illustrates that not all of the STRIDE therapists had recognised this:
R4 then conversationally asked ST2 about each of these areas and then commented ‘I just did a FIND
[a technique used in assessment to explore the extent of the problem by exploring Frequency,
Intensity, Number and Duration] on you, did you notice?’ [. . .] ST3 had noticed that R4 had used the
FIND questions as part of his questioning but it was less obvious to the others.
Field notes of group supervision, 25 July 2012
The supervision provided by the psychologists was valued by the STRIDE therapists. Based on their
experience, the STRIDE therapists suggested that access to a multidisciplinary team would have been
helpful. Although they were able to access the expertise of the STRIDE therapist with a physiotherapy
background, and were sometimes able to discuss specific physical issues with physiotherapists based at
participating sites, more formal arrangements for future CBTi delivery were seen as essential:
The access to physios, because like ST1 was saying just that the ability to go and check with someone
who knows. So if someone develops a new pain as happened with one of ST1’s clients, is it because
of the walking that they’ve been doing? Is it safe to continue walking? Having that validation from an
expert means you can go back
Informal discussion, R4 and ST1, 17 December 2013
Peer support
Peer support was identified by the STRIDE therapists as a key adjunct to the formal supervision that was
provided by the psychologists. This tended to be on an ad hoc basis, although the three STRIDE therapists
aimed to meet weekly, usually for 2–3 hours, particularly at the beginning of their work. None of these
meetings was observed, but the STRIDE therapists described them as covering a wide range of areas,
including self-audit; discussing concepts; talking through alternative strategies for use with specific clients;
and general issues relating to the conduct of the research. The process of self-audit was illustrated through
a discussion captured as part of a group supervision session:
We did like a mini thing between the three of us one day, where we analysed each other’s assessment
to see if we came up with the same formulation as was written down . . . In all three, we all came up
with pretty much the same rationale from the information provided on the assessment.
ST1, group supervision, 23 January 2013
The frequency of peer support varied throughout the study depending on workload, working arrangements
and team dynamics. Different STRIDE therapists were seen as having different strengths, for example the
STRIDE therapist with a physiotherapy background was seen as having particular skills and knowledge that
was relevant to clients who had difficulties in managing pain.
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In addition to support relating to working with clients, the meetings also focused on establishing and
owning the infrastructure to facilitate delivery of the CBTi. The psychologists highlighted the extent to
which the STRIDE therapists gained a sense of involvement and ownership of the CBTi:
They were doing so much problem solving during those meetings. They were thinking locked
briefcases, transport, continuation sheets, forms, referral. They were thinking through all these things
as – as a group in a way we should’ve thought through. But they were coming up with it on the hoof
and taking ownership of how they were going to do it. And that – and again that helped them bond.
R4, informal discussion, 5 July 2012
Factors affecting the delivery of the cognitive–behavioural
therapy intervention
A formal evaluation of intervention fidelity was not included in the process evaluation; however, insights
into the delivery of the intervention were provided through available data. Through supervision,
the psychologists were confident that the intervention was being delivered as intended, and identified the
competencies and skills that each STRIDE therapist brought to her work with clients:
ST1’s behavioural work is good in terms of exposure [. . .] we talked in detail last time about it, about
a client who had a real phobia about going out, there were some issues to do with mobility but again
she worked that very well.
R4/R12, discussion, 19 June 2013
ST2’s very good at breaking stuff down [. . .] and selling that to those people, so she’s using the
knowledge and skills that she has in a good CBT way which is great.
R4/R12, discussion, 19 June 2013
I think ST3’s got a lovely way with the clients, a lovely style, there’s humour, she’s able to listen, she’s
able to contain people and you know, this is good, very good therapy that’s how it sounds.
R4/R12, discussion, 19 June 2013
There were a number of subtle shifts in the emphasis of the CBTi over the period of the study (Box 2).
The CBTi evolved in these ways as a result of a range of factors (Table 39); these included challenges to
delivering the CBTi as planned and increased insight and understanding of fear of falling as the STRIDE
therapists gained more experience.
BOX 2 Evolution of the CBTi over time
l Exploration of barriers to activity (rather than fear of falling).
l Emphasis on falls preparation (rather than falls prevention).
l Emerging advocacy role.
l Emergence of supportive role (with clients with no experiential avoidance).
l Shift to exercise-based goals.
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TABLE 39 Overview of challenges to implementation of CBTi and their implications for the study
Challenge Components Impacts
Multidimensionality of fear of
falling
Clients identified a range of barriers
to activity
Some clients with fear of falling
have no experiential avoidance
Delays in embedding skills after training
(initially)
Shift to barriers to activity rather than fear of
falling
Emergence of supportive role
Working with clients with complex
and unmet medical needs
Medical issues
Managing unmet needs
Impact on client motivation and restrictions
on feasible goals
Shift to falls preparation
Emergence of advocacy role
Fit of CBTi with existing
interventions
Conflicts between medical advice
and CBTi
Ethos of CBTi and existing
interventions
Timing of interventions
Willingness of clients to engage and faith in
STRIDE therapists and CBTi
Potential burden for clients; restrictions on
feasible goals
STRIDE therapist uncertainty over
underlying rationales and specific
techniques
STRIDE therapist anxiety
Difficulties in transmitting principles
of CBTi to clients
Difficulties tuning into client
motivation
Uncertainties in enacting key skills
Tendency to revert to familiar/established
ways of working
Varied understandings of the intervention
Extent to which principles embedded by
clients varied
Dependency on STRIDE therapists
More didactic style by STRIDE therapists
Problems with setting SMART goals
Shift to exercise-based goals
External factors relating to the RCTa Viability of the study
Issues relating to practical
organisation and management
Delays in embedding skills as a result of slow
recruitment rate
Involvement of STRIDE therapists in
recruitment
Source of anxiety; distraction from CBTi
SMART, specific, measurable, achievable, realistic and time-limited.
a See Conduct and delivery of the randomised controlled trial.
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The factors were interrelated, for example low recruitment rates to the RCT led to the addition of two new
sites, which raised issues concerning the fit of the CBTi with existing interventions and increased the
number of clients with complex and unmet medical needs. These shifts in the focus of the CBTi raised
questions over the identity of the CBTi:
R4: So, was what you were doing still CBT? [4 second pause]
ST1: Yes [ST2/ST3: Yes].
R4: What made it CBT and not physio?
ST1: Well, it’s how you de– well, possibly semantics I don’t know, because it’s graded activity
[ST2/ST3: Yeah] that you were doing.
ST3: It’s their goals that they’ve come up with or you’ve worked out together.
Focus group 1, 2 July 2014
Later in the same focus group, however, the STRIDE therapists clarified the differences between the CBTi
delivered in the present study and CBT:
ST1: It wasn’t CBT, it was supportive therapy we were providing.
ST3: Sort of a stripped back, simplified version.
Focus group 1, 2 July 2014
We’re not CBT therapists. We weren’t trained to do that, and now reading back about what they
should be has just highlighted the difference.
ST3, ST focus group 1, 2 July 2014
These comments partly reflect the timing of the focus group which met shortly after two of the STRIDE
therapists had received additional CBT training towards the end of the study and also after they had
revisited the majority of clients for the 6-month follow-up. The perceived ability of clients to sustain
changes contributed to the STRIDE therapists questioning the relationship between the CBTi they had
delivered and CBT:
I think after the 8 weeks they probably, for the vast majority of them we probably have made a
difference but come their 6-month follow-up or their 12-month certainly, it’ll be gone.
ST3, focus group 1, 2 July 2014
At this point in the study, the STRIDE therapists’ impressions of the CBTi seemed at odds with those of the
psychologists, who were confident that the intervention had been delivered as planned.
Multidimensional nature of fear of falling
The Phase I interviews to inform the development of the CBTi indicated that fear of falling was a more
complex construct than had previously been recognised and three distinct types of clients were identified
(see Figures 1–3). Through the delivery of the CBTi to clients, the multidimensional nature of fear of falling
was further revealed and even clients with apparently similar presentation responded differently to the CBTi:
There’s a lot more issues coming out than what we first thought I think, we had the pain, the fear and
the ones that were just getting on with it. I know we had that to begin with but it’s much more
complicated than that because you could have two patients with pain issues but completely different
and they can do completely differently.
ST3, interview, 4 September 2012
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As part of the initial formulation, the STRIDE therapists identified the factors that were thought to have
precipitated fear of falling. A total of 391 precipitating factors were identified by 132 clients (four
identified no precipitating factors and data were missing for two clients). After recoding the data to avoid
double counting of similar factors, 317 unique factors were identified (a mean of 2.3 per client); 31% of
clients identified three precipitating factors and 11% identified four or more.
The most common precipitating event was a fall, blackout or problems with balance (reported by 81% of
clients). Other common precipitating factors were bereavement (21%) and life events, such as family
disputes, retirement and caring responsibilities (17%). Clients also identified a wide range of other medical
problems that contributed to their current difficulties (these are described below).
Clients therefore presented with a range of challenging medical and psychosocial conditions (some
examples are provided in Box 3). The psychologists acknowledged that it would be challenging for any
therapist to work with the complex clients recruited to the study, many of whom were described as
experiencing ‘existential narrowing’ (R4) as a result of poor health, bereavement and social isolation. In this
context it proved difficult for the STRIDE therapists to embed their newly acquired skills:
It can be really quite difficult when you’re actually trying to implement something that you think
you’ve got the hang of now but actually the clients don’t fit that kind of you know they’re not doing
what they’re supposed to you know kind of they’re not saying what they’re supposed to, they’re not
presenting as we’ve been told they were going to be, and that can be quite, well very unsettling.
R4/R12, discussion, 24 October 2012
Faced with this complexity, it was crucial for the STRIDE therapists to be flexible and able to adapt their
approach. Understandably, this was challenging at the outset of the study, although the STRIDE therapists
grew in confidence over time. As it was clear that the factors restricting activities were rarely limited to fear
of falling, the STRIDE therapists shifted from a focus purely on fear of falling to a broader focus on the
range of barriers that led to clients limiting their lives and avoiding certain situations or activities:
ST1: It started off with like, fear of falling, that’s what we originally aimed at looking, but it started
becoming like more, what is causing you to avoid different things [. . .].
ST3: And it didn’t matter so much as what necessarily caused the avoidance if we could reverse that
cycle and that improved that situation.
Focus group 2, 17 June 2014
BOX 3 Examples of multiple precipitating factors
l Stroke; quadruple heart bypass; wife died in last year; BPPV; diabetes; blackouts.
l Hysterectomy last year; husband died 5 months ago (was primary carer); falls; heart attack 15 years ago;
son died; second son brain damaged after car crash; bladder cancer 3 years ago.
l Fell and fractured shoulder; osteoarthritis of knees; raised blood pressure; breast cancer.
l Couple of falls; heart issues; total knee replacement and total hip replacement some years ago; wife died in
2003; anxiety attacks.
l Whiplash injury in car crash in 1990s; recent death of husband; two falls in last 2 years; poor kidney
function; neuropathy in feet; frozen shoulder.
l Fell and broke two ribs 6 years ago; husband died 4 years ago; lots of falls over last 4 years; mini stroke in
cerebellum; pain in left foot.
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Working with clients with complex and unmet medical needs
Although site 3 aimed to prevent falls by reviewing and addressing risk factors of patients identified
through screening in primary care, patients attending sites 1 and 2 typically had more complex medical
histories and were perceived as more frail (as suggested by the difference in some of the baseline
characteristics reported in Table 12). Precipitating factors relating to medical problems were recoded into
three groups: musculoskeletal problems (including knee and hip replacement, arthritis; reported by 51% of
clients); cardiovascular and respiratory problems (23% of clients); and other medical problems (e.g.
diabetes, cancer; 38% of clients). As would be anticipated with an older client group, only a minority of
clients (20%) did not describe medical problems in any of these categories, and 29% identified problems
across two or three of these categories. STRIDE therapists and clients agreed that the CBTi was most
effective after any medical issues had been resolved, as it enabled clients to maximise the benefits of their
improved health by tackling any residual loss of confidence and encouraging them to try new activities:
If you work on that physical strength, definitely the confidence comes back. But [. . .] the variety of
applications of that confidence is quicker because you’re getting different ideas of how to apply it.
C5969 interview, 29 January 2014
Professionals in sites 1 and 2 similarly suggested that greater integration of different interventions would
be beneficial:
I just think it’s a missed opportunity, probably for interventions to be joined up [. . .] if somebody’s
having ongoing medical intervention it may be that, that that’s not as joined up.
P20 interview, 24 March 2014
Not all complex medical conditions were optimally managed, with some clients having significant unmet
needs. The STRIDE therapists were frustrated by the lack of appropriate care provided to some clients,
particularly when they felt that this was creating dependency and reducing quality of life. This led to the
emergence of an advocacy role to expedite appropriate interventions; this usually involved encouraging
clients to seek further medical help but sometimes the STRIDE therapists intervened on a client’s behalf:
We’re signposting patients before they go into the GP practices and telling them what they need to
tell the GPs because in seven minutes they’re getting nothing [. . .] we’re doing a lot of like almost
skills rehearsal, ‘right the GP needs to know this’.
ST2, interview, 19 June 2013
The advocacy role occasionally taken by the STRIDE therapists was valued by staff in participating sites,
as it enabled them to address any deterioration or emerging problems promptly.
The multiple medical issues faced by many clients led to a growing recognition by the STRIDE therapists
that further falls were (often) inevitable. This in turn prompted a subtle shift to a more explicit focus on
falls preparation whereby the STRIDE therapists aimed to minimise the psychological and physical impact of
falls by making clients more robust, increasing positive safety behaviours (e.g. carrying a mobile phone)
and providing advice on getting up after a fall:
Well I’m still worried about it [falling] because I’ve got Parkinson’s and I shake a lot but I was like
given a lot of confidence when I actually did fall just by what she said ‘well just sit there and take
some deep breaths and then try to get up and make sure you’re all right’ and that sort of thing.
I’m still confident with that.
C4465, interview, 26 June 2014
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Fit of cognitive–behavioural therapy intervention with
existing interventions
All sites either provided in-house interventions or referred clients to appropriate community resources
(e.g. Staying Steady or strength and balance classes; see Table 5). Given the varied nature of existing
interventions available to clients, we explored the fit between the CBTi and these interventions. Clients
interviewed for the process evaluation generally valued all of the interventions that they received. The
physiotherapist at site 1 similarly saw the CBTi as being complementary to existing provision:
. . . quite often what we’re able to do is very clinic based. So I can give people exercises to do. I can do
a certain amount of goal setting with them, but I can’t go out and see them at home [. . .] So I think it
might be quite a nice opportunity to make some of the clinic-based stuff a little bit more meaningful.
Interview with P20, 24 March 2014
However, other professionals sometimes saw the CBTi as potentially overlapping or conflicting with
existing interventions. This was particularly the case when goals related to deconditioning and clients were
doing activities, such as sit to stand exercises and practising going up and down a single step. Although
the STRIDE therapists considered the exercises as graded activities, as these movements were an integral
component towards achieving the broader goal, clients typically perceived them as ‘exercises’ and
described them as such when asked about the CBTi by professionals. Unsurprisingly, professionals at site 2
were concerned that the STRIDE therapists were giving patients additional exercises that were outside the
scope of their rehabilitation programme. The study team tried to address this by arranging for a STRIDE
therapist to attend a team meeting at site 2 but this did not entirely dispel their concerns about the CBTi:
So that’s why we went over there and talked to them, and told them what we were doing and how
we’d gone about it a different way, and for a lot of them they were very open in that, in that meeting
and for some of them, you got the impression they were sceptical. [. . .] I was very careful not to give
exercises. I asked about ‘Have you been given exercises from your knee classes? What are you doing
with the falls clinic? Could you do them a little bit more? Could that feed into what we’re doing?’ But
a lot of it was breaking down say, sitting to standing, or people wanting to get on and off the floor to
do their garden. I could break it down, because of my movement background and they might see that
as being – it’s exercise but it was functional. It was very much functional, but then you did feel as
though you were sort of treading a line.
ST2, focus group 1, 2 July 2014
A more general issue for the STRIDE therapists was how to manage conflicting advice. This arose most
frequently in relation to the use of walking aids and care after a hip or knee replacement. All of the
STRIDE therapists worked with clients who had internalised advice given after hip or knee replacement
surgery and changed their behaviour permanently as a result (e.g. by never kneeling or by holding on to
bannisters on the stairs). The STRIDE therapists were aware of the potential conflict between the CBTi and
advice given by clinicians:
ST2: They are being told by the NHS ‘don’t do this any more; and don’t do that any more’ and ‘that
would be dangerous’.
ST3: And we come in.
ST2: And we’re coming in saying ‘no, try it’.
Informal discussion ST2/ST3, 7 March 2014
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The extent to which clients were willing to try the STRIDE therapists’ advice partly depended on the extent to
which it was congruent with their own wishes and preferences. For example, one client who was dependent
on a walking stick following a stroke wanted to return to the running track (having been a runner all of his
life). The initial goal set with the STRIDE therapist was to walk round the track once or twice using his stick:
Anyway, the first time I went round, I walked round twelve times. I just put my stick down, that was it,
walking round. Not just walking, speed, speed walking [. . .] The first two laps, I walked gently round.
Then I’d, you know, get in my STRIDE, get faster and faster and faster. Then I’ll do ten fast laps,
roughly three, four hundred metres in three, three and half minutes, or three and a quarter minutes.
Which is what I’ve been doing all my life, this. Done running all my life. I felt, God, that’s great. So
from that day on, I had the stick with us, all the time but I never, ever use it.
C4458 interview, 2 July 2014
Although this is an extreme example, it illustrates the ways in which clients could underestimate their
physical abilities through becoming dependent on walking aids. Strategies that the STRIDE therapists might
use to deal with potentially conflicting advice were explored in a group supervision session:
R4 asked whether they had tried to change clients’ behaviour. Although the STRIDE therapists had
sometimes tried to tackle the issue, ‘but they’ve still got that ‘the doctor has said’. R4 suggested that
one approach would be to say ‘ok your doctor was right, but that was for the acute period’. ST3 said
that she had tried this approach and said that it had seemed to work. R4 elaborated that they could
continue by saying: ‘that’s for the recovery period, it is absolutely the right thing to do, but in fact
what you might be doing now is inadvertently keeping your knees a little bit weak . . . so agree with
the doctors’ advice, so you’re not setting up an opposition between you and the doctor but just
translate it, point out the difference between acute and ongoing’.
Field notes of group supervision, 19 September 2013
Other tensions between the CBTi and existing interventions related to the underlying ethos of services.
This was most evident in site 2, which seemed more risk averse than the other sites. Their emphasis on safety
was evident in the assessment documentation (which recorded whether or not a risk assessment was needed
in relation to a range of areas, including moving and handling, medication, mental status); observations of
interactions between staff and patients; and comments made by clients in therapy sessions and informal
discussions and meetings with the STRIDE therapists:
. . . at the end of the assessment, a member of staff commented that it was ‘really, really safe here’.
She then elaborated that two people usually walk patients down to the rehabilitation room. If patients
are unsteady and are with just one member of staff, they will use a wheelchair to get them from the
waiting room to the rehabilitation room.
Field notes of observation at site 2, 29 October 2013
But they tell you at the falls clinic never do exercises where you’re stretching yourself, only do them
within your own limits.
C4661, session 2 with ST2, 10 December 2013
STRIDE therapist uncertainty over underlying rationales and
specific techniques
The complexity of the clients inevitably challenged the STRIDE therapists in the light of their relatively limited
training. Three specific areas in which the STRIDE therapists’ skills could have been developed further were
the ability to transmit CBT principles to clients; tuning into client motivation; and setting SMART (specific,
measurable, achievable, realistic and time-limited) goals. The psychologists anticipated that the STRIDE
therapists would revert to existing patterns of interacting with clients in situations in which they were anxious
or uncertain about new techniques. Two examples of such patterns were being directive when clients did not
seem to be taking an active role in the CBTi, and focusing on exercise-based goals (particularly for the STRIDE
therapist with a background in physiotherapy, as this was her area of expertise).
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Transmitting principles of cognitive–behavioural therapy intervention
to clients
Although the STRIDE therapists could clearly articulate the overall purpose of the CBTi, they had difficulties
in transmitting this information to clients. A recurrent theme in discussions with the STRIDE therapists
was the extent to which clients ‘got’ the intervention. The STRIDE therapists’ discussions of client
understandings of CBTi often implied that clients were responsible for understanding the intervention.
Although, towards the end of the study, one of the STRIDE therapists acknowledged her responsibility for
facilitating client understanding, she still felt ill equipped to do so:
ST1: I feel it’s down to how I present a reiteration of how I worked with it. I didn’t do it effectively
enough; because they should be able to get it if I’ve explained it well.
R4: How would you do it more effectively now?
ST1: I don’t know. I still don’t know.
Focus group 1, 2 July 2014
Observation of CBTi sessions (and listening to recordings) indicated that the language used by the STRIDE
therapists could sometimes be inaccessible (e.g. terms used included deconditioning, generic, premise,
functional) and that there could be a lack of fluency, with repetitions and hesitations, in explaining the
CBTi, which would exacerbate client difficulties in making sense of the intervention. The STRIDE therapists
had very different approaches to explaining the intervention (Box 4) and also adapted their approach to
individual clients. Consequently, it is difficult to identify which approaches were more successful in
facilitating client understanding.
BOX 4 Sample explanations of CBTi to clients
. . . the core with cognitive behavioural therapy is [. . .] you can work on one area and it will help with the
others. And it’s called cognitive behavioural because you work on those two; of the four you work on how
you think and what you’re doing.
ST1/C6285, session 1, 7 February 2014
. . . so the pain and dizziness affect your sleep which creates fatigue and life has become more limited, you
feel more stressed in busy public places and as a consequence you possibly don’t go out in those busy
places so it’s all closed in a little bit. So what I’d like you to do is, we have to come up with, one of the
areas, what STRIDE’s about is increasing your confidence and your independence and your energy levels.
ST2/C2018, session 1, 4 December 2012
So what we could do through this treatment is we could look at your balance, look at a few simple
exercises you could do to try and improve that a little bit, support you to try and increase your activity
levels a little bit more, get you out walking maybe a little bit more to obviously improve your balance,
lose a little bit of weight, get your confidence.
ST3/C5359, session 1, 15 October 2013
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Although the psychologists highlighted the importance of ensuring that clients understood the rationale
for CBT, limited attention was paid during the training to how this might be achieved in practice. Useful
ideas for explaining the intervention were often embedded in other activities, for example when practising
formulation skills one of the psychologists commented on:
. . . the need to be explicit about what CBT could offer clients; R4 advised the STRIDE therapists that
the intervention was not going to ‘cure’ people, or ‘magically make it better’, but would just give
them a bit more control over their life.
Field notes of training, day 3, 13 June 2012
However, the extent to which the STRIDE therapists absorbed these ideas to use in their own introductions
was unclear, and the training provided few opportunities for them to rehearse how they might introduce
the CBTi to clients.
The psychologists frequently emphasised that the STRIDE therapists would embed the skills and principles
of the CBTi through practice and success with clients. This process also applied to clients, particularly in
relation to relapse prevention. The STRIDE therapists found that relapse prevention sessions made more
sense to clients, and helped to embed skills, if they were delivered at the time as a client had a fall or
other setback, rather than being done in the abstract:
ST1: I had one patient recently that I did much better with relapse prevention because something
happened during therapy. [ST2: Mmm.]
ST3: It makes a difference.
ST1: When something happens it’s so much easier to talk about it, than prep what if something
happens. [ST2: Yes.]
Focus group 1, 2 July 2014
The varied client understanding of CBTi was confirmed by the client interviews conducted for the process
evaluation, which showed that clients conceptualised the CBTi in a number of ways (see Table 40).
Beyond further training, suggestions for improving understanding of the CBTi focused around better
preparation of clients, for example by a pre-assessment session or by providing materials, such as the client
manual, in advance:
A lot of the clients will be, yes they’ll have signed up, in a sense, and accepted it, [. . .] but in terms of
actually their understanding and you know something like you know them having access to the
manual or something beforehand or whatever might be one way of then people’s, ‘Oh right so it’s
about this and these are the kind of things’ you know. So it was a sense of actually what they’re
being expected to perhaps being expected to do. So I think some pre-interview might actually be
helpful with that.
R12, interview, 2 October 2012
The STRIDE therapists similarly suggested that a pre-assessment session would be useful to introduce the
ideas and ‘socialise’ the clients into the idea of the CBTi. A separate session would enable the STRIDE
therapists to provide a more leisurely introduction to the CBTi, and help clients to understand what was
required of them if they were to get the most benefit from the CBTi. As the assessment and formulation
session was perceived as off-putting to clients, a pre-assessment session could also help to build rapport in
preparation for this session. Although the patient information leaflet provided an explanation of the study,
a personal explanation, which could be tailored to the individual, was seen as essential.
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Tuning into client motivation
Client investment in the process of CBTi was perceived as a key factor affecting the success of the
intervention. Some clients preferred adapting their environment to changing themselves, others were
thought to have ‘given up’ and accepted the limitations on their lives:
ST3: They move things, like instead of using upstairs cupboards they’ll put it on lower shelves so they
don’t have to reach, things like that, just little things like that and gradually it deconditions them.
ST2: And then finally the mind-set of ‘they’re old and want to give up on living’ because we‘re seeing
a lot of that.
ST2/ST3, informal discussion, 7 March 2014
Working with clients with low motivation is always challenging, even for experienced therapists.98 It is
therefore not surprising that the STRIDE therapists sometimes found working with these clients frustrating
and were not always sure how to address the issue of motivation:
I think the ones that are going well; they have been engaged with the process. So it’s been like their
personal, it’s been nothing that I could control; they’ve just been interested right from
the beginning.
ST2, group supervision, 16 January 2013 (author‘s emphasis in bold text)
The STRIDE therapists developed a range of strategies to try to tap into client motivation, including
negotiating, persuading, giving examples of other people in similar situations, exploring barriers, exploring
benefits of change, exploring values and trying to encourage them to make even small changes:
Like I say you pick your battles, like some people yeah they don’t want to go out and do things but
they might be willing to do something in the house so you encourage them doing that, they might
have an exercise bike which might be the only thing you can encourage them to do so it’s just a
case of supporting them to do what they’re willing to do [. . .] and the other thing is look at the
parameters, so like the lady I just mentioned about her excuse is always ‘oh well it depends on the
weather, I’ll only go out if the weather is nice’, so I might be looking around ‘well what do you class
as nice weather’ and trying to shift it so instead of it being well blue skies, sunny, warm, changing it
to well it might be a little bit cloudy but the threat of rain isn’t there so it’s like kind of making their
willingness a bit bigger, if that makes sense.
ST3, interview, 20 May 2013
When these strategies were not successful, the STRIDE therapists tended to take a more directive role and
suggest exercise-based activities and goals:
But if you go in and you say, ‘Maybe if you try sitting to standing a few more times?’ and they come
in and do that, that might be their level of engagement and for some of them, that sometimes is all
they need to do.
ST2, focus group 1, 2 July 2014
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The feasibility of delivering CBTi successfully with clients with low motivation was questioned by one of the
psychologists and the STRIDE therapists, and introducing further eligibility criteria or a pre-assessment
session that explicitly explored motivation to change, were suggested as possible ways of targeting the
CBTi on clients who were most likely to benefit:
I think probably there needs to be a sophisticated vetting process for the client [. . .] the FES thing,
then that doesn’t, I think it doesn’t really tap into people’s motivation to change. And I mean that’s,
you know you can say that for any therapeutic intervention, but I really think that’s critically important
if you want to maximise your resources and so on, then you do need to be clever about who gets the
intervention. It’s not for everybody.
R12, interview, 2 October 2012
As a result of discussions about the importance of client motivation and engagement, the STRIDE
therapists were asked to rate each client’s engagement with the intervention on a 7-point scale. Of the
138 clients for whom ratings were available, mean level of engagement was 5.2 (SD 1.5), with only
9 (6.7%) rated as having low engagement. (This is similar to the proportion of clients who ‘rarely’ or
‘never’ completed homework assignments in a study of group CBT.)94 This suggests that discussions
focused disproportionately on those clients with low motivation. Nevertheless a number of suggestions
were made which could help to focus the CBTi on clients who were motivated to change, for example,
by requiring clients to take responsibility for arranging at least the initial session (while this was not
feasible in the context of a RCT, it may be appropriate if the intervention is rolled out in practice) or by
formally assessing motivation to change, for example, by using measures such as Suitability for short term
Cognitive therapy.99
Setting specific, measurable, achievable, realistic and time-limited goals
Although the identification of valued goals that could be worked towards during the initial eight sessions
was a central component of the CBTi, the ability of the STRIDE therapists to work collaboratively with
clients and identify SMART goals was varied. The STRIDE therapists had no difficulties in explaining the
principle of breaking down goals:
ST3 then reiterates that next time ‘we’ll come up with some goals that you want to achieve over the
eight weeks’. She explains that they will ‘break them down into bite-sized chunks, or baby steps that
we’ll work on over the weeks to build up to the long term goals’. She draws a parallel with running a
marathon, developing a training plan and building up the distance over time.
Field notes of observation of session 1, ST3/C1521, 9 September 2013
As in the above example, the example of running a marathon was frequently used by the STRIDE
therapists; more appropriate examples may have been more helpful (particularly as client feedback on the
manual indicated that they valued examples with which they could identify). The importance of setting
SMART goals and exploring obstacles was emphasised in supervision:
R4 highlighted the importance of defining clear homework goals; and signposted the STRIDE
therapists to work on implementation intentions which indicated that people were more likely to
follow through if there was a clear plan in terms of when, how often etc. [. . .] R4 went back to the
issue of verbally negotiating the goal and ensuring that goals were SMART; he also suggested that
they should explore potential obstacles to the goal.
Field notes of group supervision, 19 September 2012
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These principles, however, were not always put into practice, and the STRIDE therapists could not always
see how to break a goal into tasks:
Sometimes it’s helpful breaking these up, but some things, things don’t apply to it. So, because it’ll be
like, you know, they’re like, ‘I want to arrange . . . you know, I want to go to the theatre and stuff’,
okay, so it’s like, ‘Book a seat at the theatre’.
ST1, interview, 11 September 2013
In the above example, exploring implementation intentions and potential obstacles could have helped to
identify specific tasks that the client could have worked on (e.g. anxieties about travel, difficulties hearing
on the telephone, worries about delaying people in adjoining seats if they are not able to negotiate their
way out of the seats quickly).
Identifying goals with clients who were ‘stoics’ (i.e. clients with fear of falling but no experiential
avoidance; see Figure 3) was particularly difficult as:
They were really pretty much doing the things, they just needed that bit of support and guidance
really in to what they wanted to do. And there’s only so much you can do with those people.
ST1, interview, 23 August 2012
This led to the emergence of a ‘supportive’ role, for which the STRIDE therapists primarily encouraged
clients to continue with their existing activities rather than identifying new goals and applying
CBT techniques.
Despite the strong emphasis in the training on working collaboratively with clients, as already described,
when faced with clients who did not seem to ‘get’ the intervention or who seemed to lack motivation, the
STRIDE therapists tended to become more directive and suggest goals. These were typically informed either
by the process of assessment and formulation or through observation:
As she walked to the door I said ‘you’re touching all the walls’. I said ‘maybe we could look at
creating a little programme where you improved your balance in the house’.
ST2, group supervision, 16 January 2013
Goals were also circumscribed by the physical abilities of clients and this contributed to the shift towards
more exercise-based goals. The physiological knowledge of the STRIDE therapist with a background in
physiotherapy was valued by the psychologists, as it complemented their knowledge base:
By nature of our training we think everything is psychological, so we forget that if you have been
stuck at home for five years you’re probably not that fit, so when you do go out the house your heart
rate is going to go up a lot because you’re not fit and you’re going to interpret that as an anxiety and
you’re just going to start the whole panic cycle, so actually having that kind of physiological
complement to that where you address the physiological deconditioning in tandem with that.
R4/R12 discussion, 7 May 2014
Reflecting the varied health and social circumstances of the clients, there was wide variation in the scope
of the goals identified. For example, goals ranged from ‘picking something up off the floor’ (C1514) to
‘going to live in London for a month to learn a foreign language’ (C5072). Review of the goals recorded in
the STRIDE therapist summaries highlights the non-specific nature of many goals. A total of 234 goals
were identified by 129 clients (seven clients had no goals and data were missing for two clients). Of the
234 goals, context was specified for half (49%), duration for 14% and frequency for 8%. Reviewing goals
and homework tasks recorded in case notes during supervision might have helped the STRIDE therapists to
refine their ability to set SMART goals. The goals were coded into nine categories (Figure 30); walking-
related goals were most common, with relatively few goals relating to social activities.
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As part of the CBTi, it was intended that clients would grade the perceived difficulty of their goals at the
outset of therapy, approximately midway through the sessions and in the eighth session. These ratings
would indicate the extent to which the CBTi enabled clients to meet their individual goals and supplement
the formal outcome measures. There was, however, significant variability between the STRIDE therapists in
the extent to which these ratings were completed (the percentage of clients having ratings for at least one
goal at all three time points ranged from 25% to 71%; p< 0.01; chi-squared). The STRIDE therapists found
it difficult to elicit ratings from some clients, as they often preferred to describe their progress or difficulties
verbally rather than attaching a numeric value. For the 118 goals for which ratings were available at the
start of therapy and in the eighth session, the majority were rated as having reduced in difficulty (78.8%),
with only a minority either remaining at the same level of difficulty (14.4%) or being more difficult (6.8%).
The difficulties in consistently obtaining ratings from clients suggest that further training and discussion of
eliciting ratings was needed.
Acceptability of the cognitive–behavioural
therapy intervention
This section focuses primarily on the perspectives of clients receiving the CBTi and the professionals from
participating sites. Where relevant, however, the perspectives of other stakeholders are also included. This
allows an integrated perspective on each theme or issue rather than presenting the views of different
stakeholder groups in isolation. In exploring acceptability we have focused on client views on the CBTi and
the STRIDE therapists; the perceived benefits of CBTi; the practical organisation of CBTi; and professional
views of the CBTi.
Client perspectives of cognitive–behavioural therapy intervention and the
STRIDE therapists
Client interviews suggested that they conceptualised the intervention in terms of four domains: increasing
self-awareness; learning practical techniques; companionship; and ‘not for me’ (Table 40). Although some
clients perceived the intervention to focus exclusively on a single domain, others recognised two or more
of these domains. Their perspective on the intervention also reflected the extent to which they took an
active or passive role in the CBTi (see Table 40).
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Within the category of self-awareness there was a distinction between clients who viewed the CBTi as an
opportunity to learn more about themselves and gain insight into the factors contributing to their fear of
falling and those who took a more passive role and relied on the STRIDE therapist to ‘make you think
about it’ (C4158). In terms of practical techniques, some clients understood the intervention in terms of
identifying targets and breaking these into manageable activities, whereas others perceived the CBTi as
essentially exercise based. The latter clients, together with those who conceptualised the CBTi as primarily
about companionship, tended to take a more passive role.
A final group of clients perceived the CBTi as ‘not for me’; these clients tended to withdraw either from
CBTi or from the RCT altogether. Previous studies of falls prevention strategies have highlighted that older
adults may perceive strategies as ‘better for others than for me’.100 Clients who were already managing
their fear of falling by continuing to be active despite their fear of falling (‘stoics’) tended to see the CBTi
as superfluous, as they had no experiential avoidance. Although some of these clients continued with the
intervention, with the STRIDE therapist taking a supportive role, others chose to drop out (see Table 40).
A small number of clients did not identify as having lost confidence and therefore did not see the CBTi as
relevant (this is consistent with dropout rates being associated with lower FES-I scores; see Table 22):
So we got to the rationale part and I said well ‘it sounds as if you’ve lost a little bit of your
confidence’, ‘no I’m a very confident person, I don’t think this is for me’, really shut down, and I was
like ‘OK well this is not for everybody, do you want to keep hold of the manual?’ ‘No, no I’m
not interested’.
ST3, group supervision, 5 September 2013
TABLE 40 Client understandings of the CBTi
Understanding
of CBTi
Example of when clients were taking:
A more active role A more passive role
Self-awareness I think for once you get to be me, you get to
have you time and analyse yourself and find
out your own strengths and weaknesses
C3028
She saw which way I was thinking and she
pointed us down the right road how to think
in that direction
C4158
Practical
techniques
I’m always seeing that long end target and
what I picked up with talking with ST2 and
from here [the manual] you know it’s to
tackle things in small bite-size chunks
PC07
There’s one exercise she was telling me – just
stand behind that settee, grab a hold and go
down on my, balance myself and go down;
I couldn’t do that before she started
C4465
Companionship – We talk about what’s going on. She asks me
what I’ve been doing, and I tell her what I’ve
been doing, we have a chat about it and
she’s good company
C0506
‘Not for me’ I appreciate what you’re trying to do but I’ve
got a feeling probably that what I’m doing
myself is as good as it’s going to be
C5367
I cannot see the point, I get depressed, I get,
waste of time
C5074
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Other clients who thought the intervention was ‘not for me’ tended to have a wider sense of resignation
about their lives and capabilities and were not interested in pursuing change:
It’s no good doing things that are out of your reach; you’ve got to be feasible.
C5371/ST3, withdrew after session 3, 23 January 2014
Finally, a number of clients withdrew from the CBTi for reasons unrelated to the intervention including life
events (e.g. bereavement), poor health and ongoing medical investigations or treatment:
She ended up withdrawing from the CBT side of things because it wasn’t appropriate for her at that
time because she had far too much that needed to be done before true CBT could be carried out.
ST1, focus group 2, 17 June 2014
Dropout rates provide some indication of acceptability of the CBTi. Overall, 65.7% of clients allocated to
CBTi completed the study (all of whom completed all nine sessions of the CBTi); 8.1% withdrew from the
intervention but continued to complete outcome measures and 26.2% fully withdrew. Of those who
withdrew from CBTi, 12.9% did so before their first CBT session, and 21.4% during the intervention after
attending an average of 3.0 (SD 2.5) sessions.
Relatively few caregivers were directly involved with the CBTi; when they provided support to clients this
mainly took place outside formal sessions. The involvement of caregivers centred on providing encouragement:
I have fell a couple of times like I told ST3 and it did knock us back and my husband after reading the
manual opened the front door, put us out, closed the front door and locked it and said ‘you’ve done it
before, go 3 doors up and come back’ and that’s the way I did it. I started from the beginning again.
PC14, interview, 13 September 2012
Independent of their understandings of the CBTi, clients consistently valued their interactions with the
STRIDE therapists and the small number of caregivers interviewed similarly emphasised the interpersonal
skills of the STRIDE therapists. In describing these interactions, comments related to four domains: the
development of a therapeutic alliance; negotiation; support and challenge; and technical skills/advice
(Table 41). The development of a therapeutic alliance is key to the success of psychological interventions101
and the STRIDE therapists proved skilled at developing positive relationships with clients. The challenges in
working collaboratively with clients to identify goals was highlighted earlier in this chapter; while most
clients reported that the process of developing goals and identifying tasks was shared, some of the
phrasing used suggests that the STRIDE therapists sometimes took a more directive approach:
She [STRIDE therapist] used to spend an hour just doing exercises and talking about how you feel,
how your confidence feels, setting yourself goals, like going to a football match. I used to be right into
that and she said ‘well get one of your sons to take you’.
C4465 interview, 26 June 2014 (author‘s emphasis in bold text)
I can truly say that if she set me an objective the first week, we would discuss it the next time. She
came and discussed it but she never let it go, until she could write it off and I knew that, so I did have
to try.
C5969 interview, 29 January 2014 (author‘s emphasis in bold text)
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TABLE 41 Views on interactions with the STRIDE therapists
Domain Example
Building a
therapeutic
alliance
She’s got such a pleasant manner and not overbearing or condescending or anything like that
C2042 interview, ST1, 28 January 2014
I wish it would go on and on because I love her coming. I look forward to her coming, I think she’s
good company and she’s got a lovely nature and she is the right type of person for the job I think
C3009 interview, ST2, 22 October 2012
She was very understanding with what I was saying and trying to say and she understood how I felt
about going out and about the anxiety I felt about falling and she was really very understanding
PC14 interview, ST3, 18 June 2013
Negotiation It was more like two friends meeting over a coffee and suddenly you think ‘oh I need an answer to
this’ and then as you’re talking the answer comes
C3028 interview, ST1, 8 November 2013
We would just sit and chat and she would maybe suggest it or I would or maybe I would say something
and she would say ‘oh, we could use that as . . .’ you know, for such and such or she would be talking
about something and I’d say ‘oh that’s a good idea’. So it was, sort of, just between us
C5960 interview, ST2, 28 January 2014
C: It was a two-way thing all the time, she wasn’t sort of saying all the things, she was saying a
little bit and then I would put my bit in and what I thought, but I can’t think
F: Well like you discussed together targets that you might use
C: That’s right, that’s right
F: . . . to help, didn’t you? But when she discussed them with you, she was finding out what you
thought you could manage, rather than what she thought you could manage
C3020 and daughter interview, ST3, 11 June 2013
Support and
challenge
With her being friendly and not sort of ‘oh, you must do it’ or ‘you’ve got to try harder’, it gives you
more encouragement to try to please, you know, and reach that goal. As I say, I’m really looking
forward to seeing her face when I say ‘I’ve made it!’
C2042 interview, ST1, 28 January 2014
Encouragement, encouragement; telling us I could do it
C4458 interview, ST2, 2 July 2014
I had to go to Sainsbury’s, so I goes out, lovely day, walks up the hill and everything, gets up to
Sainsbury’s, does me shopping, coming out of Sainsbury’s the man at the top of the street says
‘Are you going straight home [client’s name]?’ I says ‘yes’. ‘Come on pet, I’ll give you a lift’. So I did,
I got the lift back. She said ‘we’re not counting that because you’ve got to go both ways – up the
hill and down again’
C5969 interview, ST3, 29 January 2014
Technical
skills/advice
About the middle of her sessions, she took me down to the metro station and showed me just how
the ticket machine operated, which seems stupid, but you know you get frightened of these things
and in fact it had changed quite a bit since the last time I’d used it
C5377 interview, ST1, 30 June 2014
She put me in touch with bereavement people and everything, which was very good
C4465 interview, ST2, 26 June 2014
She came with some really good ideas to do things
C5969 interview, ST3, 29 January 2014
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It was clear, however, that clients did not find this approach oppressive or too directive. This suggests that
the STRIDE therapists modified their style in terms of working collaboratively or being more directive
according to the extent to which clients took an active role in identifying goals and/or tasks. The support/
challenge model highlights the importance of judging the optimal levels of both support and challenge.98
The interviews indicated that clients felt able to modify tasks that seemed too challenging, and were fully
supported by the STRIDE therapists in doing so. Some challenges seemed (from the perspective of the
process evaluator) too great; for example, one client reported having been physically sick prior to going
out in the dark for the first time for years; another client had been terrified during a 10-minute walk down
a hill (which took her 45 minutes to complete). Both of these clients, however, reported feeling an
immense sense of pride and achievement on successfully completing these challenges.
Although professionals in participating sites received relatively little feedback from patients about the
intervention, any comments tended to focus on the interpersonal aspects of the CBTi and were consistent
with the interview data:
I mean people have come and said, you know, ‘That nice ST3 comes out to see me’ or, ‘Isn’t ST1
lovely, she comes to see me.’ And, and so they’ll tell me more about, I think, the interaction that
they’ve had, the interpersonal side of things.
P20 interview, 24 March 2014
Perceived benefits of cognitive–behavioural therapy intervention
A range of positive outcomes from the intervention were identified by clients, caregivers and STRIDE
therapists (Table 42). Although some clients reported specific changes, others found it difficult to explain
the outcomes of the CBTi:
All I know is how I feel and I feel different. I feel good and I don’t think ‘oh I’d like to go to such as
such – Oh I couldn’t manage that’; now ‘I’d like to go such and such, right we’ll go’. It is nebulous, it’s
very difficult to explain.
C3028 interview, ST1, 8 November 2013
No negative outcomes of the CBTi were reported, even when clients had fallen during the intervention
period. Caregivers generally identified similar outcomes, although some felt the client was exaggerating
the benefits. Some caregivers had directly benefited from the CBTi, either because of reduced anxiety or
concern about the client, or because of improvements in the client’s mood (see Table 42).
Professionals working in participating sites occasionally gained some insight into client experiences of the
intervention during follow-up appointments:
The ones that have been in the treatment arm all seem to be, they have engaged I think and they’ve,
all the ones that come back anyway that see us, they seem to be very positive, they’ve all been doing
a bit of exercise as well as whatever the CBT aspect is and most of them seem to have benefited, I
haven’t had anybody who has said it’s been a negative experience at all.
P4 interview, 19 June 2014
Internalising the principles of cognitive–behavioural therapy intervention
A key aim of the intervention was to equip clients with the skills to apply CBTi principles to new contexts
and become, in a sense, their own therapists. Although available data provide only limited insight into the
extent to which the principles were internalised and the factors that facilitated or inhibited clients’ abilities
to generalise the CBTi to new challenges, it was clear that clients varied in the extent to which they had
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TABLE 42 Outcomes of CBTi reported by clients, caregivers and STRIDE therapists
Domain Example
Increased confidence She just told us I could do it. I just, I felt I would never be able to do anything again. And
when ST2 told us to try, I went and said, ‘Maybe I can do it’
C4458 interview, ST2, 2 July 2014
Certainly I’m very much more confident than I was before it started
C5377 interview, ST1, 30 June 2014
Decreased anxiety I was getting I didn’t want to go out, you know? And I thought, ‘Oh I could go out today
and I might fall’, you know? And it was on my mind all the time, where now, I don’t even
think about it
C3514 interview, ST3, 30 June 2014
I’ve always had a thing about coming down these stairs, I’ve always stopped at the top and
thought ‘right, now I’ve got to get down these stairs’, now I don’t, I just come out of the
room and go down
C3028 interview, ST1, 8 November 2013
Increased
independence
Well my husband’s over the moon. Yeah because I used to rely on him a lot to do a lot of
things and now, I mean if I needed a birthday card he used to have to go and get it because
I wouldn’t even venture up to [place 33] on me own
PC14 interview, ST3, 13 September 2013
Improved mood,
enjoyment
I’m much more cheerful and outgoing
C3028 interview, ST1, 8 November 2013
When I was going out it was lovely, it was nice well summer is nice anywhere when you’ve
got lovely early mornings, I felt like I was grabbing the new day, it uplifted me [. . .] it gave
me an energy boost, it felt good
PC07 interview, ST2, 1 November 2012
I mean, with her getting frustrated she’ll yell at me for the least thing [. . .] I’m calling it
depression but I would say frustration might be a better word. And she couldn’t do it and if
things went wrong, if she dropped something or whatever and couldn’t. . . ‘Aargh,’ type of
thing, you know? But now since we’ve had the five weeks with ST3 and different things is
happening, getting better, getting more relaxed again
C3029 and husband interview, ST3, 11 June 2013
Increased activity Just by doing the tasks, and setting myself little tasks as well. Going somewhere, and saying,
‘Well, I’ll go here.’ So I used to sit, planning, and when ST3 went away, I said, ‘What can I do?
What am I doing? Where am I going?’ Get my days planned out, which meetings I’ve got to
go to, and then other things, into the town [. . .], I often go down there, just shopping.
Having a look around the shops
C0506 interview, ST3, 22 October 2012
Increased
self-acceptance
I’ve got over the feeling that it [falling] is totally embarrassing and it’s not right to fall, it’s not
shame to fall flat or whatever, you know. And now I think if I fell I would be all right. Yes,
I would have the confidence to say, ‘Well you either help me or you don’t’
C5969 interview, ST3, 29 January 2014
I know I cannot do the marathon now, you know. I know, like, me limitations a bit better
and accepting them, that’s the thing I think
C4158 interview, ST2, 29 January 2014
continued
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embedded the underlying principles. For some clients, the role of the STRIDE therapist in providing
encouragement seemed crucial and, when such support was withdrawn at the end of the eight sessions,
they were not necessarily able to sustain changes on their own:
There are patients where you’ve gone back and it’s been like, ‘So how have you done?’ ‘Well, I did it
for a bit.’ ‘So what stopped you? What curtailed it?’ ‘Oh, well I just stopped doing it as much.’ I think
it’s – and they’re like, ‘Well you weren’t here’.
ST1, focus group 1, 2 July 2014
Although some clients continued with the exercises suggested by the STRIDE therapist, they did not always
have the ability to identify new goals and break these into manageable (and relevant) steps. For example,
when one client was asked in an interview whether he had any current goals, his response was ‘to be able
to go out by myself and maybe have a pint in the pub’ (C4465, ST2). When asked about how he planned
to achieve this, he explained:
. . . just actually getting around in the house and being more independent, our [name of son] still
comes every morning and me other son comes at teatime and before I go to bed one of them will
ring us.
C4465 interview, ST2, 26 June 2014
When the interviewer tried to clarify how this related to the goal, the client explained:
Oh I’ve got miles to go yet; it’s in [village], it’s about a mile and a half away, 2 mile, so I don’t think I’ll
ever achieve that one.
C4465 interview, ST2, 26 June 2014
Applying the principles of the CBTi to going out during the winter was challenging. Some clients simply
reported that they would not venture outdoors in poor weather, but one client explained how she would
use the techniques learned:
If it’s just snowing I’m fine. But once it starts getting a little bit slippy, I just refuse to go out, you
know? I just haven’t got that confidence for that yet, you know?
C3514 interview, ST3, 10 June 2013
TABLE 42 Outcomes of CBTi reported by clients, caregivers and STRIDE therapists (continued )
Domain Example
Improved walking/
balance
I used to leave a bruise on her [sister’s] arm. She used to have a bruise every time she went
home. She used to say, ‘Do you know you’ve got my arm black and blue,’ ‘cause honestly
I used to cling on for grim death.’ And she used to say, ‘For goodness’ sake, can you not
leave go?’ And now I don’t need her arm
PC14 interview, ST3, 18 June 2013
We’re getting people off their sticks, I’ve have a few people that don’t use their stick as
much – either stopped using it in the house or just carry when they’re out and about, which
I think makes a big difference
Informal discussion ST2/ST3, 7 March 2014
Increased motivation I’m more confident about doing other things, and getting on with them, instead of sitting
and saying, ‘Oh, I’ll do it tomorrow. I’ll do it tomorrow, or the next day.’ I’ll tend now to get
on with it
C0506 interview, ST3, 22 October 2012
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I would judge on the day how I feel, what the weather is like, but I’d also take into account now I’ve
had these sessions with ST2 ‘well really wait a minute how can we get around this and make it better,
what if it’s going to be icy for a week you’re not going to get out, I’ve got to get out, how am I going
to get out?’ So yes, I would be starting to think again ‘what’s the best way?’ Like my footwear I’ve
got special things I put on over my shoes and walking you know I look where I’m going. I mean even
when it’s been really bad [. . .] I’m thinking you cannot be wrapped up in cotton wool all the time, you
cannot. So yes it has made a difference because I would break it down again.
PC07 interview, ST2, 1 November 2012
The manual was a valued resource for some clients who referred back to it to enable them to maintain
progress despite setbacks:
The way I did it was I sort of like cut my brain in half and had a conversation with the left side of my head
and the right side of my head. When the left side of my head said ‘no you were going to fall’ I took on
board, if it makes sense to you, the manual and convinced myself I wasn’t going to fall because the
manual said positive thinking and that’s what I did and I used to have this conversation in my head and I
mean I was telling my sister and she looked at us as though I was going crackers but it does work, it does.
PC14 interview, ST3, 13 September 2012
Increased awareness of the ways in which fear of falling (often alongside physical impairments and ill
health) had limited their activities often helped motivate clients to maintain activities:
I do sometimes think, ‘I’m not going back there.’ And the coffee morning, not last Saturday but the
Saturday before, was that wet day and I’m sitting there [. . .] and I’m thinking, ‘I’m not going. Oh I’m
not going to go. I’m not going to get soaking wet and not go. No, I’m not going to bother.’ And then
I just thought, ‘Aha, get yourself organised. Go in the car.’ And that was it, so I went.
C5969 interview, ST3, 29 January 2014
Practical organisation of cognitive–behavioural therapy intervention
The perspectives of all stakeholders are included in this section. Few quotations are included in this section
due to space limitations; instead an overview of the advantages/disadvantages of existing arrangements
and suggested changes is provided in Table 43.
Several suggestions made by clients were already in place. For example, the STRIDE therapists occasionally
accompanied clients with tasks; this was seen as a legitimate activity by the psychologists, particularly in
the initial stages:
I think if people can do it on their own that’s you know it’s even better but we want safe experiences,
people to have safe experiences, we don’t want failure experiences, so if it means going out with a
STRIDE therapist then I would certainly encourage them.
R4/R12, discussion 19 June 2013
Although some clients suggested more flexibility in the timing and duration of sessions, this was already
offered by the STRIDE therapists, as and when needed. Although the therapy nominally comprised eight
sessions at weekly intervals, in reality the sessions were scheduled to fit in with clients’ other commitments
(reflected in the average duration of the initial eight sessions; see Chapter 4). This meant that the 8-week
assessment, designed to capture immediate postintervention outcomes, frequently took place before the
CBTi was complete (see Chapter 4). The duration of sessions was also flexible; some clients (typically those
who were well motivated and/or for whom the STRIDE therapists had a supportive role) had sessions of
only 15–20 minutes once the intervention was under way. The flexibility in delivering the CBTi reflects the
constraints of working in a ‘real world’ setting. Many of our clients were active, but many more were
unwell with multiple comorbidities, and hospital and GP appointments, and hence found it difficult to
commit to a rigid timetable of weekly sessions.
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There was a strong preference for home visits among clients and, despite the additional costs in terms of
travelling time, the STRIDE therapists also thought home visits were appropriate for this client group
(particularly at the beginning of the intervention):
Well initially one of the things that you’re fighting against is going out, so you wouldn’t go to a clinic
[. . .] it would be an easy cop out not to go. There’s no way would you not be in for somebody coming
to your home. But you would use any excuse [not to go to a clinic], the cold, the rain, too sunny, too
hot. You would use any excuse.
C5969 interview, ST3, 29 January 2014
TABLE 43 Views on practical organisation of CBTi
Aspect Benefits of existing arrangements
Drawbacks of existing
arrangements Suggested changes
Number,
duration and
frequency of
sessions
Generally seen as appropriate Eight sessions was not seen
as adequate to work
successfully with clients with
multiple barriers
Clients seen during the
summer had little chance to
apply principles to icy
weather
More flexibility
Shorter, more frequent sessions
Seasonal booster session to
prepare clients for the winter
‘Homework’ Generally seen as helpful Varied compliance STRIDE therapists to accompany
clients with initial tasks
Home visits Convenience
Clients felt relaxed
STRIDE therapists could see the home
environment
Appropriate for clients with fear of
falling who often struggled to go out
(or to use public transport) and who
admitted that they might not have
attended clinic appointments
Time-consuming for STRIDE
therapists
Home environment could be
distracting
Use clinic appointments when
congruent with client goals
(or when preferred by clients)
Timing of
follow-up
session
Gives opportunity to put skills into
practice
Easy to lose incentive or
forget techniques
Long time to wait if the
client has a setback shortly
after the initial sessions
More flexibility so support can
be accessed in the event of a
setback
More gradual withdrawal
after initial eight sessions (e.g.
follow-up at 1, 3 and 6 months)
Individual
sessions
Opportunity for in-depth discussions
Intervention could be tailored to
individuals
No opportunities to
compare strategies and
provide a sense of solidarity
(or competition)
Addition of a group session to
explain CBTi at the beginning
Addition of a group session at
the end/after the 6-month
follow-up to maintain impetus
and provide support
Client
manual
The presentation, content and
language used were acceptable to
clients
Clients valued the examples,
particularly when they could identify
with them
Some clients did not engage
with written materials
Production of a simplified
version
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From the STRIDE therapists’ perspectives, offering an intervention in primary care seemed more appropriate
than basing a service in secondary care or specialist falls services. This would allow the early identification
of clients with fear of falling (or barriers to activities) and could avoid some of the problems of
implementing CBTi at the same time as addressing other medical problems:
Or even offer a service within a GP practice – if you have any concerns about your confidence, about
your walking kind of book an appointment with dadadadada. You know, that may be the best way to
start as such to actually having someone within your primary as supposed to your tertiary and
secondary’s and stuff. Or even have sort of more person bouncing between GP practices to GP
practice spending a day in each one.
ST1, focus group 2, 17 June 2014
As highlighted in previous sections, other suggested changes included a pre-assessment interview,
assessment of client motivation to change, ensuring that any medical conditions were optimally managed
prior to the start of the CBTi and better integration with existing interventions, in particular combining
CBTi with specialist input relating to exercises.
ST1: Ideally you should do them [rehabilitation and CBTi] combined; doing one before the other
doesn’t quite work as well I would have thought. Obviously we didn’t have the opportunity to really
do it properly but I think if you combined some of the stuff we did in CBT with like physio rehab on
the patient . . .
ST3: Like strength and balance classes.
ST1: . . . would work really well.
Focus group 2, 17 June 2014
Professionals’ views of cognitive–behavioural therapy intervention
None of the sites offered specific interventions targeting fear of falling. The views of professionals in site 3
on the CBTi have already been described (see Chapter 2). Senior staff in site 2 hoped that the CBTi would
complement their existing rehabilitation programme by directly addressing fear of falling:
Fear of falling wasn’t really changing or was increasing so that’s where this comes in because we were
hoping that the addition of the talk through the CBT would possibly help us.
P21/P22 interview, 28 November 2013
Although at the outset of the study, some professionals subscribed to the view that fear of falling would
automatically decrease with improved physical strength, their views seemed to have changed by the end of
the study:
There are some people still I see with very severe fear of falling and it’s a great shame that there
doesn’t seem anything to do other than offer them physiotherapy in the vain hope that this is
somehow going to improve their confidence.
P4 interview, 19 June 2014 (author‘s emphasis in bold text)
Despite the lack of robust feedback, staff at sites 1 and 2 expressed an interest in providing CBTi after the
end of the study, for example by training existing staff to deliver CBT alongside their existing rehabilitation
programme or by employing one of the STRIDE therapists on a sessional basis:
I think the useful part is thinking about our own healthcare assistants being trained to do it; they do a
lot of the rehab and so they build up quite a relationship with patients so in that way I think it would
be useful, very useful.
P21/P22 interview, 28 November 2013
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In site 1, where there were perceived to be ‘pockets’ of CBT within the Trust, it was suggested that a
‘generic CBT team’ could be developed who could work into different hospital departments and clinics
as needed:
. . . that means that you’re not just relying on one person so if they then leave or go somewhere [. . .]
you’ve got a bit of succession planning and you’ve got a bit of a group.
P4, interview, 19 June 2014
Conduct and delivery of the randomised controlled trial
Managing a perpetual state of flux
The study faced a number of challenges throughout, including delays with research passports,
disagreements over the funding and banding of the HCAs to deliver the intervention, threats to the
continued funding of the initial (single) site and recruitment difficulties which resulted in a threat to the
continued funding of the study. In addition, as with most studies, changes to the protocol and sites
resulted in a number of ethical amendments. The STRIDE therapists also had to cope with a number of
practical challenges including not having an office or access to computers when they were first appointed.
The timing of these various events meant that the study team was faced with an almost continuous stream
of challenges; although these challenges are by no means unique, the number and pace of them was
particularly relentless within the present study. Although morale generally remained high among core staff
(i.e. those most heavily involved in the study on a day-to-day basis), there were moments at which morale
dipped either individually or (less frequently) collectively:
I think there was a real loss of morale 2 weeks ago, everybody was thinking about different jobs, they
were all thinking everything was ‘going down the pan’ as they put it, so even if they were invested in
the therapy, they weren’t invested in the study because they didn’t believe it was working.
R4, informal discussion, 3 May 2013
As with previous research,102 delays with research passports impacted on the study either by delaying data
collection by staff already in post or by delaying the appointment of temporary staff to facilitate
recruitment. The process of adding the study to CB’s existing research passport took 7 months, meaning
that fieldwork and analysis relating to Phase I of the study had to be condensed into a very short period.
Even when additional staff were recruited to temporary posts to facilitate recruitment and/or baseline
assessments, some took up other posts because of delays in obtaining their research passports. Similar
difficulties were experienced in providing support with recruitment in site 2:
R30 had been keen to help on a voluntary basis with recruitment in site 2 but had not been able to
start until December despite having agreed to help out in August. These delays had occurred despite
having supportive human resources and research and development departments.
Field notes of TSC meeting, 16 January 2014
The recruitment of the STRIDE therapists proved more complex than anticipated. The planned grading of
the posts (band 2) was contested and following extensive consultations the posts were advertised at band
4 because of the relative clinical independence of the posts. Owing to factors outside the control of the
study team, the posts were advertised as CTAs based within the CRF. A generic CTA job description was
used with the only permitted modification being the addition of a single sentence (on p. 5) explaining that
the purpose of the post was to deliver a CBT intervention to older people. As a result, one candidate
assumed that CBT would just be one part of the role and that the post would be based ‘. . . in a clinic,
possibly taking blood’ (ST2 interview, 27 June 2012) and a second candidate thought ‘it was going to be
like a drugs trial or something like that’ (ST3 informal discussion, 2 July 2012).
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The implications for the study and the generalisability of the findings relate to whether the candidates
applying for a CTA post differ systematically from those who would have applied for a HCA post
(as originally intended). Several professionals queried the extent to which the STRIDE therapists were
typical of HCAs:
Is ST1 a typical representative of a Band 4? I don’t know, it seems to me she’s quite exceptional [. . .]
she’s got great, far greater skills I think, personal skills and engagement and again professionalism and
reliability and not off sick [. . .] you didn’t really have typical people.
P4, interview, 19 June 2014
Despite their reservations, professionals recognised that it was becoming increasingly common for people
with degrees to work as HCAs in the current economic climate. Indeed nearly all of the applicants for the
posts were graduates:
The health-care assistants I’ve come across in previous, in private physio practices are almost all
graduates with things like sports science degrees [. . .] that might just be the current demographic
where there’s a lot of people who want to go into medicine or physio or sort of health-related
sciences and can’t get a vocational training job.
Given the nature of the post – delivering a CBT intervention – it is likely that the post would have attracted
recent psychology graduates who were interested in pursuing a career in health care. The fact that two of
our STRIDE therapists were from this background suggests that the people whom we appointed were not
untypical. The third STRIDE therapist had a background in physiotherapy and was studying for a master’s
degree in clinical research.
The study was initially funded as a single site study. The funding of this site came under threat on three
occasions during the lifetime of the study and, eventually, funding was withdrawn and the clinic closed at
the end of the study recruitment period. Negotiations with the commissioners meant that we succeeded
in delaying the closure of the site by reducing clinic hours for the last few months of the study. The
recruitment of two further sites had significant implications for the team in terms of research governance,
travelling time and in understanding how the intervention ‘fitted’ with the service already provided at each
of the three sites.
Recruitment to the trial
Low recruitment rates led to a monitoring meeting with the funders in February 2013 (month 9 of the
32-month data collection period) and the potential withdrawal of study funding. The level of the core
team’s investment in the study was highlighted by the intense efforts made to reach recruitment targets to
ensure continued funding. This took its toll on team members both physically and emotionally and led
to reallocation of resources to ensure the continued viability of the study. An agreement by the funder that
the power of the study could be reduced from 90% to 80% enabled the required sample size to be
reduced from 580 to 412. Even with this reduced target, the issue of recruitment remained challenging
until the end of the study when we succeeded in achieving the recruitment target the day before
recruitment closed. A range of factors contributed to our difficulties in meeting our recruitment target,
none of which is unique to the present study.103 An overview of the challenges and strategies implemented
to address these is provided in Table 44. The strategies used to enhance recruitment were informed by
Patient and Public Involvement (PPI) and client interviews.
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TABLE 44 Overview of challenges to recruitment and retention and strategies to address these
Stage of recruitment Challenges Strategies
Determine eligibility Additional work for professionals in
sites 1 and 2
Lack of research experience in site 2 in
maintaining screening log
Lack of systems in site 2 for recording
whether or not patients had been
approached and/or the outcome of an
approach
Difficulties in operationalising eligibility
criteria
Limited administrative support provided in
site 1 by one member of staff who
facilitated recruitment
Trial manager provided some support/
training
Senior staff introduced a more robust
system for monitoring contacts, but
implementation continued to vary
Re-checked at consent visit by RAs using
eligibility checklist
Provide with study details and
expression of interest form
Professionals in participating sites had
only a vague understanding of the CBTi
Extent to which professionals were
willing and able to introduce the study
varied
The lack of focus on fear of falling
within participating services created
genuine difficulties in introducing the
study, as it did not readily flow from
existing routines and interactions
Insufficient time to explain the study to
patients in a way that was tailored to
their individual circumstances
Briefing meetings held with professionals to
provide more information about the CBTi
External staff (STRIDE therapists, CTAs or
volunteer) were provided to approach
patients
‘Script’ or bullet points provided to help
professionals give a brief introduction
EoI form returned to study team EoI form was easily ‘lost’ in the routine
paperwork provided (particularly at
site 3)
PIS seen as inaccessible to clients
Process of opting in seemed too
burdensome for the client group, many
of whom had low levels of motivation
By involving external staff, paperwork
relating to the study was given separately to
that relating to the clinic
PIS revised and shorter version produced
Process simplified to reduce client burden
Contacted by RA, eligibility
confirmed, consented, baseline
assessment completed and
randomised
Difficult to engage clients in meaningful
discussion of study over the telephone
Concerns of RAs who were responsible
for recruitment over pressurising clients
into participation
Difficulties in explaining CBTi to clients
in an accessible way
Perception that the study was not
relevant to clients
Emphasis on arranging a visit to discuss the
study in person
Recruitment meeting to explore concerns;
further support provided via office meetings
Discussion of strategies; STRIDE therapists
trained external staff involved in recruitment
Review of common concerns raised by
clients and ways to respond to these
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Although using external staff provided by the CRF to introduce the study to eligible clients was successful,
the study team was not always informed which clinics were being covered by CRF staff or when CRF staff
were on leave. This resulted in incomplete coverage of clinics. Clinic staff were similarly unaware of when
CRF cover was being provided and so were unsure whether or not they should discuss the study with
patients. Improved communication enabled most of these issues to be resolved. Successful changes to the
recruitment strategies resulted in an influx of work and backlogs in clients waiting to be contacted by the
RAs for consent and baseline assessment, which required further shifts in resources to enable clients to be
seen and randomised with minimal delay.
In order to meet recruitment targets, the STRIDE therapists became involved in recruitment. This had a
number of benefits – chief among them the successful recruitment of the required number of clients for
the study. Other benefits for the STRIDE therapists were an increased awareness of participating sites and
more insight into the client pathway into the study. There were also wider benefits for the study, as the
direct contact with the STRIDE therapists increased professionals’ confidence in the intervention:
So I knew that they were nice, nice isn’t the word, professional people, so that makes a difference
because if you have somebody who is going to see somebody who is disinterested or not bothered or
whatever then you don’t, then that would have an effect on their perception of our unit, but I didn’t,
I knew that they weren’t like that and I knew that they you know they’re always good with their
appointments and you know they turn up, they’re reliable aren’t they?
P4, interview, 19 June 2014
Capturing the outcomes of cognitive–behavioural therapy intervention
While there is a comprehensive evidence base surrounding the use of the FES-I in the evaluation of fear of
falling,29,31,56,104 professionals in all sites expressed concerns about the use of the FES-I as the primary
outcome measure for the trial. Sites 2 and 3 had before-and-after FES-I scores for patients who had
completed the in-house rehabilitation programme, and strength and balance training, respectively. Neither
of these interventions had resulted in an improvement in FES-I scores, leading staff to question whether or
not the FES-I would capture any changes resulting from the CBTi. One professional additionally queried the
interpretation of any changes in FES-I score:
TABLE 44 Overview of challenges to recruitment and retention and strategies to address these (continued )
Stage of recruitment Challenges Strategies
Obtaining complete outcome
measures at all time points
Perceived burden of diaries and
outcome measures
Some clients found questions in
self-completion measures off-putting
Any missing data identified and RAs
checked for non-returned data
(self-completion questionnaires and falls
diaries) at final visit
Focus on key outcome measures
Telephone administration of FES-I and key
data within questionnaires if client unwilling
to have a final home visit
Telephone reminder for non-returned
self-completion questionnaires introduced
Clients advised to exclude any questions
with which they did not feel comfortable
Self-completion questionnaires completed
by RA at 6- and 12-month follow-up visits
where possible
DOI: 10.3310/hta20560 HEALTH TECHNOLOGY ASSESSMENT 2016 VOL. 20 NO. 56
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Parry et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
103
They’re grading how confident they feel on a range of activities which may or not be important to
them. So I think it’s very difficult to say, ‘Well I’ve gone from four to two on sweeping the floor’ you
know, that’s good, but what does it actually mean to that person?
P20, interview, 24 March 2014
One problem for the RCT was the need to specify the outcome measures in the bid prior to the preliminary
therapeutic interviews which provided an understanding of the factors involved in fear of falling and the
likely outcomes of an intervention:
We need to know what sorts of things they think they are likely to change before we choose
R4, informal discussion, 13 July 2011
The interviews with clients confirmed that their underlying fear of falling might not have changed, despite
a range of other positive self-reported outcomes (see Table 44). The psychologists and STRIDE therapists
similarly identified a wide range of outcomes that might not be captured by the FES-I:
Some people’s lives have certainly blossomed as a consequence of it and you know that may only be
the fact that you know they’re obviously walking up the stairs now within their house, or they’re
actually able to walk to the kitchen and so on without you know to going out you know
independently around town on you know on metros and are walking on the promenade or whatever.
R4/R12, interview, 7 May 2014
Reflections on the process evaluation
In terms of the models of qualitative work in trials, the present process evaluation was an example of an
‘integral-in-practice’ model105 for which senior qualitative expertise (TF) was incorporated throughout the
study; the qualitative researcher (CB) was valued as a ‘full’ member of the team;105 the process evaluation
was adequately resourced and the team were committed to acting on the findings. The role of the process
evaluator was facilitated by the openness of the research team to a degree of observation and self-
reflexivity exceeding that which would normally be expected in such studies. This proved a key strength of
this study which has allowed the capture of important data concerning the processes (and challenges) of
delivering a CBTi to older people with fear of falling. Although colleagues recognised the challenges of the
process evaluation, they were willing to be involved:
I can understand it’s fascinating. I think God that must be such a slippery place to be in terms of data
and all that kind of stuff. I think God I’m not sure that’s something I would want to get involved in
doing it. But it’s interesting that it’s actually being done and I think it’s a really good – a
great opportunity.
R12 interview, 14 November 2011
The close working relationship between the process evaluator and one of the psychologists was key to the
success of the process evaluation in terms of providing support, ongoing discussion of data and
exploration of emerging issues and reflecting with a colleague with a therapeutic, rather than a qualitative,
perspective. In commenting on drafts of this chapter, one of the psychologists reflected on the difficulties
CB was having in writing about how the STRIDE therapists and clients made sense of the CBTi:
The struggle that you are having is a mirror of the struggle that both STRIDE therapists and clients will
have had in that process of negotiating a shared understanding of what it was they had found
themselves doing together in the room!
R12, e-mail, 19 March 2015
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The challenges for the process evaluation were largely concerned with resource management and
prioritisation. Many different tasks and situations competed for attention, with the process evaluator even
becoming involved in recruitment at times to ensure that the study continued. Some of the difficulties
were common to any process evaluation – in particular the inability to know at the time of data collection
which factors might emerge as central in explaining the trial results. This tended to result in a focus on
data collection at the expense of analysis. It was sometimes difficult to know whether or not and how to
use sensitive information. Responsibility for enacting decisions was not always clear and this could result in
agreed actions either never happening or being delayed. A separate challenge related to disentangling
effects; for example, the shift to more exercise-based interventions reflected multiple factors and
understanding cause and effect in this context was impossible.
Despite the challenges, our experience has confirmed the value of undertaking in-depth process evaluation
alongside the development and delivery of a RCT,106 in an iterative manner that allows for timely feedback
to optimise processes where necessary.
Understanding the findings of the process evaluation using
normalisation process theory
The process evaluation for the STRIDE study aimed to identify, describe and explain the professional and
organisational factors that promoted or inhibited the implementation and integration of the CBTi. This
should facilitate the transfer and integration of the CBTi into routine clinical practice. We have highlighted
the complexity of delivering the CBTi and the ways in which the STRIDE therapists and psychologists
sought to adapt the intervention to meet the varied clientele. We have also reported factors affecting the
conduct and organisation of the trial, and shown how core team members and the STRIDE therapists were
highly committed to the study and made strenuous efforts to ensure its successful completion. In the
following discussion, NPT is used as a framework to explain the factors which influenced the extent to
which the CBTi was embedded in practice. NPT focuses on understanding the collaborative ‘work’ that is
needed to support the embedding of a new practice, and in this study various stakeholder groups –
STRIDE therapists, clients, professionals working in participating sites and the research team – were key to
this process. Our main emphasis here is on the embedding of the CBTi, rather than the trial itself, although
these are inextricably linked and, for some groups (e.g. research team), the work of embedding the CBTi
was primarily through the study processes. Implications and recommendations for future delivery of the
CBTi are presented and discussed in Chapter 7.
Making sense of cognitive–behavioural therapy intervention
For stakeholders to invest the necessary time and effort in making the CBTi ‘work’, the intervention needed to
have coherence, that is to ‘make sense’ to the different stakeholders involved in the study. The achievement
of this varied both across and within stakeholder groups. For the STRIDE therapists the work of ‘making
sense’ of CBTi was initially hindered by the greater than anticipated diversity of clients and slow recruitment.
Through the process of enacting CBTi over time, supported by the initial training and ongoing supervision, the
STRIDE therapists’ understandings of the intervention developed, although they remained less confident with
some aspects of the CBT approach. For clients achieving coherence at a conceptual level could be difficult and
they had varying understandings of what the intervention involved. For some, the intervention came to make
sense through the process of ‘doing’ CBTi; others, however, never ‘got’ the intervention, which could limit
their ability to internalise and generalise the underlying principles of CBTi. Some professionals were uncertain
about the relevance of psychological therapy to clients attending for falls assessment and the team had to
work to address these concerns during the intervention development phase to ensure that staff would be
comfortable recruiting clinic patients into the trial (see Chapter 2). This process was more challenging in site 2,
where no members of the study team were directly involved in service provision and there was a risk averse
culture. The research team shared a general understanding of the CBTi and the study as a whole, although at
times different understandings about study processes (e.g. data collection) among team members became
apparent, and needed to be resolved.
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Investing in cognitive–behavioural therapy intervention
Engagement and commitment to making the CBTi ‘work’ – cognitive participation – was generally high.
The STRIDE therapists were employed to learn the skills required for delivering the CBTi, but thoroughly
embraced their role and became central to problem-solving. The training gave therapists legitimacy,
despite raising their awareness of challenges in working with the client group. Over time, the therapists
became increasingly engaged in the practical organisation of therapy, ‘taking ownership’ of the CBTi, as
well as some study processes and documentation. Clients themselves engaged variably with the CBTi.
Although the STRIDE therapists utilised a range of strategies to promote clients’ engagement with therapy,
their efforts were not successful with all clients. The engagement of professionals, who had a key role in
recruiting participants into the trial, was variable across the sites. The core research team were highly
motivated to complete the study, solving problems as they presented, and actively engaging in additional
roles and tasks where required to achieve study milestones (e.g. recruitment).
Enacting cognitive–behavioural therapy intervention
The collective action work around conducting the CBTi, and the trial as the supporting structure for it,
presented challenges for all stakeholders. The successful conduct of both the CBTi and the study were
dependent on the resources, arrangements, relationships and skills that were required to make the
intervention work. For the STRIDE therapists, a series of practical problems (e.g. not having dedicated
office space, logistical barriers to travelling to appointments) initially impacted on their capacity to
efficiently complete their work but were resolved over time. Their work was facilitated by the support
provided by the team (and each other) for ongoing skill development, and by the high level of confidence
from the team in the work they did with clients. The extent to which clients were actively involved with the
therapy varied widely; although some enthusiastically set themselves challenges and made significant
progress in a short space of time, others relied on the STRIDE therapist to provide impetus. This variation
seemed to reflect differences in personal approaches and motivation, perceived benefits of the CBTi and
the complex and multiple comorbidities that they experienced. Professionals contributed variably to
recruiting participants to the trial, for a range of reasons relating to both individual (e.g. attitudes towards
therapy) and structural/cultural (e.g. risk averse) factors. The core research team worked hard to address
problems that arose in conducting the study, and although highly motivated, experienced challenges in
resolving some issues
Appraising and adapting cognitive–behavioural therapy intervention
A final NPT mechanism, key to understanding the embedding of the CBTi, is the capacity to appraise the
value of the intervention and scope for making improvements and adapting it the local contexts – reflexive
monitoring. The STRIDE therapists demonstrated a high degree of reflectiveness and adaptation
throughout the delivery of the CBTi, to the extent that some changes in the focus of the intervention
raised questions over the identity of the CBTi. The extent to which clients internalised the skills that they
had learned and applied these to new situations following the completion of therapy was variable. For
some clients, increased self-awareness, together with an understanding of basic CBT techniques (such as
graded exposure) enabled them to sustain changes. Others, however, found it difficult to generalise CBT
principles to new situations without the support of the STRIDE therapists. Professionals at the sites had
much more limited capacity to make appraisals of any impact of the CBTi, as there were no formal
mechanisms established for staff to receive feedback about clients following therapy. Some received
informal feedback from patients who were clients in the study, at times this was positive but in some
instances this generated professionals’ anxiety about increased risk of falling. As noted already, the core
research team were continually engaged in problem-solving and ‘troubleshooting’ as the study progressed.
However, a higher degree of anticipation of problems and forward planning may have facilitated the
conduct of the study, and reflections on learning from the process to apply in further studies have been
made by the team.
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Summary of findings
l To deliver the CBTi, HCAs needed to learn complex new skills. Although the training was generally felt
by the psychologists and the HCAs to be adequate, further adaptation for a non-specialist audience is
recommended. The HCAs’ ability to embed and develop their CBTi skills was facilitated by individual
and group supervision sessions and the HCAs’ self-initiated peer support sessions.
l The HCAs’ delivery of the CBTi was evaluated positively by the psychologists, although some skills
could be further developed. The delivery of the CBTi was shaped over time by their growing experience
of the client group, the complexity of fear of falling and the tendency to revert to existing skill sets.
l The value of the CBTi for this client group was recognised by some professional staff providing usual
care. Senior professionals expressed interest in the ongoing delivery of the CBTi services, and suggested
scope for improved integration of the CBTi with existing interventions. There were, however, issues
over the ‘fit’ of CBTi with the underlying ethos of one participating site.
l Client engagement with and understandings of the CBTi varied. Nevertheless, clients valued their
interactions with the HCAs and perceived a range of benefits from the CBTi including improvements in
confidence, independence, mood, activity levels, walking/balance, self-acceptance, and motivation, and
reductions in anxiety.
l The organisation and delivery of the CBTi in terms of the materials, session content, frequency and
duration, was generally acceptable to clients although more flexibility over the follow-up session was
suggested. There was a strong preference for delivery in the client’s home.
l The study was threatened by numerous and varied challenges, including threats to clinic funding,
sub-optimal staff recruitment processes, delays in access approvals for research staff, and difficulties
meeting recruitment targets. Continual investment in troubleshooting, resource management and
teamwork was required to successfully complete the study. These processes were facilitated by the
embeddedness of the process evaluation within the study.
l The study has highlighted the extent to which older people’s lives are curtailed by medical and
psychosocial events; very few of the clients who received the CBTi would have considered or been
eligible for help from existing psychological services.
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Chapter 6 Health-economic evaluation
Introduction
The aim of the economic evaluation was to determine whether or not the novel CBTi plus usual
multidisciplinary care is cost-effective compared with usual multidisciplinary care alone for patients – with
significant fear of falling – attending a community falls service.
The economic evaluation comprised both a within-trial cost-effectiveness analysis (CEA) and a within-trial
CUA. The perspective (i.e. whose costs and benefit are considered relevant) of the evaluation is the health
service provider (NHS), but a broader analytical perspective incorporating NHS costs and those of informal
caregivers is also considered.
Methods
The primary measure of cost-effectiveness was the incremental cost per unit reduction in FES-I at 12 months.
The analysis followed an ITT approach. In addition, as estimates of the incremental cost per unit reduction in
FES-I might be difficult to interpret according to standard decision-making criteria within the NHS,107 a CUA
was also performed, with the incremental cost per quality-adjusted life-year (QALY) being estimated at
12 months. As the duration of the study was 12 months, discounting of future costs and benefits was
not required.
As part of the within-trial economic evaluation the following outcomes were reported:
l costs to the NHS at 12 months
l costs to the NHS, and patient’s informal caregivers at 12 months
l FES-I at 12 months
l QALYs over 12 months, based on responses to the EQ-5D (5L) and SF-6D questionnaires administered
at baseline (pre-randomisation), 8 weeks, and 6 and 12 months.
For the purpose of the analysis, data on costs and effects of the interventions were combined to obtain an
incremental cost-effectiveness ratio (ICER). The ICER summarises the cost-effectiveness of a health-care
intervention. It is defined by the difference in costs between the intervention and control group, divided by
the difference in effect between the two groups. It represents the average incremental costs of one
additional unit of the effect. The ICER can be estimated as:
ICER =
(C1−C0)
(E1−E0)
, (1)
where C1 and E1 are the cost and effect in the intervention arm, and C0 and E0 are the cost and effect in
the control group. Costs are described in monetary units, whereas effects can be measured in terms of
health status (FES-I) or another outcome of interest, such as the QALY.
This provides the cost per additional unit of effectiveness (e.g. unit reduction in FES-I or QALYs) gained.
The ICER can be used to aid decision-making regarding resource allocation. If a decision-maker can
establish a willingness-to-pay (WTP) value for the outcome of interest, it is possible to use this as a
threshold. If, for a given intervention, the ICER is above this threshold then it will be deemed too expensive
and thus should not be funded, whereas if the ICER lies below the threshold then the intervention can
be judged to be cost-effective. The results are displayed on the cost-effectiveness plane from which a
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cost-effectiveness frontier was generated. The cost-effectiveness frontier allows us to determine the
treatment option that maximises net benefits at our chosen ceiling ratio. For example, in a CUA NICE
typically adopted a threshold value for society’s WTP of £20,000 per QALY. However, it is unclear what the
ceiling ratio is for cost per a unit reduction in FES-I. Prices were reported in 2013–14. All statistical analyses
were performed using IBM SPSS Statistics release 22 and Microsoft Excel® version 14 (Microsoft
Corporation, Redmond, WA, USA). Statistical significance was at p-values of < 0.05.
Identification and measurement of resource use
Cognitive–behavioural therapy intervention costs
The costs of the intervention (CBTi) were microcosted and estimated on a per-patient basis for those in the
intervention arm of the trial. The intervention costs comprised two components: the costs of (1) training and
supporting three HCAs who delivered the CBTi and (2) its delivery. The costs of training the HCAs who
delivered the intervention included a 5-day programme that was delivered by two psychologists (costed as
clinical psychologists). During the delivery of the intervention, each HCA received a 1-hour fortnightly
one-to-one supervision meeting (with NSa) plus a 1-hour monthly team meeting (with VD). The costs of
training were apportioned to each individual taking part in the intervention arm of the trial.
Valuation of NHS and informal care giving resource use
With the exception of the CBTi intervention, patient-level resource use relating to falls and mobility,
including all NHS and informal caregiver costs, were identified and measured using a resource utilisation
form (see Appendix 7) self-completed by participants in both arms of the trial at 6 and 12 months after
randomisation. The use of the resource utilisation form allowed us to divide NHS resource use into
secondary care, primary care, community care and ambulance journeys. It also allowed the collation of
informal care giving time. Secondary care resources included inpatient stays, accident and emergency
(A&E) visits and outpatient visits. Primary and community care resources included general practice (GP) and
home visits, practice nurse visits at the surgery, and district nurse visits in the home. With respect to the
use of ambulances, the number of trips was recorded. Informal caregiving time comprised the average
time per week spent by family and/or friends who were helping participants with activities that they would
have usually been able to undertake if they had not experienced problems with mobility or a fall.
For each trial participant, all components of treatment costs stratified by category of resource use were
computed by multiplying units of resource use by their unit costs. These were then summed over all
resource-use categories to obtain a total annual cost for each participant both from a NHS perspective and
a NHS and caregiver perspective. This was then used to generate the average cost per patient in each arm
of the trial.
Unit cost sources included NHS reference costs and Unit Costs of Health and Social Care.108 The unit costs
utilised for each category of resource use can be found in Tables 45 and 46 and are expressed in 2013–14
UK pounds sterling (£).108
Secondary care costs
The use of secondary care resources related to falls or mobility problems included numbers of A&E visits,
inpatient admissions, outpatient visits and inpatient length of stay. We assumed that each hospital
admission incurred a tariff relating to inpatient care following a fall.109 The impact of the use of this tariff
was tested in the sensitivity analysis. In general, the frequency of use of these health-care resources was
multiplied by the national tariff to get the total follow-up cost per patient. Table 45 provides a detailed
description of the unit costs used and where they were sourced from.
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In addition to the secondary care costs, ambulance journey costs were included for those who had
reported a frequency of use on the resource utilisation form. The unit cost of this was £192 per journey
and was estimated from North East Ambulance Service data.
Primary and community care costs
The health-care resources available to participants at a primary care setting include GPs and health-care
workers including practice nurses and district nurses. We assumed that a visit to the health-care practice to
see a health-care worker was an appointment with a practice nurse, and a visit to the home was made by
a district nurse, with average costs to the NHS estimated per guidance.108 As GP visits can occur at the
health-care practice or at the participant’s house, we distinguished between the different locations of each
consultation to account for the different costs associated with each consultation. Table 46 provides a
description of the unit costs used to estimate primary and community care; all unit costs are based on
Curtis’s Unit Costs of Health and Social Care 2014.108
Informal care giving costs
Data were also collected on the amount of informal care giving time from family or friends that
participants had received on average on a weekly basis. This was then extrapolated over the 12-month
follow-up period and multiplied by an hourly cost of informal caregiver time. The national minimum wage
of £6.50110 was taken as a proxy for the value of informal caregivers’ time.
Identification and measurement of outcomes: Falls Efficacy
Scale–International version and quality-adjusted life-years
The primary economic analysis mirrored the analysis of effects by focusing on FES-I and estimating the
incremental cost per a unit change in FES-I at 12 months. As previously discussed, the FES-I is a validated
instrument for assessing fear of falling, which itself is defined as an ongoing concern about falling which
ultimately limits activities of daily living.29 It is a 16-item questionnaire using a 4-point scale (1= not at all
concerned, 4= very concerned) and was administered at baseline, 8 weeks, and 6 and 12 months’
follow-up.
TABLE 46 Unit costs for primary and community care
Health Professional Unit Unit cost (£)
GP – at practice Per visit 46
GP – at home Per visit 92
Practice nurse Per visit 11
District/community nurse – at home Per visit 39
TABLE 45 Unit costs for secondary care
Resource Unit Cost (£) Source
Inpatient falls without specific cause, with CC score
of 2–3
Per hospital admission 2672 NHS tariff WA23B
Consultant-led outpatient geriatric medicine visit Per attendance 207 NHS tariff WF02B
A&E attendance Per attendance 169 NHS tariff VB05Z
Non-elective long-stay excess bed-day Per bed-day 242 NHS tariff WA23B
CC, complications and comorbidities.
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In line with NICE recommendations,107 outcomes in the economic analysis were also identified and
measured using QALYs. Data used to estimate QALYs were collected using two instruments: the EQ-5D (5L)
and SF-6D. These were used to collect information about participant’s health-related quality of life (HRQoL)
at baseline and 8 weeks, and 6- and 12-month follow-up periods. Both instruments allow HRQoL to be
valued on a scale on which perfect health and death are ‘1’ and ‘0’, respectively. The values for each health
state were obtained from the respective UK population valuation sets for the two instruments.
The EQ-5D (5L)111 is increasingly being used in preference to the earlier EQ-5D-3L tool to assess the quality
of life for participants with different medical conditions. The EQ-5D (5L) questionnaire describes health
status in five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each
of these dimensions has five levels, ranging from the best possible situation to the worse possible situation.
The number of dimensions and levels within each dimension provide 3125 possible health states in which
participants could be at any point in time. The responses to the EQ-5D (5L) questionnaire were transformed
using a standard algorithm to produce a health-state utility score at scheduled intervals during the
follow-up for each participant in each of the treatment groups.112 Although the EQ-5D (5L) is the most
commonly used instrument to measure HRQoL, there are concerns about ceiling effects that it may not be
capable of distinguishing between health states that are close to full health.113 For this reason we used
version 2 of the SF-36,114 which contains questions regarding eight domains of HRQoL compared with the
five contained in EQ-5D (5L). Utility values for the states described by the SF-36 are obtained using the
SF-6D algorithm.65
Mean QALY differentials between the groups were generated from the utility values derived from
responses to the EQ-5D (5L) and SF-6D during the follow-up period using the regression approach,
controlling for baseline utility.115 This area under the curve approach puts a time weight on to each utility
score, which allows us to generate QALY values for each participant. Furthermore, stratification variables
(pain when walking, referral to strength and balance training classes and gender) were included as
fixed effects.
Data analysis
Within the economic analyses, the mean volume of health-care resources and informal care giving time
associated with each arm were estimated and reported together with their SDs. Mean differences and
95% CIs were calculated using non-parametric bootstrapping. Mean costs were estimated and reported
together with their SDs for each trial arm. In order to account for the skewed nature of the cost data,
mean cost differences and CIs were estimated using non-parametric bootstrapping.
In order to inform whether or not the intervention is cost-effective, methods recommended by NICE
technology assessment guidance107 have been adopted to report and present the results of the incremental
costs and outcomes (FES-I and QALYs) of CBTi compared with usual care. The incremental costs and
outcomes were combined within an ICER for six scenarios:
1. NHS costs and FES-I
2. NHS and caregiver costs and FES-I
3. NHS costs and EQ-5D (5L) QALYs
4. NHS and caregiver costs and EQ-5D (5L) QALYs
5. NHS costs and SF-6D QALYs
6. NHS and caregiver costs and SF-6D QALYs.
For the purpose of the analysis, data on costs and effects of the interventions were combined to obtain an
ICER. This was performed by calculating the mean difference in costs between the intervention and control
group, divided by the difference in effect between the intervention and control group. This provides the
cost per additional unit of effectiveness (e.g. unit reduction in FES-I or QALYs) gained. The results are
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displayed on the cost-effectiveness plane, from which a cost-effectiveness frontier was generated. The
cost-effectiveness frontier allows us to determine the treatment option that maximises net benefits at our
chosen ceiling ratio. For example, in a CUA NICE typically adopted a threshold value for society’s WTP of
£20,000 per QALY. However, it is unclear what the ceiling ratio is for cost per a unit reduction in FES-I.
Prices were reported in 2013–14. All statistical analyses were performed using IBM SPSS Statistics release
22 and Microsoft Excel® version 14. Statistical significance was at p-values of < 0.05.
Uncertainty surrounding the cost-effectiveness ratios was addressed using the bootstrapping technique,
utilising 5000 bootstrapped samples. The results of the bootstrapping simulations were presented on
the ‘cost-effectiveness plane’, which highlights the preferred treatment option. If the results lie in the
north-west or south-east quadrants the preferred treatment is clear, as one option dominates the other
(i.e. is less costly and more effective). If the results lie in the north-east or south-west quadrants, the
decision as to which is the preferred treatment is less clear (i.e. one option may be less costly but also less
effective, or more effective but at greater cost); the ICER may aid this decision. The bootstrapping was
also used to estimate CIs for both costs and effects of the two arm comparison. A cost-effectiveness
acceptability curve (CEAC) based on the net benefit approach116 was also used to present the probability
of a treatment being cost-effective, based on a range of values for society’s WTP for a unit of outcome.
Base-case results used data with complete information, the ‘complete cases’ for both costs and effects.
Sensitivity analysis
In addition to the stochastic sensitivity analysis, which was undertaken to allow presentation of the level of
variance around outcome measures included in the CEA and CUA, sensitivity analysis was also performed
to gauge the impact of varying key assumptions and/or parameter values in the base-case analysis.
Specifically the cost of an inpatient admission was varied. This was conducted to more accurately capture
the impact of length of stay on total costs as a few participants had very high lengths of stay. For this
analysis, rather than use a single tariff for inpatient admissions, we separated the hospitalisation costs and
the treatment costs by utilising the relevant non-elective long stay reference cost for length of stay then
multiplying this by the average length of stay for the national tariff. These costs were then subtracted from
the national tariff to estimate the treatment costs without any length of stay component. Total costs per
patient were calculated by multiplying the treatment cost by the number of hospital admissions and
multiplying their length of stay by the non-elective long-stay reference cost relevant to the national tariff.
Missing data
Missing data can be separated into:
1. Item-level missingness Data missing as a result of blank returns on particular items of questionnaires
that had been returned partially completed.
2. Missing because of questionnaire non-response Data missing as a result of dropout.
Item level missingness for resource use and costs was dealt with by using a simple imputation which
involved imputing the lower and upper interquartile range for participant’s use of each item of the
resource utilisation form when there were missing data. We used this range as the mean value was very
skewed because of a small number of participants who used very high quantities of medical services and
the majority of participants who responded to the questionnaires had little resource use. We used a simple
imputation method to interpolate missing HRQoL data at 8 weeks and 6 months by utilising the weighted
average of each participants’ adjacent observations at each time point.
Missing cost and QALY data resulting from dropout were imputed using multiple imputation to allow for
comparison and test the robustness of the base-case results. The regression analyses used to impute
missing data included the following variables measured at baseline: age, sex, gait and balance score,
handgrip strength, functional reach, falls efficacy, concern about falling (0–10 scale), pain when walking,
participation score, loneliness score and site. In addition, the number of sessions of the CBTi completed
was included as a predictor variable. The QALYs and costs were imputed at 12 months using regression
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models with the above variables included as predictors. Each of these methods was undertaken separately
for each study group and both groups together (with group added as a predictor variable). In each case,
50 data sets were imputed and a pooled estimate of the impact of the intervention at 1 year across data
sets was based on an analysis of covariance model with adjustments for baseline (with QALY data) and
randomisation strata.
Results
Data completeness
Data were missing either because questionnaires were not fully completed at all time points or because of
patient dropout, as presented in Chapter 4. A total of 415 participants were randomised: 205 to the
control arm and 210 to the intervention arm. A participant was included in the deterministic cost analysis
and categorised as complete data if they had returned either a 6- or 12-month resource utilisation form or
both of these. This gave the maximum numbers for analysis. The number of participants included for
analysis was 169 (82%) in the control arm and 155 (74%) in the intervention arm. Thus, a total of 324
(78%) participants who had returned information on resource use either at 6 or 12 months’ follow-up
were included in the analysis. Missing data within the resource-use questionnaire varied across questions
(4.6–9.9%). Complete EQ-5D (5L) data to estimate QALYs for which patients completed the questionnaires
at each of the four time points were available for 112 (61%) of patients in the control arm and 85 (46%)
of patients in the intervention arm. The number of responses returned with completed EQ-5D (5L)
questionnaires by trial arm are shown in Figures 31 and 32.
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FIGURE 32 Completion of EQ-5D (5L) data at baseline and follow-ups in the control arm.
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FIGURE 31 Completion of EQ-5D (5L) data at baseline and follow-ups in the intervention arm.
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The figures suggest that the loss to follow-up in the intervention arm was greatest at 8 weeks and 6 months
compared with the control arm. Those who completed the EQ-5D (5L) questionnaires at 6 months, in the
intervention arm, appeared to be no less likely to be lost to follow-up than those who completed the
6-month follow-up in the control arm.
Complete SF-6D data to estimate QALYs for which participants completed the SF-36 at each of the four
time points were available for 84 (45%) of participants in the control arm and 69 (36%) of participants in
the intervention arm. The number of responses returned with completed SF-36 questionnaires by trial arm
is shown in Figures 33 and 34. These completion rates are lower than those for the EQ-5D (5L), which
might be expected given the higher response burden associated with the SF-36.
As in the case of EQ-5D (5L), the majority of cases were lost to follow-up before month 12, with more
losses occurring in the intervention arm.
Complete cost and FES-I outcome data were available for 310 (75%) patients: 159 (78%) in the control
arm and 151 (72%) in the intervention arm. Complete cost and EQ-5D (5L) QALY data were available for
187 (45%) patients: 79 (39%) in the control arm and 108 (51%) in the intervention arm. Complete cost
and SF-6D QALY data were available for 152 (37%) of patients: 69 (34%) in the control arm and 83
(40%) in the intervention arm. The base-case cost-effectiveness analyses used complete cost and outcome
data (n= 310 for FES-I; n= 187 for EQ-5D (5L) QALYs; n= 152 for SF-6D QALYs), but we also include
results for all available data, where possible, to maximise transparency of results.
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FIGURE 34 Completion of SF-36 data at baseline and follow-ups in the control arm
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FIGURE 33 Completion of SF-36 data at baseline and follow-ups in the intervention arm.
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Costs and resource use
Initial intervention cost
The total cost of providing the intervention was calculated and the average intervention cost per patient
was calculated by dividing the total costs by the number of patients in the intervention arm of the trial
(n= 210). The costs of providing the intervention are detailed in Table 47.
Resource use
Inspection of the histograms and associated tests for normality of the distribution of the data
(Kolmogorov–Smirnov test and Shapiro–Wilk test) showed that the resource utilisation and cost data were
not normally distributed (p< 0.05). Further analysis revealed the data to be right skewed and truncated at
zero because of the small numbers of high resource-use patients and the number of participants who
incurred no costs. Table 48 shows mean resource use and the bootstrapped 95% CIs. Visits to A&E and
visits to the home by GPs and district nurses, along with caregiver time, were higher on average in the
intervention arm than in the control arm. However, as the CIs illustrate, there was no evidence of a
difference between randomised groups.
Costs of NHS services and caregivers’ time
For each trial participant, all components of treatment costs stratified by category of resource use were
computed by multiplying units of resource use by their unit costs. These were then summed over all
resource-use categories to obtain a total annual cost for each participant both from a NHS perspective and
a NHS and caregiver perspective. This was then used to generate the average cost per patient in each arm
of the trial. Table 49 shows the average costs per resource-use category and average cost differences
bootstrapped 95% CIs.
Table 49 shows the average costs per participant for each cost category at follow-up and the mean
differences in average costs for all cost categories. With the exception of the cost of the intervention itself,
the CIs illustrate there was no evidence of a difference between randomised groups although the width of
the CIs suggests that there may be economically important differences for many of the cost categories that
could favour either intervention.
TABLE 47 Costing of CBTi
Resource use Quantity Cost (£)
Training: psychologists’ time, £138 per hour108
Block training days with psychologists 10 days 10,350
Fortnightly supervision meetings with each HCA 107 hours 14,766
Monthly group meetings 21 hours 2898
Training: HCA time, £7.04 per hour108
Block training time 112.5 hours for three HCAs 792
Fortnightly supervision meetings for each HCA 107 hours 753
Monthly group meetings 21 hours 444
Delivery of intervention, £7.04 per hour108
HCA staff time costs delivery of intervention 9.5 hours per patient 67
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TABLE 48 Resource use: mean number for each resource-use category and difference between groups using all
available data
Follow-up resource use
12 months
Intervention CBTi Control usual care Mean difference (95% CI
bootstrapped difference
between means)n Mean (SD) n Mean (SD)
Number of visits to A&E 155 0.16 (0.64) 169 0.14 (0.58) 0.02 (–0.10 to 0.16)
Number of inpatient admissions 155 0.07 (0.44) 169 0.07 (0.33) 0.00 (–0.08 to 0.09)
Number of outpatient attendances 155 1.18 (2.68) 169 1.50 (4.31) –0.32 (–1.14 to 0.44)
Number of ambulance journeys 155 0.71 (0.83) 169 1.13 (1.30) –0.42 (–1.33 to 0.29)
Number of GP contacts at practice 155 1.55 (2.96) 169 1.71 (3.74) –0.16 (–1.00 to 0.54)
Number of GP home visits 155 0.12 (0.60) 169 0.06 (0.34) –0.04 (–0.04 to 0.18)
Number of practice nurse contacts 155 0.18 (0.82) 169 0.22 (0.88) –0.04 (–0.22 to 0.15)
Number of district/community nurse
visits at home
155 0.37 (2.18) 169 0.22 (1.71) –0.25 (–0.25 to 0.62)
Number of hours of caregiver time 155 249.60 (572.76) 169 235.31 (428.60) 14.29 (–100.88 to 130.68)
TABLE 49 Average costs per resource-use category and differences between groups using all available data
Cost item
Intervention CBTi Control usual care
Mean differences, £
(95% CI bootstrapped)n Mean, £ (SD) n Mean, £ (SD)
Cost of visits to A&E 155 27 (108) 169 23 (98) 3 (–21 to 25)
Cost of inpatient admissions 155 174 (1170) 169 176 (887) –2 (–214 to 244)
Cost of outpatient attendances 155 243 (556) 169 310 (892) –67 (–238 to 83)
Cost of ambulance journeys 155 137 (158) 169 218 (250) –80 (–232 to 52)
Cost of GP contacts at practice 155 71 (136) 169 79 (172) –7 (–43 to 23)
Cost of GP home visits 155 11 (56) 169 6 (32) 5 (–4 to 16)
Cost of practice nurse contacts 155 2 (9) 169 2 (9) 0 (–2 to 2)
Cost of district/community
nurse visits at home
155 14 (85) 169 9 (67) 6 (–12 to 23)
Cost per week of caregiver
time
155 1622 (3723) 169 1530 (2786) 93 (–658 to 876)
Cost of intervention 155 139 (0) 169 0 (0) 139 (139 to 139)
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Table 50 shows the average total costs per participant for each arm of the trial from both a NHS
perspective and a NHS and caregiver perspective. Costs from the NHS perspective include the intervention
costs and all NHS costs during follow-up. Costs from the NHS and caregiver perspective include
intervention costs, all NHS costs during follow-up, and the informal care giving costs during follow-up.
The mean cost per participant from the NHS perspective was £689 for the intervention group and £616
for the control group. The difference in mean cost between the intervention and control groups was
£73 (bootstrapped 95% CI –£239 to £422). The mean cost per participant from the NHS and informal
caregiver perspective was £2102 for the intervention group and £1874 for the control group. The
difference in mean cost between the intervention and control group was £228 (bootstrapped 95% CI
–£512 to £1075). As the CIs illustrate, there was no evidence of a difference between randomised groups
although the width of the CIs suggests that there may be economically important differences from both
cost perspectives that could favour either group.
Effectiveness: quality-adjusted life-years
The QALY gains for CBTi compared with usual care only are presented with utility values from both EQ-5D (5L)
and SF-6D. As noted above, the results presented in this section are based on only those participants with
complete HRQoL responses at all four time points (n= 197 for EQ-5D (5L); n= 153 for SF-6D).
The model used to estimate a 1-year QALY was two-twelfths of any utility gain (or loss) made between
baseline and 8 weeks plus four-twelfths of any gain (or loss) between 8 weeks and 6 months plus
six-twelfths of any gain (or loss) between 6 and 12 months (see Equation 1, above). In each case sex,
study site and baseline utility were controlled for.
QALYi = α + β1 × u0, 1 + β2 × s1i + β3 × s2i + β4 × f i + β5(
u2, i−u0, i
0:167
+
u6, i−u2, i
0:333
+
u12, i−u6, i
0:500
)
+ β6 × CBTi + ei,
(2)
where u0,i is baseline utility for the ‘i th’ participant; u2,i, u6,i and u12,i are the utilities at 8 weeks, 6 months
and 12 months; s1i and s2i are the dummy variable for the different sites; fi is the dummy representing the
gender of the ‘i th’ participant; and CBTi is the intervention dummy.
European Quality of Life–5 Dimensions (5 Level)
The analysis of EQ-5D (5L) and SF-6D QALYs gained at 12 months is shown in Table 51. The changes in
utility have been calculated using an area under the curve method including patients who (1) completed
responses at each time point and (2) completed baseline and 12 months responses and one interim
response. In the latter, the missing item interim response was interpolated using a weighted average of the
prior- and post-utility score. Weighting was by time to adjacent observation and effect of intervention
estimated by regression, controlling for sex, site and baseline HRQoL for both EQ-5D (5L) and SF-6D.
TABLE 50 Average total costs of CBTi versus usual care from a NHS perspective and a NHS and
caregiver perspective
Cost
Intervention CBTi Control usual care
Mean cost difference, £
(95% CI bootstrapped)n Mean, £ (SD) n Mean, £ (SD)
Total cost NHS perspective 155 689 (1453) 169 616 (1483) 73 (–239 to 421)
Total cost NHS and informal caregiving
perspective
155 2102 (3982) 169 1874 (3044) 228 (–512 to 1075)
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The results for EQ-5D (5L) show that both groups experienced an increase in QALYs estimated by the
constant; however, the intervention arm gained less (with a negative estimate for the intervention variable)
but with a CI including ‘0’, indicating that there was no evidence of a difference between groups. The
results for SF-6D QALYs show a similar pattern in terms of both groups gaining QALYs; however, the
intervention group gained more than the control group but, again, with no evidence of a difference
between groups.
Incremental cost-effectiveness
These are based on a data set of complete cases both in terms of costs and outcomes (n= 310 for FES-I;
n= 187 for EQ-5D (5L) QALYs; n= 152 for SF-6D QALYs).
Incremental cost-effectiveness ratio based on Falls Efficacy Scale–International version
The results show that, using FES-I as an outcome, on average, CBTi was more costly and more effective
than usual care alone (Table 52). The incremental cost per unit reduction in FES-I for CBTi compared with
usual care, only from a NHS perspective, was £24. The incremental cost per reduction in FES-I for CBTi
compared with usual care, from a NHS and caregiver perspective, was £71.
The deterministic results do not illustrate the imprecision surrounding estimates but these can be illustrated
using the results of the bootstrapping. The estimated likelihood of treatment, akin to the 1 – p-value in a
one-sided statistical test produced from the results of the bootstrapping, are also shown in Table 52.
Graphically, the results of bootstrapping are shown for FES-I (Figure 35) and cost-effectiveness of CBTi
being cost-effective compared with usual care only. This figure illustrates the statistical imprecision
surrounding estimates of costs but the majority of iterations produced from the bootstrapping analysis are
in the north-east and south-east quadrants, which illustrates that CBTi has a more beneficial impact on
FES-I than usual care alone. The CEAC presented in Figure 36 is the graphical presentation of the data
presented in Table 52 on the likelihood that each treatment is cost-effective. This figure highlights that as
society’s WTP for a unit reduction in FES-I increases, there is an increase in the likelihood that CBTi and
usual care would be considered cost-effective.
TABLE 52 Cost-effectiveness analysis (n= 310) using FES-I: CBTi vs. usual care alone
Intervention Cost (£)
Comparison of FES-I
at 12 months adjusted
for baseline
Incremental cost
per unit reduction
in FES-I (£)
Probability that the intervention is
cost-effective for different threshold
values for different threshold values
for society’s WTP for a unit reduction
in FES-I:
£0 £1000 £10,000
NHS perspective
CBTi 704 5.67 24 0.33 1 1
Usual care only 624 2.28 0.67 0 0
NHS and caregiver perspective
CBTi 2154 5.67 71 0.29 1 1
Usual care only 1915 2.28 0.71 0 0
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Figures 37 and 38 show the analysis from the NHS and caregiver perspective. These figures illustrate shows
broadly similar results to those when the perspective was of the NHS alone.
Incremental cost per quality adjusted life-year gained based on
European Quality of Life-5 Dimensions (5 Level) responses
The results in Table 53 show that, using the EQ-5D (5L) QALY, from the NHS perspective, CBTi was, on
average, more costly and less effective than usual care alone. From this cost perspective, CBTi was
dominated, on average, by usual care. However, from a NHS and caregiver perspective, CBTi was less costly
but less effective than usual care. Thus, the incremental cost per QALY gain for usual care compared with
CBTi and usual care from a NHS and caregiver perspective was £3250. The difference in finding is caused by
differences between the two analyses in which participants were able to contribute complete data.
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FIGURE 35 Cost-effectiveness plane showing bootstrapped replicates of the ICER for NHS costs and FES-I.
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FIGURE 36 Cost-effectiveness acceptability curve for NHS costs and FES-I, showing the probability that the
intervention is cost-effective at different WTP thresholds.
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FIGURE 37 Cost-effectiveness plane showing bootstrapped replicates of the ICER for NHS and caregiver costs and
FES-I.
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the intervention is cost-effective at different WTP thresholds.
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Figures 39 and 40 graphically show the results of the stochastic analysis from a NHS perspective. Figure 39
illustrates that the majority of iterations produced from the bootstrapping analysis are in the north-west
and south-west quadrants, and that CBTi is likely to have has a less beneficial effect on QALYs than usual
care alone. The corresponding CEAC is presented in Figure 40. As this figure illustrates, there is,
approximately, a 70% chance that usual care alone would be considered cost-effective over the range of
threshold values for society’s WTP for a QALY presented.
Figures 41 and 42 show the same analysis from the NHS and caregiver perspective. Figure 41 illustrates the
statistical imprecision surrounding estimates of costs but the majority of iterations produced from the
bootstrapping analysis are in the North West and South West quadrants and this clearly illustrates that
CBTi is likely to be less effective compared with usual care alone. The CEAC presented in Figure 42
highlights the increase in the likelihood that usual care alone would be considered cost-effective as
society’s WTP for a QALY gain increases.
TABLE 53 Cost-effectiveness analysis (n= 187) using EQ-5D (5L) QALYS: CBTi vs. usual care alone
Intervention Cost (£)
Change in EQ-5D (5L)
from baseline
Incremental cost
per QALY (£)
Probability that the intervention is
cost-effective for different threshold
values for different threshold values for
society’s WTP for a QALY:
£0 £1000 £30,000
NHS perspective
CBTi 764 –0.001 Dominated 0.36 0.35 0.24
Usual care only 670 0.003 0.64 0.65 0.76
NHS and caregiver perspective
CBTi 2017 –0.001 0.49 0.49 0.40
Usual care only 2030 0.003 3250 0.51 0.51 0.60
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FIGURE 39 Cost-effectiveness plane showing bootstrapped replicates of the ICER for NHS costs and
EQ-5D (5L) QALYs.
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FIGURE 40 Cost-effectiveness acceptability curve for NHS costs and EQ-5D (5L) QALYs, showing the probability that
the intervention is cost-effective at different WTP thresholds.
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Incremental cost per quality-assisted life-year gained-based Short Form
questionnaire-6 Dimensions data
The results in Table 54 show that, when using SF-6D QALYs as an outcome, and from a NHS perspective,
CBTi was, on average, more costly and more effective than usual care alone. The point estimate of the
incremental cost per QALY for CBTi compared with usual care only from a NHS perspective was £38,000.
Table 54 also shows that from the NHS perspective and caregiver perspective, CBTi was, on average, less
costly and more effective using the QALY than usual care alone. From this cost perspective, usual care
alone was on average therefore dominated by CBTi and usual care.
The statistical imprecision surrounding NHS costs, QALYs and incremental cost per QALY is illustrated in
Figure 43, which shows that the majority of iterations are in the north-east and north-west quadrants,
meaning that the intervention group is likely to be more expensive than usual care alone. The CEAC
presented in Figure 44 highlights, as society’s WTP for a QALY, the likelihood usual care alone would be
considered cost-effective over a range of threshold values.
0
10
20
30
40
50
60
70
80
90
100
0 3 6 9 12 15 18 21 24 27 30
Pr
o
b
ab
ili
ty
 c
o
st
-e
ff
ec
ti
ve
 (
%
)
WTP for a QALY gain
Intervention
Control
FIGURE 42 Cost-effectiveness acceptability curve for NHS and caregiver costs and EQ-5D (5L) QALYs showing the
probability that the intervention is cost-effective at different WTP thresholds.
TABLE 54 Cost-effectiveness analysis (n= 152) using SF-6D QALYs: CBTi vs. usual care alone
Intervention Cost (£)
Change in
QALYs
Incremental cost
per QALY (£)
Probability that the intervention is cost-effective
for different threshold values for different
threshold values for society’s WTP for a QALY:
£0 £1000 £30,000
NHS perspective
CBTi 771 0.021 38,000 0.40 0.40 0.39
Usual care only 695 0.019 0.60 0.60 0.61
NHS and caregiver perspective
CBTi 1913 0.021 0.67 0.67 0.66
Usual care only 2155 0.019 Dominated 0.33 0.33 0.34
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The results for the NHS and caregiver perspective are shown in detail in Figures 45 and 46. These results
show that usual care is unlikely to be cost-effective over the range of threshold values for society’s WTP for
a QALY presented.
Allowance for uncertainty
In conjunction with our stochastic sensitivity analyses, we also conducted deterministic sensitivity analyses
to explore uncertainty in the base-case analysis.
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FIGURE 43 Cost-effectiveness plane showing bootstrapped replicates of the ICER for NHS costs and SF-6D QALYs.
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FIGURE 44 Cost-effectiveness acceptability curve for NHS costs and SF-6D QALYs, showing the probability that the
intervention is cost-effective at different WTP thresholds.
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Hospital admission costs not on tariff
The impact of using a treatment cost and non-elective bed-day cost instead of a national tariff for hospital
admission for complete cases for NHS costs and FES-I (n= 310), EQ-5D (5L) QALYs (n= 187) and SF-6D
QALYs (n= 152) is shown in Table 55.
The results for the complete NHS and FES-I cases were insensitive to change. However, for NHS costs and
EQ-5D (5L) and SF-6D QALYs, the intervention group became, on average, less costly than the control.
The CIs still included zero, indicating that there was insufficient evidence of a difference but these results
highlight the potential importance of changes in the cost of hospitalisation (and because the impact would
be the same changes in the duration and incidence of hospitalisations).
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FIGURE 45 Cost-effectiveness plane showing bootstrapped replicates of the ICER for NHS and caregiver costs and
SF-6D QALYs.
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FIGURE 46 Cost-effectiveness acceptability curve for NHS and caregiver costs and SF-6D QALYs, showing the
probability that the intervention is cost-effective at different WTP thresholds.
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Implications of missing data
Item level missingness
Resource-use data and costs
The analysis of costs in the base case was based on complete cases using all available cost data. The
assumption behind this was that item-level missingness arose as a result of questions on the resource
utilisation form not being relevant to some participants. In order to explore the impact of this assumption,
we imputed missing data using the lower and upper interquartile range for participants’ use of each item
of the resource utilisation form. Table 56 shows the average total costs per participant for each arm of
the trial from both a NHS perspective and a NHS and caregiver perspective for the lower and upper
interquartile range, respectively (n= 324).
For the 25th centile imputations, the average total cost from the NHS perspective and from the NHS and
caregiver perspective was higher in the intervention arm than in the control arm yet the CIs included zero.
These results are consistent with our base-case analysis. However, when we imputed resource use at the
75th centile, although the CIs still indicate no evidence of a difference between randomised groups, the
results on average favour the intervention as being the least costly. Further analysis showed that this result
was due to a skewed high number of ambulance journeys reported in the control arm for one participant.
Excluding this individual from analysis resulted in the average total cost being higher in the intervention
arm than in the control arm, from a NHS perspective, with a mean difference of £79 (bootstrapped
95% CI –£238 to £407). These imputed results overall were consistent with our base-case analysis in
which average total costs in the intervention arm were higher than in the control arm but with no
evidence of difference between the groups despite these seeming economically meaningful.
TABLE 55 Total NHS costs associated with using non-tariff based hospital admission costs
Cost
Total NHS costs
Intervention CBTi
Total NHS costs
control usual care
Mean cost difference, £
(95% CI bootstrapped)Mean, £ (SD) Mean, £ (SD)
Complete NHS and FES-I data 702 (1524) 672 (1802) 30 (–335 to 381)
Complete NHS and EQ-5D (5L) data 627 (942) 734 (1937) –106 (–549 to 285)
Complete NHS and SF-6D data 615 (980) 796 (2169) –181 (–766 to 289)
TABLE 56 Average total costs imputed using 25th and 75th percentiles for resource use
Cost
Intervention CBTi Control usual care
Mean difference, £
(95% CI bootstrapped)Mean, £ (SD) Mean, £ (SD)
Total cost NHS perspective
25th percentile 689 (1453) 632 (1532) 57 (–290 to 373)
75th percentile 945 (1594) 1002 (1492) –57 (–402 to 282)
Total cost NHS and informal caregivers’ perspective
25th percentile 2340 (4075) 2280 (3518) 60 (–725 to 890)
75th percentile 2665 (4108) 2803 (3490) –138 (–891 to 683)
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Health-related quality-of-life scores and quality-adjusted life-years
We used a simple imputation method to interpolate missing HRQoL data at 8 weeks and 6 months by
utilising the weighted average of adjacent observations at each time point. These interpolated results
therefore include those individuals who had completed questionnaires at baseline and 12 months and had
missing data at time points in between. This increased the sample size from 199 to 262. The results
suggest that neither method of estimating greatly alters the base-case analysis results (Table 57).
Using the same approach, and obtaining interpolated values for HRQoL using the SF-6D, resulted in an
extra 65 observations (Table 58). As with the EQ-5D (5L) data, neither method identifies any QALY
difference associated with the intervention.
TABLE 57 European Quality of Life–5 Dimensions (5 Level) estimates of QALYs gained at 12 months
Variable
No interpolated EQ-5D (5L) values Interpolated EQ-5D (5L) values
Unstandardised
coefficients: B
(standard error) 95% CI
Unstandardised
coefficients: B
(standard error) 95% CI
(Constant) 0.015 (0.010) –0.006 to 0.035 0.019 (0.009) 0.000 to 0.037
Falls and Syncope
Service
–0.002 (0.007) –015 to 0.012 –0.007 (0.006) –0.019 to 0.004
Galleries Day Unit –0.006 (0.014) –0.033 to 0.022 –0.008 (0.011) –0.031 to 0.014
Intervention –0.004 (0.006) –0.015 to 0.008 –0.001 (0.005) –0.011 to 0.010
Sex –0.010 (0.007) –0.023 to 0.003 –0.006 (0.006) –0.017 to 0.005
Baseline EQ-5D (5L) tariff –0.006 (0.013) –0.032 to 0.021 –0.015 (0.012) –0.039 to 0.009
TABLE 58 Short Form questionnaire-6 Dimensions estimates of QALYs gained at 12 months
Variable
No interpolated SF-6D values Interpolated SF-6D values
Unstandardised
coefficients: B
(standard error) 95% CI
Unstandardised
coefficients: B
(standard error) 95% CI
(Constant) 0.043 (0.11) 0.022 to 0.064 –0.022 (0.018) –0.057 to 0.014
Falls and Syncope
Service
0.002 (0.004) –0.005 to 0.009 –0.007 (0.006) –0.019 to 0.006
Galleries Day Unit 0.002 (0.008) –0.013 to 0.018 –0.018 (0.012) –0.041 to 0.006
Intervention 0.002 (0.003) –0.005 to 0.008 0.002 (0.006) –0.009 to 0.013
Sex –0.003 (0.004) –0.010 to 0.005 0.000 (0.006) –0.012 to 0.013
Baseline SF-6D tariff –0.071 (0.017) –0.105 to –0.037 0.037 (0.028) –0.019 to 0.093
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Missingness due to questionnaire non-response
Impact of non-response on costs and quality-adjusted life-years
A joint modelling approach to missing data was undertaken based on the assumption that time to drop
out would be predictive of final outcome. The rationale behind this approach was that there is some
underlying characteristic of the participant, usually referred to as ‘frailty’, which is associated both with
dropout and outcome. As demonstrated in Chapter 4, the dropout did not occur regularly through the
study, but was triggered by particular activities arising from participation in the study. A large proportion
of the dropout occurred prior to week 8; a smaller proportion of dropout accrued over the remaining
44 weeks. Consequently, the impact of missing data was assessed using multiple imputation. The results
of the multiple imputation on the cost data are presented in Table 59.
Adjusting for missing data resulted in a decrease in NHS costs in the intervention arm and a smaller
reduction in the control arm, explaining a smaller mean difference between the two arms of the trial.
However, as in the base case, although costs were higher in the intervention group, there was no evidence
of a difference between groups. Adjusting for missing data resulted in an increase in NHS and caregiver
costs in the intervention arm and a small reduction in the control arm. Consistent with the base case –
with higher costs in the intervention arm – there was no evidence of a difference between the two arms of
the trial.
The impact of multiple imputation on QALYs is presented in Table 60. In the case of EQ-5D (5L), the
reduction in QALY gain was greater once missing data were accounted for by multiple imputations.
For SF-6D, the small positive effect of the intervention was reversed, with the control group experiencing
the greater QALY gain. Following the multiple imputation the estimated QALY gains in each arm were
presented (see Table 61).
TABLE 59 Estimated impact on costs using imputed data sets
Method
Imputation model: equality of means
Mean difference Bootstrapped 95% CI
NHS costsa 66 –363 to 495
NHS and caregiver costsb 367 –555 to 1293
a Estimate from complete case analysis= 73 (bootstrapped 95% CI –239 to 422).
b Estimate from complete case analysis= 228 (bootstrapped 95% CI –512 to 1075).
TABLE 60 Estimate of effect on QALYs using multiple imputation
Method
Imputation model-based analysis
Regression model, EQ-5D (5L) Regression model, SF-6D
Unstandardised
coefficient for CBTi 95% CI
Unstandardised
coefficient for CBTi 95% CI
By group –0.005 –0.018 to 0.007 0.002 –0.005 to 0.012
Complete sample –0.007 –0.019 to 0.006 0.002 –0.004 to 0.009
Complete case analysis
Regression model, EQ-5D (5L) Regression model, SF-6D
m 95% CI m 95% CI
–0.004 –0.015 to 0.008 0.002 –0.009 to 0.013
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In summary, no method of allowing for lost data showed any difference between groups in terms of
QALY gains.
Incremental cost-effectiveness ratio with costs and Falls Efficacy Scale–International
version following multiple imputation
The results of the stochastic sensitivity analysis using all available complete case costs and FES-I data (see
Figure 23) from the multiple imputation analysis are presented in Table 61. The results show that CBTi was
more costly and more effective using FES-I as an outcome than usual care alone, the same as the base-
case analysis. The incremental cost per unit reduction in FES-I for CBTi compared with usual care only from
a NHS perspective was £22. The incremental cost per reduction in FES-I for CBTi compared with usual care
from a NHS and caregiver perspective was £121.
Incremental cost-effectiveness ratio with costs and European Quality of Life–5
Dimensions (5 Level) quality-adjusted life-years following multiple imputation
The results of the stochastic sensitivity analysis using costs and EQ-5D (5L) QALY data following multiple
imputation care presented in Table 62. The results show that, using EQ-5D (5L) QALYs as an outcome,
CBTi was more costly (from both cost perspectives) and less effective than usual care alone.
TABLE 61 Cost-effectiveness of CBTi vs. usual care alone using imputed NHS cost and FES-I data
Intervention Cost (£) Change in FES-I
Incremental cost
per unit reduction
in FES-I (£)
Probability that the intervention is
cost-effective for different threshold
values for society’s WTP for a unit
reduction in FES-I:
£0 £1000 £30,000
NHS perspective
CBTi 653 2.79 22 0.39 1 1
Usual care only 587 5.84 0.61 0 0
NHS and caregiver perspective
CBTi 2201 2.79 121 0.28 1 1
Usual care only 1832 5.84 0.72 0 0
TABLE 62 Cost-effectiveness analysis using imputed NHS cost and EQ-5D (5L) QALYs: CBTi vs. usual care alone
Intervention Cost (£)
Change in EQ-5D (5L)
from baseline
Incremental cost
per QALY (£)
Probability that the intervention is
cost-effective for different threshold
values for society’s WTP for a change
in QALYs:
£0 £1000 £30,000
NHS perspective
CBTi 653 0.002 Dominated 0.38 0.37 0.43
Usual care only 587 0.007 0.62 0.63 0.57
NHS and caregiver perspective
CBTi 2201 0.002 Dominated 0.22 0.22 0.37
Usual care only 1832 0.007 0.78 0.78 0.63
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Incremental cost-effectiveness ratio with costs and Short Form questionnaire-6
Dimensions quality-adjusted life-years following multiple imputation
The results of the stochastic sensitivity analysis using costs and SF-6D QALY data following multiple
imputation care are presented in Table 63. The results show that, using SF-6D QALYs as an outcome,
CBTi was more expensive (from both cost perspectives) and slightly less effective than usual care alone.
The intervention was therefore dominated and would not be considered cost-effective.
Summary of cost-effectiveness results
Using FES-I as an outcome measure, the base-case analysis suggests that CBTi is more costly and more
effective than usual care alone. Stochastic sensitivity analysis suggests that when society’s WTP for a unit
change in FES-I was > £20, the probability of CBTi and usual care being cost-effective would approach ‘1’.
The analogous threshold for NHS and caregiver perspective was £58. These base-case results were
insensitive to changes explored in all of the sensitivity analysis, including multiple imputation.
When QALYs derived from EQ-5D (5L) were taken as the outcome measure, the results from a NHS costing
perspective suggest that CBTi was, on average, more expensive and less effective than usual care alone.
CBTi is therefore dominated by usual care and cannot be considered as the most cost-effective treatment
option. However, from a NHS and caregiver costing perspective, CBTi was cheaper than, but less effective
than, usual care. However, stochastic sensitivity analysis suggested that the intervention is unlikely to be
cost-effective over a range of threshold values for society’s WTP for a QALY. These base-case results were
insensitive to the sensitivity analyses, including the multiple imputation, for which the intervention is
dominated by usual care from both costing perspectives.
When QALYs were based on the SF-6D scores, from a NHS perspective costing perspective the intervention
was more costly but more effective than the control. From a NHS and caregiver perspective, although the
intervention was more effective, it was less costly than the control. However, results from the CEAC
suggest that it is unlikely that CBTi would be cost-effective at typical values that society might be willing to
pay from a NHS costing perspective. Only when costed from a NHS and caregiver perspective could the
intervention be considered to be cost-effective. The results of the sensitivity analyses, and, in particular,
the multiple imputation, suggested that CBTi was dominated by usual care and cannot be considered
as the most cost-effective treatment option.
TABLE 63 Cost-effectiveness analysis using imputed NHS cost and SF-6D QALYs: CBTi vs. usual care alone
Intervention Cost (£)
Change in SF-6D
from baseline
Incremental cost
per QALY (£)
Probability that the intervention is
cost-effective for different threshold values
for society’s WTP for a change in QALYs:
£0 £1000 £30,000
NHS perspective
CBTi 653 0.081 Dominated 0.38 0.38 0.3
Usual care only 587 0.083 0.62 0.62 0.7
NHS and caregiver perspective
CBTi 2201 0.081 Dominated 0.21 0.21 0.19
Usual care only 1832 0.083 0.79 0.79 0.81
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Chapter 7 Discussion and conclusions
Developing a novel cognitive–behavioural therapy intervention
for fear of falling in older adults
The development of the CBTi followed established principles in CBT, but required in-depth exploration of
the issues relevant to older people with fear of falling and the development of a training approach that
would equip non-specialist HCAs to deliver the CBTi in the trial. The initial assessment interviews
conducted to inform the intervention development opened up and challenged notions of the concept
of ‘fear of falling’, uncovering both its heterogeneity (diversity of views and experiences) and complexity
(in terms of associations between falls, appraisals of these, and related behaviours). In developing the
intervention it was necessary to acknowledge and accommodate the importance of the network of
comorbid physical complaints, interpersonal relationships and/or social isolation revealed as central to
fear of falling. This was addressed by introducing individualised formulations that added to the complexity
of the intervention and created uncertainty over the feasibility of successful delivery of the CBTi by
relatively inexperienced HCAs.
The complexity of fear of falling highlighted here reflects recent arguments for a deeper understanding of
fear of falling that have developed out of analysis of associations of structured measures relating to the
concept.30 Our findings also support guidance for the adaptation of CBT for older populations, particularly
the recommendation to avoid approaches relying on rigid manualisation.117
The process evaluation complemented the intervention development work by highlighting the work
required to develop an intervention that would ‘make sense’ to key groups whose participation was
expected and/or required. For the CBTi for fear of falling, this included addressing key issues such as
determining what to call it, developing participants’ understandings of what it would involve, and what
benefits it might have for patients.
Summary of main findings of the Phase II randomised
controlled trial
The results of the STRIDE study are clear. A novel CBTi that was delivered by HCAs in addition to usual
care in community-dwelling elders who were attending falls services resulted in a significant reduction in
fear of falling, as measured by the FES-I, compared with those receiving usual care alone. The estimated
impact of the CBTi on FES-I at 12 months, based on an analysis of covariance model in which we adjusted
for baseline FES-I score and randomisation strata (prespecified primary end point and method of analysis),
was a mean change of –4.02 (95% CI –5.95 to 2.1), with reductions in score reflecting improvements in
fear of falling. This was from a mean baseline FES-I of 40.9 in the CBTi group and 39.8 in the control
group. Similar improvements in FES-I scores to those at 12 months were seen at 8 weeks and 6 months,
despite the absence of intervention for the final 6 months of follow-up, and our study was powered on
the basis of a 4-point reduction in FES-I scores. Although there are no definitions of minimal clinically
significant changes in FES-I or any other fear of falling measure,25 our FES-I effect size is among the highest
reported, with recent randomised studies on interventions in fear of falling using the FES-I reporting
significant decreases in scores ranging from 0.53 to 3.7.118–120
Dropouts from the study were at variable time points and tended to be triggered by activities arising from
the study (e.g. example the CBTi in the intervention group). Even allowing for such differential dropouts
between groups using multiple imputation with ITT, and the most conservative set of assumptions, there
was still a mean change in FES-I score of –3.65 (95% CI –5.84 to 1.46). Furthermore, an ‘as-treated
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analysis’ based on the proportion of CBT sessions completed showed a mean change of –4.4 (95% CI
–6.5 to 2.2). It would thus appear that the primary analysis was robust. In addition, fear of falling as
measured by the single question numerical rating scale from 0 to 10 was highly correlated with FES-I scale
scores, with an mean estimated impact of CBTi of –1.0 (95% CI –1.6 to 0.5), supporting the validity of
our main finding.
There were significant improvements in HADS Depression scores in the CBTi group, an important finding
given the high incidence of depression in older people, in particular those with fear of falling.40,43
Depression may have shifted as a result of the similarity of the evidence-based treatment for depression
and the STRIDE intervention. ‘Behavioural activation’, encouraging people to re-engage with avoided
pleasurable and challenging tasks, is the main behavioural intervention for low mood, and was also a key
component of the STRIDE intervention.
There were no differences in social participation, loneliness, quality of life or physical function on a variety
of measures; the fact that many trial participants suffered a multitude of comorbid physical difficulties and
adverse life events that could not be addressed by the CBTi may explain the lack of responsiveness in
these measures. The estimated impact of the CBTi on the likelihood of falling corresponds to an incidence
risk ratio of 0.88 (95% CI 0.61 to 1.27). The point estimate of 0.88 suggests a slight reduction in the risk
of falling but the 95% CI includes one; the difference between groups is not statistically significant. There
were no significant harms associated with the CBTi, with lower fall and fracture rates in the intervention
group, although these were not statistically significant.
Understanding the delivery of cognitive–behavioural therapy
intervention by health-care assistants: insights for NHS delivery
from the process evaluation
One of the key components of the STRIDE study was the delivery of the CBTi by HCAs, given the high
prevalence of the problem and the difficulties for the NHS in either finding or funding sufficient trained
CBT therapists and clinical psychologists to satisfy this need. The HCAs’ delivery of the CBTi was evaluated
positively by the psychologists, although some skills could be further developed as discussed below.
Delivery of the CBTi was shaped over time by the HCAs’ growing experience of the client group, the
complexity of fear of falling and the tendency to revert to existing skill sets.
The value of the CBTi for this client group was recognised by some professional staff providing usual care.
Senior professionals expressed interest in the ongoing delivery of the CBTi services, and suggested scope
for improved integration of the CBTi with existing interventions. There were, however, issues over the ‘fit’
of CBTi with the underlying ethos of one participating site.
Client engagement with, and understandings of, the CBTi varied. Nevertheless, clients who persisted with
the CBTi valued their interactions with the HCAs and perceived a range of benefits from the intervention,
including self-reported improvements in confidence and independence.
The organisation and delivery of the CBTi, in terms of the materials, session content, frequency and
duration, was generally acceptable to clients although more flexibility over the follow-up session (here
scheduled for 6 months after the end of the initial course of therapy) was suggested, and there was a
strong preference for delivery in the client’s home.
These observations highlight the crucial part played by the recruitment, training and supervision of HCAs
in any attempt to translate our findings into routine clinical practice and will be explored in more
detail below.
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Recruitment
The level of skill and autonomy required by the HCAs meant that employment at NHS Band 4 or above
would be vital, with recruitment taking into account understanding and experience of the client group,
empathy, team working and communication and problem-solving skills.
Training
Health-care assistants needed to learn complex new skills in order to deliver the CBTi. Initial training was
short, with ongoing supervision by the psychologists. The training was generally felt to be adequate by the
psychologists and the HCAs, and could usefully be adopted as core training for potential HCAs delivering
the CBTi. Key areas to address in future training include an emphasis on the rationale for the CBTi before
moving on to more detailed techniques to ensure that trainees understand the intervention in a more
holistic way rather than focusing on a more protocol-driven, technical approach. One of the most difficult
skills for the HCAs to master was how to introduce CBT to clients, many of whom were sceptical of
‘talking treatments’. Greater emphasis on modelling, role playing and practising the introduction of CBT
should facilitate client understanding of, and engagement with, such an intervention at the earliest stages
of treatment.
The use of ‘real play’, for which trainees use their own issues and problems to explore CBT techniques,
was key in helping trainees start embedding their skills while providing insight into the experience of being
a client at the start of their training. This approach further facilitates learning, with the use of CBT
techniques during training enabling trainees to address their own anxieties and thereby increasing their
confidence in the intervention. Soft skills, such as empathy and collaborative working should be more
explicitly worked on, alongside training on the support and challenge model. Working towards valued
goals identified by patients is an important part of effective and collaborative therapy. Although goal
setting was covered in the initial training, data suggest that detailed review of patient goals in supervision
would help to embed the principles of SMART goal setting and ensure genuinely individualised therapy.
Finally, top-up training should be available to trainees to address any skill gaps and provide opportunities
to practise skills at the point at which they are being used. Initial training provides an excellent grounding,
but there is a great deal of new material delivered in a relatively short space of time; reinforcement over
time is vital.
Supervision
The HCAs’ ability to embed and develop their CBTi skills was facilitated by individual and group supervision
sessions and the HCAs’ self-initiated peer support sessions. The ‘real play’ techniques, highlighted above,
are powerful tools in the training process and need to be appropriately resourced and supervised.
Consideration of the role and availability of additional multidisciplinary support is helpful for trainees,
given the complex needs of many of their client group. Very few of the clients who received the CBTi
would have considered or been eligible for help from existing psychological services despite the NHS IAPT
(Improving Access to Psychological Therapies) programme. This was exemplified by our HCAs’ growing
health advocacy role, through which individual clients’ new or worsening intercurrent illnesses
(e.g. increasing confusion, blackouts, chest pain, injurious falls) required medical and other input that
would otherwise have been left to a much later stage. The study has graphically highlighted the extent to
which older people’s lives are curtailed by medical and psychosocial events that are frequently unreported
to health and social care professionals.
Health-economic analysis
Given the greater reduction in FES-I score in the intervention arm, there is evidence that the intervention
is effective and could be considered cost-effective in reducing FES-I between groups. However, such
effectiveness is not reflected when using QALYs. Although multiple imputation on the cost-effectiveness
DOI: 10.3310/hta20560 HEALTH TECHNOLOGY ASSESSMENT 2016 VOL. 20 NO. 56
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Parry et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
135
data attempted to overcome potential biases from missing data, there was still no evidence that the
intervention was cost-effective using QALYs. In support of this finding, the ICER in relation to incremental
costs per unit reduction in FES-I and the associated CEAC were insensitive to change following multiple
imputation. Furthermore, stochastic sensitivity analysis in base-case analysis for NHS costs and QALY types
suggests that the intervention would not be considered cost-effective relative to usual care.
Reported resource-use and associated costs were greater on average in the intervention arm relative
to the control arm; however, the CI for the difference includes zero and is sufficiently wide to include
economically important differences in favour of either group. In terms of costs (from both perspectives)
per improvement in FES-I, it is difficult to assess the relative cost-effectiveness according to standard
decision-making criteria within the NHS,107 as WTP for a unit reduction in FES-I is not known.
Strengths and limitations
The conduct and reporting of the development of the intervention development and subsequent RCT have
followed Medical Research Council complex interventions,93 TIDieR45 and CONSORT90 recommendations.
The study used a web-based randomisation system to conceal allocation and conducted primary outcome
analyses using multiple imputation and ITT techniques, with a further ‘as treated’ analysis to account for
actual CBTi sessions completed according to a predefined statistical analysis plan agreed with the TSC.
A high proportion of those eligible for study inclusion were recruited, with 43% of eligible patients
eventually included in the study, 18% of those screened (see Figure 4). Baseline comparability of the CBTi
and control groups was excellent, with balance achieved for the prespecified strata (gender, pain with
walking, referral to strength and balance training classes). The recruitment-driven progression from a
single-centre study to a three-centre study became a strength in terms of the differing nature of the three
falls services and hence the generalisability of our findings. Our dropout rate was 24.6%, almost exactly
the anticipated 25% dropout rate based on previous experience with this client group and published data
from group CBT studies in fear of falling (see Chapter 3). Sixty-nine patients dropped out of the CBTi arm
of the study, along with 43 control subjects; although many of these continued in the study for data
collection purposes, for those who did not, multiple imputation and an ‘as-treated’ analysis (see Chapters 3
and 4) were utilised to take statistical account for this. Those dropping out of CBT tended to have lower
FES-I scores at baseline, suggesting a degree of self-selection in terms of need for intervention. The original
FES13 was not designed to provide a summary numerical scale with diagnostic cut-offs to diagnose fear of
falling; rather it was intended as a tool to explore factors affecting patients’ perceptions of their falls’ self-
efficacy. In a comprehensive longitudinal study of the clinical and psychometric properties of the FES-I in
500 community-dwelling elders, Delbaere et al.,40 using receiver operating curve cut-offs, suggested a
score of > 23 as indicating high levels of concern about falls. Scores around this level can be generated by
minor degrees of apparent concern that more accurately reflect physical issues rather than fear of falling,
as highlighted during the intervention development phase noted above and in Chapter 2. As with any
questionnaire-based diagnostic tool, cut-offs will occasionally include cases in which there is none and vice
versa. In the absence of any competing diagnostic information, we used the > 23 FES-I score as our
inclusion criterion for fear of falling, but are mindful that this level may have included those who did not
identify themselves as having such issues. However, the repeated assessment by the RAs of FES-I before
confirming participant eligibility and the relatively high mean baseline FES-I scores at this repeated
assessment (with an average score of 40 in both intervention and control groups) suggests that the study
group, as a whole, suffered significant fear of falling. These considerations have important implications for
any future use of the FES-I in this respect.
It is possible that respondent burden, related to the volume of outcomes assessed, may have contributed
to loss to follow-up. However, we judged that the range of outcome measures utilised were necessary
for a comprehensive assessment of the impact of the study intervention.
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Performance bias refers to systematic differences between groups in the care that is provided, or in
exposure to factors other than the interventions of interest. Theoretically, asking a patient to travel to a
centre (for CBT) may have had an impact on falls efficacy unrelated to the CBT provided.
Detection bias refers to systematic differences between groups in how outcomes are determined. The
primary outcome was a self-completion instrument. Theoretically, being told that they were in receipt of
an intervention may have been an impact on patients’ FES scores (relative to being told that they were in
the control group).
Recruitment difficulties during the course of study resulted in attempts to improve recruitment, including
revision of our power calculation with TSC, funder, REC and sponsor approval, as described in Chapter 3.
Although clearly not a desirable change, our subsequent recruitment to revised time and target with study
completion and appropriately comprehensive analyses mitigate this change in power. It is important to
note that a further strength was our involvement with Age UK. The local Age UK executive team, staff,
clients and their carers were a key component of the study’s development and execution, and were
instrumental in many of the changes to recruitment practices and materials, without which the study
would not have successfully completed.
The method of data imputation used in the trial analysis assumes that the data are missing at random
(MAR). For the primary outcome we assume that the likelihood that a value is missing does not depend on
the actual value of FES-I. If this assumption is incorrect then the results of the analyses on the imputed
data sets must be treated with caution. However, we believe that any association between likelihood of a
value being missing and the actual value is probably due to other factors, such as the frailty of the patient.
A number of variables that we believe are likely to capture these factors have been included in the
imputation model. We therefore believe that the investigation of the impact of missing data on our
estimates of the impact of CBT are robust.
The embedded process evaluation fostered a culture of reflection and open communication, which
enabled the early identification of procedural and interpersonal issues, and facilitated the conduct of the
study. The role of the process evaluator was facilitated by the openness of the research team to a degree
of observation and self-reflexivity exceeding that which would normally be expected in such studies. This
proved a key strength of this study, which has allowed the capture of important data concerning the
processes (and challenges) of delivering a CBTi to older people with fear of falling.
Our health-economic analysis had several limitations. We used a number of methods to investigate the
impact of missing data on the results. Simple imputation methods were used in the first instance on both
costs and utility values, and found no sensitivity to the base-case results. Simple imputation methods rely
on the assumption that the data are MAR, such that the probability of having missing data depends only
on the observed data and not on any unobserved data.88 The plausibility of the MAR assumption can be
improved by including as many covariates as possible that can help predict the missing data, for example
patient characteristics, observed cost or resource-use data, measures of effectiveness and any reasons for
the ‘missingness’.121 Inferences from multiple imputation are preferable to single imputation, as they
properly reflect the uncertainty in the predictions of the missing values, while preserving the distributions
and relationships in the data.122 We therefore used multiple imputation to overcome these issues.
The average cost of the CBTi was estimated, based on the numbers of participants in the trial and the
number of HCAs delivering it. It could be argued that these numbers would not be representative if the
CBTi were to be adopted in practice. In routine practice, if more patients are seen then this would have
the potential of reducing the average cost, which, in turn, could reverse the relative cost difference
between the two arms of the trial. If increased numbers of patients are seen or costs of training HCAs fall
and bring down the average cost of the patient to < £73 then this may reverse the increased cost of the
intervention relative to control, such that the control is more expensive.
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Other methodological issues
The FES-I scores in older adults with fear of falling tend to worsen over time,40 so it is interesting to note
that scores in our control group fell slightly at 12 months’ follow-up (–2.2, 95% CI –3.49 to 1.05). The
RAs performing outcome measures were highly empathic individuals with excellent communication skills,
and although they had no knowledge or training in the CBTi, there may have been an occult Hawthorne
effect in operation, which may have masked more significant differences between intervention and control
groups in FES-I scores.
Contemporaneous falls reporting is a key component of any study examining fall rates, and we have
successfully used falls diaries in this respect in previous trials,83,84 with return rates of up to 95%. Sixty-eight
participants (16.4%) did not return any of their monthly falls diaries at all, and the mean number of
returns was eight, so there may have been bias in either direction from under-reporting, although reports
to RAs and the HCA therapists, and the fact that falls tend to be actively reported, suggest that this is
relatively unlikely.
Implications for health care
l We can be confident in concluding that our novel CBTi improves fear of falling (as measured both
by the FES-I and 11-point fear of falling rating scale) in community-dwelling older adults who are
attending falls services. There is also evidence that the intervention may improve depression in such
individuals. The fact that the intervention was successfully delivered by HCA-grade staff has important
implications for its adoption into routine practice.
l When CBTi is integrated into existing services, it is important to ensure that the intervention is aligned
with existing practices, as there is a potential for conflicting messages that can confuse patients and
potentially confound the effects of the intervention. PPI-based ‘scripts’ for introducing the CBTi to
patients with fear of falling is important, as our process evaluation work showed clearly that clients
conceptualise the intervention in various ways, which are highly dependent on how it is presented to
them. This, in turn, profoundly influences engagement with the CBTi and the internalisation of its
principles and techniques.
l Although our study did not set out to demonstrate which subset of individuals with fear of falling
would benefit most from the intervention, it was clear that those with the lowest FES-I scores, and
those who least considered themselves to suffer from fear of falling, were most likely to drop out of
the study. This may have resource and clinical implications for targeting of patients for the CBTi.
Future research implications
l Our work shows clearly the heterogeneous nature of fear of falling and the importance of physical
factors in its genesis and promotion. There are some small studies examining the role of a joint CBT
and physical training approach in managing fear of falling,123,124 but these need to become larger scale,
appropriately powered RCTs using findings such as ours to inform power calculations.
l Research into targeting of CBTi in older people with fear of falling will aid more rational use of scarce
health service resources. As we discussed above, there is some evidence from our study of differential
uptake and completion of CBTi but these factors need to be more explicitly explored.
l Previous studies have examined group CBT for fear of falling, whereas our intervention was individually
based. From both individual effectiveness and resource perspectives it would be useful to trial a mix
of approaches.
l This study highlighted the value of an embedded reflexive component to the design and conduct of
any large trial. The presence of a qualitative component fostered a culture of reflection and open
communication, which enabled the early identification of procedural and interpersonal issues and
facilitated the conduct of the study.
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l Stakeholders identified a number of potential service models for the future delivery of CBTi, for
example in primary care and/or in generic CBT teams working into a range of departments in
secondary care.
l Future research could explore the feasibility and cost-effectiveness of alternative service provision of
CBTi; in addition, it is vital that future research addresses the minimally important difference in FES-I
scores to appropriately inform and interpret CEA.
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Appendix 1 Falls Efficacy Scale–International
version
Now we would like to ask some questions about how concerned you are about the possibility of falling. Please reply
thinking about how you usually do the activity. If you currently do not do the activity (e.g. if someone does your shopping
for you), please answer to show whether you think you would be concerned about falling IF you did the activity. For each
of the following activities, please tick the box which is closest to your own opinion to show how concerned you are that
you might fall if you did this activity.
Not at all
concerned 1
Somewhat
concerned 2
Fairly
concerned 3
Very
concerned 4
1 Cleaning the house (e.g. sweep, vacuum or dust) 1 † 2 † 3 † 4 †
2 Getting dressed or undressed 1 † 2 † 3 † 4 †
3 Preparing simple meals 1 † 2 † 3 † 4 †
4 Taking a bath or shower 1 † 2 † 3 † 4 †
5 Going to the shop 1 † 2 † 3 † 4 †
6 Getting in or out of a chair 1 † 2 † 3 † 4 †
7 Going up or down stairs 1 † 2 † 3 † 4 †
8 Walking around in the neighbourhood 1 † 2 † 3 † 4 †
9 Reaching for something above your head or on the
ground
1 † 2 † 3 † 4 †
10 Going to answer the telephone before it stops ringing 1 † 2 † 3 † 4 †
11 Walking on a slippery surface (e.g. wet or icy) 1 † 2 † 3 † 4 †
12 Visiting a friend or relative 1 † 2 † 3 † 4 †
13 Walking in a place with crowds 1 † 2 † 3 † 4 †
14 Walking on an uneven surface (e.g. rocky ground,
poorly maintained pavement)
1 † 2 † 3 † 4 †
15 Walking up or down a slope 1 † 2 † 3 † 4 †
16 Going out to a social event (e.g. religious service,
family gathering or club meeting)
1 † 2 † 3 † 4 †
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Appendix 2 Cognitive–behavioural therapy
intervention assessment and formulation
documentation
First we will have a chat about how this all started, then we will look at how this 
affects you on a day to day basis and at the end of the session we will consider what 
we can do to help. 
 
Onset - (Doing, Feeling, Thinking, Bodily Sensations) 
 
 
 
a) What - description of current problem/ symptoms  
How is this issue affecting you now? 
 
 
b) Where 
Any situations that are particularly difficult (or easy) for you?  
 
c) When 
Any times of the day / week / year etc that are difficult or easier? 
 
 
d) Who 
Is there anyone who makes it easier? Or harder?  
Bodily sensations 
 
 
 
 
Doing 
Thinking 
 
 
 
 
Feeling 
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e) Nightmare scenario (why/how) 
What is the worst thing about this/ that could happen (nightmare scenario)?  
(Aims at finding out: what’s the thing keeping any avoidance / anxiety / depression 
going) 
 
 
Frequency:  
How often is it happening during the week? 
 
 
How often in a day? 
 
 
Is it getting any better or worse?  
 
 
When was the last time it was bad or good?  
 
Intensity:  
How bad does it get? (self-rating) 
0 - - - - - - 1 - - - - - - 2 - - - - - - 3- - - - - - - 4  - - - - - - 5 - - - - - - 6 - - - - - - 7 - - - - - - 
8  
Normal         Worst 
 
Duration:  
How long does it last for? 
 
 
Anything that helps or makes it better?    Anything that makes it 
worse? 
 
 
How do you cope? 
APPENDIX 2
NIHR Journals Library www.journalslibrary.nihr.ac.uk
154
Is there anything you do less of now?  
 
 
 
 
 
 
 
 
Is there anything you do more of now? 
 
Think about: Home life, work, leisure, relationships. 
 
 
Can you tell me a little about a recent time when this was a problem for you. 
 
Bodily sensations 
 
 
 
 
Doing 
Thinking 
 
 
 
 
Feeling 
 
 
 
 
Start              Event   What happened 
after  
DOI: 10.3310/hta20560 HEALTH TECHNOLOGY ASSESSMENT 2016 VOL. 20 NO. 56
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Parry et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
155
 Waking 
 
 
Noon 
 
 
Evening 
 
 
Sleeping Pattern 
 
 
Just before 
Tell me a bit about your life before this all happened? 
 
 
Job 
 
 
Leisure activities 
 
 
Recent life events 
 
 
Relationships 
 
 
Anything else 
Typical day – doing, feeling, thinking, bodily sensations 
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Impact on life 
 
Others’ opinions/attitudes  
 
Beliefs: 
What do you think is going on? How do you think you can best manage this? 
 
 
 
 
 
 
Hope/fears: 
Do you have any hopes for the future? Do you have any fears? 
 
 
 
 
 
 
Goals: 
If you did feel a lot better, how would your life be different? What would you do that 
you can’t do now? 
 
 
Mental state 
Just a few questions about how you’ve felt in the last few weeks: 
How has your mood been? 
 
 
How are your energy levels? 
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Are you still able to enjoy things (enjoyment)? 
 
 
How do you feel about yourself (self-worth)? 
 
 
Do you think things will get better (hope / future)? 
 
 
Do you feel it is somehow your fault (guilt)? 
 
 
Do you find any troubling thoughts going through your mind? 
 
 
Have things ever got so bad that you’ve felt like ending it all (suicidal thoughts)? 
Any nervousness or worry recently? Anxiety / major worries / preoccupations / panic 
attacks? 
 
 
Any situations that make you particularly anxious?   
 
 
Pre-morbid personality 
Last few questions… 
Would you say that this problem has had an effect on you as a person? 
 
 
How are you different now from how you were before? 
 
 
How would you describe your personality then? And now? 
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Predisposing factors      Precipitating factors 
Bodily sensations 
 
 
 
 
Doing 
Thinking 
 
 
 
 
Feeling 
 
Rationale for treatment plan  
 
 
What treatment strategies are you planning to use? 
Graded exposure for anxiety  Thought diary for anxiety  
Graded exposure for pain  Thoughts diary for physical symptoms 
(pain) 
 
Graded exposure for fatigue  Thoughts diary for fatigue  
Behavioural activation for 
enjoyment/mood 
 Relapse prevention  
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Appendix 3 Falls diary
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Appendix 4 Additional statistical material
Baseline data
The primary outcome, FES-I, comprises 16 items. Tables 64 and 65 show the distribution of responses to
each item at baseline.
In Figures 47 and 48, the association between FES-I scores at baseline and patient ratings on 11-point
scales of their fear of falling and pain on walking at this time point are examined graphically. The upper
and lower edges of each box correspond to the 75th and 25th percentiles, respectively; the horizontal
line through the centre of each box corresponds to the median of the distribution, and the whiskers show
the upper and lower limits of the distribution.
It is good statistical practice to investigate the level of collinearity in any potential explanatory variables
so that outcomes can be adjusted to take into account difference between strata. Figures 49–52 provide a
graphical presentation of the primary outcome, FES-I, broken down by each of the stratification variables
[site, gender, pain on walking (no/yes), referral for strength and balance training (no/yes)]. Tables 66–69
provide summary statistics for all primary and secondary outcome measures, grouped by these
stratification variables.
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TABLE 65 Summary statistics for FES-I items at baseline
Fear of falling
Control group Intervention group Study population
n Mean Median SD n Mean Median SD n Mean 95% CI
When cleaning the
house
205 2.27 2 0.97 210 2.29 2 1.04 415 2.28 2.19 to 2.37
Getting dressed or
undressed
204 1.98 2 0.95 210 1.67 1 0.85 414 1.82 1.74 to 1.91
Preparing simple
meals
204 1.73 1 0.96 210 1.60 1 0.87 414 1.66 1.57 to 1.76
Taking a bath or
shower
205 2.62 3 1.04 209 2.55 2 1.07 414 2.59 2.49 to 2.70
Going to the shop 204 2.64 3 1.00 207 2.50 2 1.08 411 2.57 2.46 to 2.68
Getting in and out
of a chair
204 2.04 2 0.89 209 1.89 2 0.85 413 1.96 1.87 to 2.05
Going up or down
stairs
205 2.91 3 1.03 209 2.89 3 1.03 414 2.90 2.80 to 3.00
Walking around the
neighbourhood
204 2.69 2.5 1.02 209 2.72 3 0.99 413 2.70 2.61 to 2.80
Reaching for
something above or
on ground
205 2.77 3 0.97 210 2.78 3 0.90 415 2.78 2.68 to 2.87
Going to answer
telephone before it
stops
205 1.89 2 0.99 210 1.80 2 0.92 415 1.85 1.76 to 1.93
Walking on slippery
surfaces
205 3.66 4 0.63 210 3.56 4 0.68 415 3.61 3.55 to 3.67
Visiting friend or
relative
205 2.20 2 1.05 208 2.13 2 1.04 413 2.17 2.07 to 2.27
Walking in crowds 205 2.63 3 1.06 210 2.71 3 1.04 415 2.67 2.57 to 2.77
Walking on uneven
surface
205 3.41 4 0.78 210 3.42 4 0.77 415 3.41 3.34 to 3.49
Walking up or down
a slope
205 3.09 3 0.94 210 3.12 3 0.89 415 3.11 3.01 to 3.20
Going to a social event 205 2.32 2 1.11 210 2.11 2 1.02 415 2.22 2.11 to 2.32
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FIGURE 48 Distribution of baseline FES-I scores by rating on 11-point pain on walking scale.
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FIGURE 50 Distribution of baseline FES-I scores by gender.
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Distribution of secondary outcomes over time
The distribution of all secondary outcomes by visit and by group to which randomised are shown
graphically in Figures 53–66. The change from baseline for each visit is given for each outcome in
Table 70.
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FIGURE 53 Fear of falling 11-point rating scale by visit and study arm.
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FIGURE 54 Total participation score by visit and study arm.
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FIGURE 55 Gait and balance score by visit and study arm.
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FIGURE 56 Mean handgrip strength by visit and study arm.
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FIGURE 58 De Jong Gierveld Loneliness Scale by visit and study arm.
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FIGURE 60 Hospital Anxiety and Depression Scale Depression by visit and study arm.
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FIGURE 61 World Health Organization’s Quality of Life questionnaire – older adults module total score by visit and
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FIGURE 62 Lubben Social Network Scale–6 by visit and study arm.
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Outcomes at 12 months
Change from baseline to 12 months was analysed using analysis of covariance. Estimates of the impact of
the intervention are given in Table 71:
1. unadjusted for randomisation strata (as previously presented in Chapter 4)
2. adjusted for randomisation strata.
Longitudinal analysis
The estimated trend(s) and difference between groups for secondary outcomes are given in Table 72.
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Appendix 5 Process evaluation topic guide
Rather than produce multiple topic guides with considerable overlap between them, we have insteadprovided a single list of questions (and related them to the relevant construct within normalisation
process theory) and indicated to which groups of respondents each question is applicable. The questions
will be framed appropriately for different groups of respondents. The phrasing of the questions will also be
modified as appropriate at different time points.
Professionals
STRIDE
therapists Clients
Family
members
Team
members
How do you think the study/intervention is going so
far?
✓ ✓ ✓ ✓ ✓
Professionals
STRIDE
therapists Clients
Family
members
Team
members
Coherence
How confident are you in the intervention? ✓ ✓ ✓ ✓ ✓
What reservations do you have about the
intervention?
✓ ✓ ✓ ✓ ✓
What kinds of patients do you think would benefit
most from this type of intervention? Are there
patients for whom it would not be useful?
✓ ✓ ✓
Have there been any patients who met the inclusion
criteria but you felt were not appropriate for the
study?
✓ ✓
Based on your experience of the CBT sessions, who
do you think might benefit from this approach?
✓ ✓ ✓
Cognitive participation Professionals
STRIDE
therapists Clients
Family
members
Team
members
How interested do patients seem to be in the
intervention?
✓ ✓
What do you think of the name of the study? ✓ ✓ ✓ ✓ ✓
How likely are you to finish this series of CBT
sessions?
✓ ✓
In this study, HCAs are delivering the intervention.
From your perspective, what are the advantages and
disadvantages of using HCAs?
✓ ✓ ✓
From your perspective, what are the facilitators and
barriers to getting people/patients engaged in the
study?
✓ ✓ ✓
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Collective action Professionals
STRIDE
therapists Clients
Family
members
Team
members
Who takes the lead in explaining the study to patients
and how do you (they) go about it?
✓
What impact is recruiting patients for the study having
on the day to day running of the clinic?
✓
Which aspects of the CBT intervention do you feel
most confident with?
✓ ✓ ✓
Which aspects of the CBT intervention do you find
most challenging?
✓ ✓ ✓
What do you think about the suitability of the venue
for the CBT sessions?
✓ ✓ ✓ ✓ ✓
Do you feel you have the support you need to recruit
patients to/deliver the study/intervention?
✓ ✓
How easy or difficult has it been to put what you
have learned in the CBT sessions into practice?
✓ ✓
From your perspective, what are the facilitators and
barriers to implementing the intervention?
✓ ✓ ✓
Reflexive monitoring Professionals
STRIDE
therapists Clients
Family
members
Team
members
What sense do you have of how useful the
intervention is?
✓ ✓ ✓ ✓ ✓
Have you had any feedback from patients or GPs
about the intervention?
✓ ✓
What opportunities have you had to discuss the value
of the intervention with your colleagues at the clinic?
✓ ✓
Do you anticipate continuing to offer CBT to patients
with fear of falling after the end of the study? On
what basis would you like to continue to offer this
treatment?
✓
How important is it to continue to offer the CBT
sessions to people like yourself?
✓ ✓
How much scope do you feel there is for adapting
your approach to the CBT intervention?
✓
To what extent do you feel the sessions were tailored
to your individual needs?
✓ ✓
From your perspective, what are the facilitators
and barriers to evaluating the acceptability/
cost-effectiveness/efficacya of the CBT intervention?
✓ ✓ ✓
a Questions asked as appropriate depending on role.
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Appendix 6 Example client summaries
Summary for client 5377 (ST1)
Basic formulation: Predisposing: BPPV
Precipitating: Four falls in garden
Perpetuating: Bodily sensations
Dizziness
Doing
Planning
Checking
Avoiding
Thinking
I’m going to fall
Feeling
Anxiety
Intervention focus (target): 1. Anxiety
Outcome: 1. Big reduction
Goals Initial difficulty rating Review rating End rating
Improve confidence when out 7 0
Therapist rating:
In your opinion how engaged with the treatment was the patient?
1 2 3 4 5 6 7
Never did any work Constantly completed all work, often did extra
Brief overview of therapy and progress
From the start, the client was highly engaged and, as he had a background of educational psychology,
he understood all of the basics before we even started. His main problem lay with new areas, whether
walking or using public transport. The first visit ended with us testing his beliefs around using the ticket
machines at the metro. We rated his perceived level of anxiety, then went out and tested the theory,
and when back in the house rated again. This proved to be an effective start to all subsequent steps
challenged. We graded different degrees of new situations and periodically worked through them all.
On the sixth session he had reported a nasty fall, which gave the opportunity to discuss relapse prevention.
This went very well with him getting back on his feet much faster than the last time he fell. His confidence
had not suffered and it made him more determined to soldier on. By the eighth session he had very few
worries and was very positive for the next 6 months. On my return 6 months later he was still very
confident and stated that he had no anxieties about going out or tackling new situations. He felt relief not
being so worried about anything any more.
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Summary for client 4458 (ST2)
Basic formulation: Predisposing: Had always been active and interested in health
Precipitating: Brain tumour
Loss of wife
Dizziness
Perpetuating: HCB Bodily sensations
Panic attacks
Doing
Mood
Avoidance
Thinking
I need to leave situation
I feel pressure
Cannot do it like I used to
Emotions
Unwell
Frustrated
Intervention focus (target): 1. Behavioural activation for mood
2. Behavioural activation for avoidance
3. Thought analysis for anxiety
Outcome: 1. Mood much improved
2. Began to socialise much more
3. Anxiety much reduced
Goals Initial difficulty rating Review rating End rating
To go to running track 3–4 0 0
Therapist rating:
In your opinion how engaged with the treatment was the patient?
1 2 3 4 5 6 ■7
Never did any work Constantly completed all work, often did extra
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Brief overview of therapy and progress
This gentleman had experienced a very fitness-orientated lifestyle; he had been an active competitive
runner and a lot of his confidence had had come from that. Once he’d been told to start using a stick and
be careful, he felt old and that everyone was looking at him, which led to panic attacks in his local
shopping mall. He wanted to do all of the things he’d always done and was almost looking for permission
to try. He had a lot of social anxiety regarding his bowling past time which he’d recently taken up. He
treated it in a similar way to his running career. He had to do his best and push himself the entire time.
If he played poorly he found it difficult to look anyone in the eye. We spent a lot of time talking through
and challenging his thoughts, and trying to get him to see his situation from a different view point. By the
end of the sessions, he was back at the running track walking significant distances. He was going to the
gym two to three times per week and attending his bowls without the anxiety. At the 6-month follow-up
this gentleman was continuing to play bowls regularly and without the performance anxiety that he had
experienced. He had stopped going to the running track in favour of walking around the cricket pitch as it
was more picturesque. He was having problems with his back that might require surgery, but there
seemed to be a reluctance to do anything or push any further.
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Summary for client 3514 (ST3)
Basic formulation: Predisposing: Smoker
Precipitating: Knee replaced
Falls before knee replacement but not since
Anaemic
Perpetuating: HCB Bodily sensations
Knee pain and stiffness
Dizzy spells
Low energy
Doing
Less active,
Less walking
Stopped getting bus
Thinking
Will my knee hold my weight?
Feeling
Anxious
Fear of falling
Low confidence
Low mood
Intervention focus (target): 1. Fear/anxiety/confidence
2. Mood
3. Energy
Outcome: 1. More confidence, no longer worry about falling
2. Mood much improved
3. Energy ‘fantastic’
Goals Initial difficulty rating Review rating End rating
Get the bus (×2) to daughters 6 2 – done 0 – done
Go up and down the stairs 7 2 – done 2 – done
To walk up to the shop and back 7 2 – done 0 – done
Therapist rating:
In your opinion how engaged with the treatment was the patient?
1 2 3 4 5 6 ■7
Never did any work Constantly completed all work, often did extra
Brief overview of therapy and progress
Prior to having the knee replaced, she suffered from a lot of pain, stiffness and weakness, and it would
often give out. This resulted in a number of falls, lack of confidence and increased anxiety levels. This was
hampered by dizzy spells and low energy levels. All of which resulted in a lack of activity, less walking and
low mood. The treatment therefore focused on graded exposure for walking and activity. She engaged
very well right from the beginning. She started to walk a little more after the first session and even had
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potential goals ready for the beginning of the second session. She did all of the homework, and more,
each week, and really felt the benefit early in the treatment. Her mood improved quickly, along with her
energy levels and appetite. She also recorded her sleeping pattern and we went through ways to improve
it, which also helped. By the end of the treatment she was getting out nearly every day, getting the bus
regularly without any problems, walking more often and further, kneeling again, and getting to the shops
without any issues. Her confidence and independence had both increased and she was no longer afraid to
put weight on her knee and felt less frightened. She felt like she was ‘back to how I used to be’. However,
by the 6-month follow-up she had experienced a major setback. She was diagnosed with lung cancer and
had it operated on. When I visited her she was still in the early stages of recovery. She was very weak, out
of breath and could not walk more than a few feet. On top of this she had a lot of family disputes
occurring between her daughters, which made things a lot worse. The 6-month visit consisted of an
update of her health issues and support for her family issues. The 6-month session sheet was not fully
completed, as a lot of the questions were not applicable, and she asked for it not to be audio recorded, as
her ex-husband was also in the STRIDE study and she felt uncomfortable talking to me about the family
issue with the recorder on.
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Appendix 7 Resource utilisation form
The following questions are about the number of times you visited or talked to health care 
professionals.  They are only about either your difficulties in walking and going about your 
usual activities or because of any falls you might have had. There is also a question about the 
amount of help and support you required from family and friends. 
1. Over the last six months how many times have you visited your general practitioner 
(GP) because of a fall or because of your difficulties in walking and going about your 
usual activities? 
a. GP visits because of difficulties in walking and going about your usual 
activities        ______ 
b. GP visits due to a fall       ______ 
 
2. Over the last six months how many times have you visited other health professionals 
at your general practice, for instance the practice nurse, because of a fall or because of 
your difficulties in walking and going about your usual activities? 
 
a. Other general practice visits because of difficulties in walking and going about 
your usual activities       ______ 
b. Other general practice visits because of a fall    ______ 
 
3. Over the last six months how many times has your GP, or other doctor, visited you at 
home because of a fall or because of your difficulties in walking and going about your 
usual activities? 
a. GP home visits because of difficulties in walking and going about your usual 
activities        ______ 
b. GP home visits due to a fall      ______ 
4. Over the last six months how many times have other health care workers, for example 
district nurses, visited you at home because of a fall or because of your difficulties in 
walking and going about your usual activities? 
a. Other healthcare workers home visits because of difficulties in walking and 
going about your usual activities     ______ 
b. Other healthcare workers home visits due to a fall   ______ 
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5. Over the last six months, have you been admitted to hospital because of a fall? (if you 
were not admitted to hospital for either of these reasons please go to question 7) 
 
a. Number of hospital admissions because of a fall    ______ 
 
6. For each hospital admission 
a. Number of days spent in hospital?  ______ ______ ______ 
b. What was the name of the hospital? ______ ______ ______ 
c. What injury did you suffer when you fell 
(A fractured hip, for example) ______ ______ ______  
 
7. Over the last six months, have you visited hospital as an outpatient because of your 
difficulties in walking and going about your usual activities or because of a fall? (if 
you were not admitted to hospital for either of these reasons please go to question 9) 
 
a. Number of visits because difficulties in walking and going about your usual 
activities        ______ 
 
b. Number of visits because of a fall      ______ 
c.  
8. During an average week over the past six months how much time do your family and 
friends spend helping you with activities that you would otherwise be able to 
undertake were it not for your difficulties in walking and going about your usual 
activities or because of a fall? 
a. Average number of hours spent per week  because of difficulties in walking 
and going about your usual activities      ______ 
 
b. Average number of hours spent per week due to having fallen ______ 
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